<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ment Health Clin</journal-id><journal-id journal-id-type="iso-abbrev">Ment Health Clin</journal-id><journal-id journal-id-type="pmc-domain-id">3479</journal-id><journal-id journal-id-type="pmc-domain">tmch</journal-id><journal-id journal-id-type="publisher-id">mhcl</journal-id><journal-title-group><journal-title>The Mental Health Clinician</journal-title></journal-title-group><issn pub-type="epub">2168-9709</issn><publisher><publisher-name>American Association of Psychiatric Pharmacists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10836561</article-id><article-id pub-id-type="pmcid-ver">PMC10836561.1</article-id><article-id pub-id-type="pmcaid">10836561</article-id><article-id pub-id-type="pmcaiid">10836561</article-id><article-id pub-id-type="pmid">38312443</article-id><article-id pub-id-type="doi">10.9740/mhc.2024.02.033</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Literature Review</subject></subj-group></article-categories><title-group><article-title>Systematic literature review of the impact of psychiatric pharmacists</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4434-6981</contrib-id><name name-style="western"><surname>Ho</surname><given-names initials="JL">Jessica L.</given-names></name><degrees>PharmD, BCPP, BCPS</degrees></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0314-8265</contrib-id><name name-style="western"><surname>Roberts</surname><given-names initials="J">Jenna</given-names></name><degrees>PharmD, BCPP</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8592-7280</contrib-id><name name-style="western"><surname>Payne</surname><given-names initials="GH">Gregory H.</given-names></name><degrees>MBA, CAE</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5163-1158</contrib-id><name name-style="western"><surname>Holzum</surname><given-names initials="DN">Dorothy N.</given-names></name><degrees>PharmD, BCPP, BCPS</degrees><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4809-9367</contrib-id><name name-style="western"><surname>Wilkoff</surname><given-names initials="H">Hannah</given-names></name><degrees>PharmD, BCPP</degrees><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0537-7566</contrib-id><name name-style="western"><surname>Tran</surname><given-names initials="T">Tran</given-names></name><degrees>PharmD, BCPS</degrees><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0827-5485</contrib-id><name name-style="western"><surname>Cobb</surname><given-names initials="CD">Carla D.</given-names></name><degrees>PharmD, BCPP</degrees><xref rid="aff7" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9781-6545</contrib-id><name name-style="western"><surname>Moore</surname><given-names initials="TD">Tera D.</given-names></name><degrees>PharmD, BCACP</degrees><xref rid="aff8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1674-4210</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="KC">Kelly C.</given-names></name><degrees>PharmD, MAS, BCPP</degrees><xref rid="aff9" ref-type="aff">9</xref></contrib></contrib-group><aff id="aff2"><label>2</label>Clinical Pharmacist, St. Peter Regional Treatment Center, St. Peter, Minnesota</aff><aff id="aff3"><label>3</label>Director of Strategic Initiatives, American Association of Psychiatric Pharmacists, Lincoln, Nebraska</aff><aff id="aff4"><label>4</label>Pain Management/Substance Use Disorder Clinical Pharmacy Practitioner, VISN 20 Clinical Resource Hub, Boise, Idaho</aff><aff id="aff5"><label>5</label>Clinical Pharmacy Specialist- Behavioral Health, Adventist HealthCare Shady Grove Medical Center, Rockville, Maryland</aff><aff id="aff6"><label>6</label>Medical Science Liaison, Medical Affairs, Braeuburn, Plymouth Meeting, Pennsylvania; Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois</aff><aff id="aff7"><label>7</label>Founder and Consultant, Capita Consulting, Billings, Montana</aff><aff id="aff8"><label>8</label>National Program Manager, Clinical Pharmacy, Clinical Practice Integration and Model Advancement Pharmacy Benefits Management (PBM), Colorado</aff><aff id="aff9"><label>9</label>Professor of Clinical Pharmacy, University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, California</aff><author-notes><corresp id="cor1"><label>1</label>(Corresponding author) Clinical Pharmacy Specialist, Psychiatry and Pharmacogenomics, Kaiser Permanente of the Mid-Atlantic States, Burke, Virginia, <email>jessicaho108@gmail.com</email></corresp></author-notes><pub-date pub-type="collection"><month>2</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>1</day><month>2</month><year>2024</year></pub-date><volume>14</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">454989</issue-id><fpage>33</fpage><lpage>67</lpage><history><date date-type="received"><day>25</day><month>7</month><year>2023</year></date><date date-type="accepted"><day>1</day><month>12</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>03</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-22 17:25:33.850"><day>22</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/3.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="i2168-9709-14-1-33.pdf"/><abstract><sec><title>Introduction</title><p>Pharmacists focusing on psychotropic medication management and practicing across a wide variety of healthcare settings have significantly improved patient-level outcomes. The Systematic Literature Review Committee of the American Association of Psychiatric Pharmacists was tasked with compiling a comprehensive database of primary literature highlighting the impact of psychiatric pharmacists on patient-level outcomes.</p></sec><sec><title>Methods</title><p>A systematic search of literature published from January 1, 1961, to December 31, 2022, was conducted using PubMed and search terms based on a prior American Association of Psychiatric Pharmacists literature review. Publications describing patient-level outcome results associated with pharmacist provision of care in psychiatric/neurologic settings and/or in relation to psychotropic medications were included. The search excluded articles for which there was no pharmacist intervention, no psychiatric disorder treatment, no clinical outcomes, no original research, no access to full text, and/or no English-language version.</p></sec><sec><title>Results</title><p>A total of 4270 articles were reviewed via PubMed, with 4072 articles excluded based on title, abstract, and/or full text in the initial pass and 208 articles selected for inclusion. A secondary full-text review excluded 11 additional articles, and 5 excluded articles were ultimately included based on a secondary review, for a final total of 202 articles meeting the inclusion criteria. A comprehensive database of these articles was compiled, including details on their study designs and outcomes.</p></sec><sec><title>Discussion</title><p>The articles included in the final database had a wide range of heterogeneity. While the overall impact of psychiatric pharmacists was positive, the study variability highlights the need for future publications to have more consistent, standardized outcomes with stronger study designs.</p></sec></abstract><kwd-group><kwd>patient-level outcome</kwd><kwd>pharmacist</kwd><kwd>psychiatry</kwd><kwd>systematic review</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>In 2020, approximately 1 in 5 adults in the United States were living with a psychiatric disorder, which translates to approximately 52.9 million individuals.<xref rid="i2168-9709-14-1-33-b01" ref-type="bibr">1</xref> Additionally, an average of 17% of young people experience an emotional, mental, or behavioral disorder.<xref rid="i2168-9709-14-1-33-b02" ref-type="bibr">2</xref> Psychotropic medications make up nearly 20% of the treatment approaches for psychiatric disorders.<xref rid="i2168-9709-14-1-33-b03" ref-type="bibr">3</xref> Therefore, optimizing the safe and effective use of psychiatric medications is paramount. Pharmacists focusing on psychotropic medications and practicing across a wide variety of healthcare settings have significantly improved patient-level outcomes, including attaining therapeutic goals, improving medication adherence, managing adverse effects, and avoiding hospitalizations.<xref rid="i2168-9709-14-1-33-b04" ref-type="bibr">4</xref> In 1996, the Board-Certified Psychiatric Pharmacist (BCPP) credential was established, further demonstrating pharmacists&#8217; expertise with appropriate training in managing these disorders.</p><p>Abundant evidence exists regarding pharmacist practices and their impact on patient care in psychiatric and neurologic settings. The American Association of Psychiatric Pharmacists (AAPP) Systematic Literature Review Committee developed a methodology to review articles highlighting psychiatric pharmacists&#8217; impact on medication-related outcomes. The methodology provides a mechanism to identify newly published literature to continuously add to the current research outcomes, further supporting the impact of psychiatric pharmacists in a systematic approach.</p><p>This project aimed to identify, review, and evaluate primary literature published up to December 31, 2022, highlighting the improved patient-level, medication-related outcomes psychiatric pharmacists achieve as a part of the healthcare team.</p></sec><sec id="s2"><title>Methods</title><p>A systematic search of literature published from January 1, 1961, to December 31, 2022, was conducted using PubMed. Limiting articles to PubMed ensured that all relevant studies were found in journals that abide by specific quality standards. PubMed also supports complex search queries and can export all results in a structured format; articles dating only as far back as 1961 were returned in the match. Other databases were excluded because the output required to review these additional articles would result in diminishing returns.</p><p>The search terms from the previous AAPP literature review<xref rid="i2168-9709-14-1-33-b04" ref-type="bibr">4</xref> were expanded to include disease-state terms associated with all categories of major psychiatric disorders and select major neurologic disorders with psychiatric manifestations that are primarily or secondarily treated with psychotropic medications (<xref rid="i2168-9709-14-1-33-t01" ref-type="table">Table 1</xref>).<xref rid="i2168-9709-14-1-33-b04" ref-type="bibr">4</xref> The search was limited to papers with at least 1 &#8220;pharmacist&#8221; and 1 &#8220;psychiatric&#8221; term. Articles were additionally excluded based on article type and title keywords that strongly indicated that the article was not original clinical research. Terms such as &#8220;pain&#8221; were omitted from the query, such that pain studies were only included when they involved psychiatric comorbidity(ies).</p><table-wrap position="float" id="i2168-9709-14-1-33-t01" orientation="portrait"><label>TABLE 1</label><caption><p>PubMed search criteria</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb1col1" align="left" charoff="0" char="" span="1"/><col id="tb1col2" align="char" charoff="0" char="." span="1"/><col id="tb1col3" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" colspan="3" rowspan="1">
<bold>Pharmacist Terms</bold>
<hr/>
</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1">BCPP Pharmacist</td><td rowspan="1" colspan="1">Pharmacists</td><td rowspan="1" colspan="1">Pharmacy led</td></tr><tr><td align="left" colspan="3" rowspan="1">
<bold>Psychiatric Terms</bold>
</td></tr><tr><td rowspan="1" colspan="1">ADHD Addiction Agoraphobia Alcohol use disorder Alcohol withdrawal Alzheimer Alzheimer&#8217;s Anorexia nervosa Antidepressant Antipsychotics Anxiety disorder Anxiety disorders Anxiolytic Attention-deficit hyperactivity Autism BCPP Beers Criteria Behavioral health Bereavement Binge Bipolar Bulimia nervosa Buprenorphine Catatonia Delirium Delusional disorder Dementia Depression Dysphoric Eating disorder Epilepsy Extrapyramidal</td><td rowspan="1" colspan="1">Gender dysphoria Huntington disease Huntington&#8217;s disease Hypnotic Insomnia Intellectual disability LAI LAI-A Long-acting injectable MDD Major depressive disorder Mania Mental health Mental illness Mental illnesses Mood stabilizer Movement disorder Narcolepsy Neurocognitive disorder Neurocognitive disorders Neurodevelopmental Neuroleptic malignant syndrome Neurologic Neurology Obsessive-compulsive Opiates Opioid PTSD Panic disorder Panic disorders Panic symptoms</td><td rowspan="1" colspan="1">Parasomnia Parkinson Parkinson&#8217;s Personality disorders Posttraumatic stress Premenstrual dysphoric Psychiatric Psychiatry Psychosis Psychotic Psychotropic interactions Psychotropics Schizoaffective Schizophrenia Seizure Smoking cessation Stimulant use Stimulant withdrawal Substance use disorder Suicidal Suicidality Suicide TBI Tardive dyskinesia Tobacco cessation Tourette Tourette&#8217;s Transgender Traumatic brain injury Treatment-seeking smokers&#8201;&#8201;&#8201;&#8201;&#8201; Trichotillomania</td></tr><tr><td align="left" colspan="3" rowspan="1">
<bold>Excluded Title Terms</bold>
</td></tr><tr><td rowspan="1" colspan="1">Case report Case series Consensus paper Consensus statement Mice</td><td rowspan="1" colspan="1">Monkey Monkeys Mouse Pharmacy education Pharmacy student</td><td rowspan="1" colspan="1">Placebo Rat Systematic analysis Systematic review</td></tr><tr><td align="left" colspan="3" rowspan="1">
<bold>Excluded Publication Types</bold>
</td></tr><tr><td rowspan="1" colspan="1">Bibliography Case reports Comment Congress Editorial Interview</td><td rowspan="1" colspan="1">Lecture Letter Meta-analysis News Newspaper article Preprint</td><td rowspan="1" colspan="1">Published erratum Retracted publication Retraction of publication Review Systematic review</td></tr></tbody></table><table-wrap-foot><fn><p>ADHD = attention-deficit/hyperactivity disorder; BCPP = Board-Certified Psychiatric Pharmacist; LAI = long-acting injectable; LAI-A = long-acting injectable antipsychotic; PTSD = posttraumatic stress disorder; TBI = traumatic brain injury.</p></fn></table-wrap-foot></table-wrap><p>A final search of PubMed was performed on January 10, 2023, with a publication date filter of December 31, 2022. The results from PubMed were loaded into a spreadsheet to track inclusion and exclusion. The author group completed manual reviews of each article and documented inclusion or exclusion on the spreadsheet. Any questionable articles were brought to the group for further discussion. An article was manually excluded if it met any of the following 6 criteria:
<list list-type="order"><list-item><p>No pharmacist intervention</p></list-item><list-item><p>No treatment of psychiatric disorder</p></list-item><list-item><p>No clinical outcomes</p></list-item><list-item><p>Not original research</p></list-item><list-item><p>No full-text access</p></list-item><list-item><p>No English-language version</p></list-item></list></p><p>A second reviewer evaluated at least 5% of excluded articles, predetermined by the authors, to confirm the accuracy and appropriateness of the exclusion. Publications with results describing patient-level outcomes associated with pharmacist provision of care in psychiatric/neurologic settings and/or in relation to psychotropic medications were included. <xref rid="i2168-9709-14-1-33-t02" ref-type="table">Table 2</xref> lists each study evaluator&#8217;s characterization and description of the study design and outcome measures. The quadruple aims, which include improved care, reduced healthcare costs, improved patient experience, and improved healthcare provider well-being, were also tracked for included articles to enhance outcomes data.</p><table-wrap position="float" id="i2168-9709-14-1-33-t02" orientation="portrait"><label>TABLE 2</label><caption><p>Study characteristics</p></caption><table frame="hsides" rules="none"><tbody valign="top"><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">
<bold>Studies (%)</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Practice Characteristic</bold>
</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Patient Age Group</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Adults</td><td rowspan="1" colspan="1">148 (73.2)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Multiple</td><td rowspan="1" colspan="1">26 (12.9)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Seniors (&#8805; 65 y)</td><td rowspan="1" colspan="1">21 (10.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Children (&lt; 18 y)</td><td rowspan="1" colspan="1">3 (1.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Other</td><td rowspan="1" colspan="1">1 (0.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Unknown</td><td rowspan="1" colspan="1">3 (1.5)</td></tr><tr><td rowspan="1" colspan="1">Types of Disorders Treated</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Psychiatric</td><td rowspan="1" colspan="1">125 (61.9)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Both psychiatric and medical</td><td rowspan="1" colspan="1">49 (24.2)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Neurologic</td><td rowspan="1" colspan="1">22 (10.9)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Medical</td><td rowspan="1" colspan="1">4 (2.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Other</td><td rowspan="1" colspan="1">1 (0.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Unknown</td><td rowspan="1" colspan="1">1 (0.5)</td></tr><tr><td rowspan="1" colspan="1">Treatment Settings</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Outpatient general</td><td rowspan="1" colspan="1">50 (24.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Outpatient specialty</td><td rowspan="1" colspan="1">42 (20.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Community pharmacy</td><td rowspan="1" colspan="1">37 (18.3)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Inpatient</td><td rowspan="1" colspan="1">36 (17.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Primary care</td><td rowspan="1" colspan="1">15 (7.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Long-term care facility</td><td rowspan="1" colspan="1">9 (4.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Other</td><td rowspan="1" colspan="1">11 (5.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Unknown</td><td rowspan="1" colspan="1">2 (1.0)</td></tr><tr><td rowspan="1" colspan="1">Countries</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;United States</td><td rowspan="1" colspan="1">114 (56.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;United Kingdom</td><td rowspan="1" colspan="1">15 (7.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Canada</td><td rowspan="1" colspan="1">9 (4.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Australia</td><td rowspan="1" colspan="1">8 (4.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Thailand</td><td rowspan="1" colspan="1">5 (2.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Spain</td><td rowspan="1" colspan="1">4 (2.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Germany</td><td rowspan="1" colspan="1">4 (2.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Japan</td><td rowspan="1" colspan="1">4 (2.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;The Netherlands</td><td rowspan="1" colspan="1">3 (1.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Malaysia</td><td rowspan="1" colspan="1">3 (1.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;India</td><td rowspan="1" colspan="1">3 (1.5)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Other (1-2 per country)</td><td rowspan="1" colspan="1">30 (14.9)</td></tr><tr><td rowspan="1" colspan="1">
<bold>Study Design Characteristic</bold>
</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Prospective vs retrospective</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Prospective</td><td rowspan="1" colspan="1">137 (67.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Retrospective</td><td rowspan="1" colspan="1">65 (32.2)</td></tr><tr><td rowspan="1" colspan="1">Controlled vs open</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Open</td><td rowspan="1" colspan="1">119 (58.9)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Controlled</td><td rowspan="1" colspan="1">83 (41.1)</td></tr><tr><td rowspan="1" colspan="1">Randomized vs nonrandomized</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Nonrandomized</td><td rowspan="1" colspan="1">114 (56.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Randomized</td><td rowspan="1" colspan="1">71 (35.1)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Unknown</td><td rowspan="1" colspan="1">17 (8.4)</td></tr><tr><td rowspan="1" colspan="1">Comparison</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Comparison group</td><td rowspan="1" colspan="1">112 (55.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;No comparison</td><td rowspan="1" colspan="1">44 (21.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Pre/post</td><td rowspan="1" colspan="1">42 (20.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Unknown</td><td rowspan="1" colspan="1">4 (2.0)</td></tr><tr><td rowspan="1" colspan="1">Outcome measures<xref rid="T2n1" ref-type="table-fn">a</xref></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Response</td><td rowspan="1" colspan="1">141 (69.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Medication-based</td><td rowspan="1" colspan="1">60 (29.7)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Patient experience/adherence</td><td rowspan="1" colspan="1">48 (23.8)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Resource utilization</td><td rowspan="1" colspan="1">47 (23.3)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Adverse outcome</td><td rowspan="1" colspan="1">24 (11.9)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Cost-based</td><td rowspan="1" colspan="1">19 (9.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Time-based</td><td rowspan="1" colspan="1">17 (8.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Retention or referral</td><td rowspan="1" colspan="1">13 (6.4)</td></tr><tr><td rowspan="1" colspan="1">Quadruple Aims<xref rid="T2n1" ref-type="table-fn">a</xref></td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;Better care</td><td rowspan="1" colspan="1">202 (100.0)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Improved patient experience</td><td rowspan="1" colspan="1">45 (22.3)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Reduced health care costs</td><td rowspan="1" colspan="1">27 (13.4)</td></tr><tr><td rowspan="1" colspan="1">&#8195;Provider well-being</td><td rowspan="1" colspan="1">1 (0.5)</td></tr></tbody></table><table-wrap-foot><fn id="T2n1"><label>a</label><p>Percentages do not sum to 100% because multiple options could apply to 1 study.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3"><title>Results</title><p>The <xref rid="i2168-9709-14-1-33-f01" ref-type="fig">Figure</xref> depicts the article identification, screening and eligibility, and total articles selected. A total of 4270 articles were pulled for review via PubMed. The study authors excluded 4072 articles based on title, abstract, and/or full text in the initial pass, with 208 articles selected for inclusion. The authors completed a second review of 7.5% of the articles, rather than the planned 5%. After a secondary review, 11 articles initially included were excluded, and 5 of 307 articles excluded were included, leaving a final total of 202 articles meeting the inclusion criteria (see Appendix). The top 6 journals by article count were the <italic toggle="yes">Journal of the American Pharmacists Association</italic> (14), the <italic toggle="yes">Mental Health Clinician</italic> (11), the <italic toggle="yes">American Journal of Health-System Pharmacy</italic> (8), the <italic toggle="yes">American Journal of Hospital Pharmacy</italic> (6), the <italic toggle="yes">Annals of Pharmacotherapy</italic> (6), and <italic toggle="yes">Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy</italic> (6). Over half of these articles were published in the United States. Patient demographics and other study characteristics are presented in <xref rid="i2168-9709-14-1-33-t02" ref-type="table">Table 2</xref>.</p><fig position="float" id="i2168-9709-14-1-33-f01" orientation="portrait"><label>FIGURE</label><caption><p>Review flow diagram</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="i2168-9709-14-1-33-f01.jpg"/></fig><p>All applicable outcome measures and quadruple aims for each study were included during the study review, resulting in a total percentage exceeding 100 for each of these characteristics. Response to study treatment was the most common outcome measure in 141 total studies (69.5%). Other outcome measures tracked in the order of most to least frequent were medication-based (60 studies), patient experience/adherence (48), resource utilization (47), adverse outcome (24), cost-based (19), time-based (17), and retention/referral (13). Of the studies, 57% had more than 1 applicable outcome measure. Quadruple aims tracked from the most to least frequent were better care (202 studies; 4.5% had negative outcomes), improved patient experience (45), reduced health care costs (27; 3.7% had negative outcomes), and provider well-being (1). Almost one-fourth of the studies (23.8%) had more than 1 applicable quadruple aim.</p><p>Tobacco use disorder and major depressive disorder (MDD) were the most frequently assessed disease states, accounting for 38 and 27 included studies, respectively. All other specified disease states accounted for less than 10 included articles each, while a total of 81 (40.1%) did not specify the disease state being evaluated. In the general outpatient and community settings, psychiatric pharmacists increased smoking cessation response rates through methods such as behavioral counseling and/or nicotine replacement therapy.<xref rid="i2168-9709-14-1-33-b05" ref-type="bibr">5&#8211;10</xref> Psychiatric pharmacists improved depression symptom scores in various clinical settings. Inpatients demonstrated reductions in the Hamilton Depression Rating Scale and the Patient Health Questionnaire-9 symptom scores.<xref rid="i2168-9709-14-1-33-b11" ref-type="bibr">11</xref>,<xref rid="i2168-9709-14-1-33-b12" ref-type="bibr">12</xref> Patient Health Questionnaire-9 scores improved for patients in outpatient general, outpatient specialty, and community pharmacy settings when a psychiatric pharmacist was involved in their care. Patients diagnosed with depression had enhanced medication adherence.<xref rid="i2168-9709-14-1-33-b13" ref-type="bibr">13&#8211;16</xref> Patients seeking treatment for multiple disease states, including smoking cessation, depression, post-stroke/transient ischemic attack, and neurological disorders, reported better satisfaction and attitudes.<xref rid="i2168-9709-14-1-33-b05" ref-type="bibr">5</xref>,<xref rid="i2168-9709-14-1-33-b08" ref-type="bibr">8</xref>,<xref rid="i2168-9709-14-1-33-b10" ref-type="bibr">10</xref>,<xref rid="i2168-9709-14-1-33-b16" ref-type="bibr">16&#8211;31</xref> Representing 72.8% of authorship, patients in long-term care facilities, outpatient general clinics, inpatient, primary care clinics, and community settings demonstrated improved satisfaction and attitudes when a psychiatric pharmacist was involved in their care.<xref rid="i2168-9709-14-1-33-b14" ref-type="bibr">14</xref>,<xref rid="i2168-9709-14-1-33-b18" ref-type="bibr">18</xref>,<xref rid="i2168-9709-14-1-33-b24" ref-type="bibr">24</xref>,<xref rid="i2168-9709-14-1-33-b32" ref-type="bibr">32&#8211;36</xref> In addition, the presence of a psychiatric pharmacist improved the number of patients seen per month, the hours of direct care provided, the number of patient contacts, rehospitalization rates, the number of medications prescribed, and the length of stay.<xref rid="i2168-9709-14-1-33-b37" ref-type="bibr">37&#8211;50</xref></p><p>Most of the included studies (83.2%) did not report any Board of Pharmacy Specialties (BPS) certification, including BCPP designation, or other advanced clinical training among the researchers. Some studies without evidence of BPS certification were published before the establishment of BCPP designation. Only 24 (11.9%) articles had at least 1 BCPP mentioned in the body of the paper as a part of the intervention. Eleven (5.4%) included authors with non-psychiatric certifications. The number of BCPPs represented in authorship varied by year, but no trend could be identified. Of the 64 articles from 2020 to 2022, 8 (12.5%) had at least 1 BCPP represented based on details included in the article, and 2 (3.1%) had at least 1 author with a non-psychiatric BPS certification. While BPS may not have been explicitly mentioned in the article, intervention by a &#8220;psychiatric pharmacist&#8221; was noted based on the description of the pharmacists&#8217; training and/or experience, such as completing a psychiatric pharmacy residency or years of experience in the psychiatric setting.</p></sec><sec id="s4"><title>Discussion</title><p>With 4270 articles reviewed, this was the most extensive and comprehensive evaluation of primary literature to date, highlighting the impact of psychiatric pharmacists on patient-level outcomes. The database underscores the wide range of clinical settings psychiatric pharmacists practice as well as the varied outcomes measured by their efforts. Additionally, through medication management, quadruple aims for mental healthcare were included such as improved care, reduced costs, patient experience, and provider well-being.</p><p>This review largely aligned with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), which aims to improve the reporting of systematic reviews and meta-analyses. However, there were slight deviations, such as not specifying effect measures because of the heterogeneity of the studies included and lack of certainty or confidence assessment except through a 7.5% rereview process. Although a rereview of all the articles would be ideal for verification, the authors only found a small number of articles either incorrectly included or excluded based on the second review.</p><p><xref rid="i2168-9709-14-1-33-f01" ref-type="fig">Figure 1</xref> follows the PRISMA template flow diagram detailing the identification of studies. The evidence identified and included in this report was limited to PubMed and may be considered too restrictive. While excluding non-PubMed studies is a limitation, an analysis showed that 90% (57/63) of the studies identified in the previous AAPP literature review<xref rid="i2168-9709-14-1-33-b04" ref-type="bibr">4</xref> are cataloged in PubMed, and 4 more were from the backfiles of journals that are now indexed. Additional studies may have been found through backward citation searching; however, this was not performed. Title, abstract, or full-text review were all used to exclude articles, but the proportion of articles excluded from each type of review was not quantified. An additional review of the excluded articles performed by a different reviewer on 7.5% of the articles resulted in the inclusion of 1.6% of those previously excluded articles. A total of 20 articles (0.5%) were excluded on the basis of inability to access the full text, which could be seen as a limitation. Reviewers made a reasonable attempt to obtain the full text of each article before marking it for exclusion.</p><p>Many of the studies (39, 19.3%) identified in this report were focused on tobacco cessation. This finding could pose a potential bias in the body of evidence as it may not be the most reflective of psychiatric pharmacy clinical practice. None of the tobacco cessation articles specified that a BCPP performed the intervention in the study design. A prior AAPP survey reviewing the current practice of psychiatric pharmacists in the United States<xref rid="i2168-9709-14-1-33-b17" ref-type="bibr">17</xref> found that the psychiatric conditions most commonly managed by BCPPs were depressive disorders, followed by anxiety disorders, bipolar disorders, and schizophrenia, which was not representative of the included articles. While some studies included details, such as pharmacist type, level of experience, or years of training, sufficient detail was not reported in 82.2% of the included studies, which may have offered more opportunities for critical appraisal. Because the body of evidence spanned 7 decades, the results in this report are limited by a lack of context, given how health systems and credentials for psychiatric pharmacists have evolved over time. Many excluded studies focused solely on adherence and economic outcomes, both of which are imperfect extrapolations of patient outcomes. Thus, focusing more on patient-level outcomes in such studies will be more compelling.</p><p>Despite these limitations, most outcomes in the articles included showed positive results. This may be a reflection of positive publication bias. Of the studies included, no trends were seen among those with negative outcomes. While the article selection process was not limited by year, the number of results since 1996 dramatically increased, potentially corresponding with the standardization of psychiatric pharmacy residencies with the goal of improving the quality of care provided by psychiatric pharmacists and the creation of the BCPP certification.<xref rid="i2168-9709-14-1-33-b51" ref-type="bibr">51</xref> As the number of BCPPs continues to grow, perhaps it would follow that the positive contributions toward patient care will expand as well. While the focus of the individual studies and the variety of outcomes found is problematic for aggregation, it nevertheless demonstrates the flexibility and wide scope of the BCPP role in patient care.</p><p>Only 36 (17.8%) articles reported sufficient detail related to study design, pharmacist training, and collaborators; only 20 of those articles had a duration of 1 year or longer. Also, the practice settings observed in the included articles do not reflect those observed by a prior AAPP survey.<xref rid="i2168-9709-14-1-33-b17" ref-type="bibr">17</xref> Almost half of the respondents in that study practiced in a hospital inpatient setting (47.6%), while some respondents worked in both hospital inpatient and outpatient settings (13.8%). In comparison, only 17.8% of the included articles in this review were based in inpatient settings. Most of the included articles involved a community setting, which was not specifically mentioned as a BCPP practice site in the prior AAPP survey.<xref rid="i2168-9709-14-1-33-b17" ref-type="bibr">17</xref> Ultimately, the benefit BCPPs bring to the healthcare team is useful knowledge. However, insufficient details about the pharmacists, such as residency or fellowship training and years of experience, were provided in the included articles. In some cases, the articles included were published before the establishment of BCPP.</p><p>Patient outcome data would be more impactful if derived from randomized controlled trials; however, with the majority of psychiatric pharmacists focusing on direct patient care, time and funding dedicated to randomized controlled trials may be limited. While potentially challenging with institutional review boards, more studies involving vulnerable populations (eg, children and adolescents) could further highlight the role of psychiatric pharmacists in medication management in these specific populations. Additionally, standardizing the outcomes, measures, and reported study characteristics is necessary to improve the ability to aggregate results and replicate studies. By reporting standardized data, areas of opportunity for BCPPs can be identified. Expansion in areas such as provider status and reimbursement could be better supported by data clearly outlining quadruple aims like improved care and reduced cost.</p><p>Future systematic literature reviews could re-evaluate or expand upon the search terms used. In the current review, articles were required to use the word &#8220;pharmacist&#8221; in the indexed content, which may have excluded articles that did not reference pharmacists in any indexed content (eg, title, abstract, keywords). Future reviews could consider additional secondary reviews of excluded articles. Finally, while the quadruple aims are a useful framework, articles studying patient experience, healthcare costs, and provider well-being would have been excluded if they did not also address clinical outcomes (ie, improved care). Future reviews could consider inclusion criteria for the other aims.</p><p>The existing data illustrate the varied and impactful roles that psychiatric pharmacists play to benefit patient care as part of the interdisciplinary team. The AAPP Systematic Literature Review Committee will continue to monitor new research as it is performed and published.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors thank the board of directors of the American Association of Psychiatric Pharmacists for their support of this project. They also thank Joshua Holland, PharmD, BCPP, for his contribution to the literature evaluation.</p></ack><fn-group><fn fn-type="COI-statement"><p><bold>Disclosures:</bold> The authors have no conflicts of interest to disclose.</p></fn></fn-group><ref-list><title>References</title><ref id="i2168-9709-14-1-33-b01"><label>1</label><mixed-citation publication-type="webpage"><collab>National Institute of Mental Health [Internet]</collab>.
<article-title>Bethesda: US Department of Health and Human Services</article-title><comment>[updated 2023 Mar; cited 2022 Sept 27]. Mental Health [about 10 screens]. Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nimh.nih.gov/health/statistics/mental-illness" ext-link-type="uri">https://www.nimh.nih.gov/health/statistics/mental-illness</ext-link></mixed-citation></ref><ref id="i2168-9709-14-1-33-b02"><label>2</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention [Internet]</collab>.
<article-title>Atlanta: US Department of Health and Human Services</article-title><comment>[updated 2023 Mar 8; cited 2022 Sept 27]. Data and Statistics on Children&#8217;s Mental Health [about 9 screens]. Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/childrensmentalhealth/data.html" ext-link-type="uri">https://www.cdc.gov/childrensmentalhealth/data.html</ext-link></mixed-citation></ref><ref id="i2168-9709-14-1-33-b03"><label>3</label><mixed-citation publication-type="webpage"><collab>SAMHSA [Internet]</collab>.
<article-title>Rockville: Substance Abuse and Mental Health Services Administration</article-title><comment>[updated 2022; cited 2022 Sept 27]. National Mental Health Services Survey [about 2 screens]. Available from</comment>: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.samhsa.gov/data/quick-statistics-results?qs_type=nmhss&amp;state=United%20States&amp;year=2020" ext-link-type="uri">https://www.samhsa.gov/data/quick-statistics-results?qs_type=nmhss&amp;state=United%20States&amp;year=2020</ext-link></mixed-citation></ref><ref id="i2168-9709-14-1-33-b04"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Werremeyer</surname><given-names>A</given-names></name><name name-style="western"><surname>Bostwick</surname><given-names>J</given-names></name><name name-style="western"><surname>Cobb</surname><given-names>C</given-names></name><name name-style="western"><surname>Moore</surname><given-names>TD</given-names></name><name name-style="western"><surname>Park</surname><given-names>SH</given-names></name><name name-style="western"><surname>Price</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders</article-title><source>Ment Health Clin</source><year>2020</year><volume>10</volume><issue>(6)</issue><fpage>358</fpage>&#8211;<lpage>80</lpage><pub-id pub-id-type="doi">10.9740/mhc.2020.11.358</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33224694/" ext-link-type="uri">33224694</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653731" ext-link-type="uri">PMC7653731</ext-link><pub-id pub-id-type="pmid">33224694</pub-id><pub-id pub-id-type="pmcid">PMC7653731</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b05"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baluch</surname><given-names>WM.</given-names></name></person-group><article-title>Pharmacists&#8217; role in a smoking-cessation program at a health maintenance organization</article-title><source>Am J Health Syst Pharm</source><year>1995</year><volume>52</volume><issue>(3)</issue><fpage>287</fpage>&#8211;<lpage>93</lpage><pub-id pub-id-type="doi">10.1093/ajhp/52.3.287</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7749956/" ext-link-type="uri">7749956</ext-link></comment><pub-id pub-id-type="pmid">7749956</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b06"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>TE</given-names></name><name name-style="western"><surname>Crocker</surname><given-names>H</given-names></name><name name-style="western"><surname>Ruffin</surname><given-names>RE.</given-names></name></person-group><article-title>Smoking habits and cessation programme in an Australian teaching hospital</article-title><source>Aust N Z J Med</source><year>1998</year><volume>28</volume><issue>(4)</issue><fpage>446</fpage>&#8211;<lpage>52</lpage><pub-id pub-id-type="doi">10.1111/j.1445-5994.1998.tb02079.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/9777112/" ext-link-type="uri">9777112</ext-link></comment><pub-id pub-id-type="pmid">9777112</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b07"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zillich</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>M</given-names></name><name name-style="western"><surname>Adams</surname><given-names>A</given-names></name><name name-style="western"><surname>Yeager</surname><given-names>B</given-names></name><name name-style="western"><surname>Farris</surname><given-names>K.</given-names></name></person-group><article-title>Effectiveness of a pharmacist&#8208;based smoking&#8208;cessation program and its impact on quality of life</article-title><source>Pharmacotherapy</source><year>2002</year><volume>22</volume><issue>(6)</issue><fpage>759</fpage>&#8211;<lpage>65</lpage><pub-id pub-id-type="doi">10.1592/phco.22.9.759.34073</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12066966/" ext-link-type="uri">12066966</ext-link></comment><pub-id pub-id-type="pmid">12066966</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b08"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>MD</given-names></name><name name-style="western"><surname>MeGhan</surname><given-names>WF</given-names></name><name name-style="western"><surname>Lauger</surname><given-names>G.</given-names></name></person-group><article-title>Pharmacist counseling and outcomes of smoking cessation</article-title><source>Am Pharm</source><year>1995</year><volume>35</volume><issue>(8)</issue><fpage>20</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1016/s0160-3450(15)30095-7</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7677052/" ext-link-type="uri">7677052</ext-link></comment><pub-id pub-id-type="pmid">7677052</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b09"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calleja</surname><given-names>MA</given-names></name><name name-style="western"><surname>Perez</surname><given-names>S</given-names></name><name name-style="western"><surname>Martinez-Martinez</surname><given-names>F.</given-names></name></person-group><article-title>Pharmaceutical care in smoking cessation</article-title><source>Patient Prefer Adherence</source><year>2015</year><volume>9</volume>:
<fpage>209</fpage>&#8211;<lpage>15</lpage><pub-id pub-id-type="doi">10.2147/PPA.S67707</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25678779/" ext-link-type="uri">25678779</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319467" ext-link-type="uri">PMC4319467</ext-link><pub-id pub-id-type="pmid">25678779</pub-id><pub-id pub-id-type="pmcid">PMC4319467</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bouchet-Benezech</surname><given-names>B</given-names></name><name name-style="western"><surname>Champanet</surname><given-names>B</given-names></name><name name-style="western"><surname>Rouzaud</surname><given-names>P.</given-names></name></person-group><article-title>Smoking cessation at the pharmacy: feasibility and benefits based on a French observational study with six-month follow-up</article-title><source>Subst Abuse Rehabil</source><year>2018</year><volume>9</volume>:
<fpage>31</fpage>&#8211;<lpage>42</lpage><pub-id pub-id-type="doi">10.2147/SAR.S152186</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30046265/" ext-link-type="uri">30046265</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054276" ext-link-type="uri">PMC6054276</ext-link><pub-id pub-id-type="pmid">30046265</pub-id><pub-id pub-id-type="pmcid">PMC6054276</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Canales</surname><given-names>PL</given-names></name><name name-style="western"><surname>Dorson</surname><given-names>PG</given-names></name><name name-style="western"><surname>Crismon</surname><given-names>ML.</given-names></name></person-group><article-title>Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting</article-title><source>Am J Health Syst Pharm</source><year>2001</year><volume>58</volume><issue>(14)</issue><fpage>1309</fpage>&#8211;<lpage>16</lpage><pub-id pub-id-type="doi">10.1093/ajhp/58.14.1309</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11471478/" ext-link-type="uri">11471478</ext-link></comment><pub-id pub-id-type="pmid">11471478</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohd-Sidik</surname><given-names>S</given-names></name><name name-style="western"><surname>Akhtari-Zavare</surname><given-names>M</given-names></name><name name-style="western"><surname>Periasamy</surname><given-names>U</given-names></name><name name-style="western"><surname>Rampal</surname><given-names>L</given-names></name><name name-style="western"><surname>Fadhilah</surname><given-names>SI</given-names></name><name name-style="western"><surname>Mahmud</surname><given-names>R.</given-names></name></person-group><article-title>Effectiveness of chemotherapy counselling on self-esteem and psychological affects among cancer patients in Malaysia: randomized controlled trial</article-title><source>Patient Educ Couns</source><year>2018</year><volume>101</volume><issue>(5)</issue><fpage>862</fpage>&#8211;<lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2018.01.004</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29336859/" ext-link-type="uri">29336859</ext-link></comment><pub-id pub-id-type="pmid">29336859</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finley</surname><given-names>PR</given-names></name><name name-style="western"><surname>Rens</surname><given-names>HR</given-names></name><name name-style="western"><surname>Pont</surname><given-names>JT</given-names></name><name name-style="western"><surname>Gess</surname><given-names>SL</given-names></name><name name-style="western"><surname>Louie</surname><given-names>C</given-names></name><name name-style="western"><surname>Bull</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group><article-title>Impact of a collaborative pharmacy practice model on the treatment of depression in primary care</article-title><source>Am J Health Syst Pharm</source><year>2002</year><volume>59</volume><issue>(16)</issue><fpage>1518</fpage>&#8211;<lpage>26</lpage><pub-id pub-id-type="doi">10.1093/ajhp/59.16.1518</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12185826/" ext-link-type="uri">12185826</ext-link></comment><pub-id pub-id-type="pmid">12185826</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finley</surname><given-names>PR</given-names></name><name name-style="western"><surname>Rens</surname><given-names>HR</given-names></name><name name-style="western"><surname>Pont</surname><given-names>JT</given-names></name><name name-style="western"><surname>Gess</surname><given-names>SL</given-names></name><name name-style="western"><surname>Louie</surname><given-names>C</given-names></name><name name-style="western"><surname>Bull</surname><given-names>SA</given-names></name><etal>et al.</etal></person-group><article-title>Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial</article-title><source>Pharmacotherapy</source><year>2003</year><volume>23</volume><issue>(9)</issue><fpage>1175</fpage>&#8211;<lpage>85</lpage><pub-id pub-id-type="doi">10.1592/phco.23.10.1175.32760</pub-id><pub-id pub-id-type="pmid">14524649</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubio-Valera</surname><given-names>M</given-names></name><name name-style="western"><surname>Pujol</surname><given-names>MM</given-names></name><name name-style="western"><surname>Fern&#225;ndez</surname><given-names>A</given-names></name><name name-style="western"><surname>Pe&#241;arrubia-Mar&#237;a</surname><given-names>MT</given-names></name><name name-style="western"><surname>Trav&#233;</surname><given-names>P</given-names></name><name name-style="western"><surname>del Hoyo</surname><given-names>YL</given-names></name><etal>et al.</etal></person-group><article-title>Evaluation of a pharmacist intervention on patients initiating pharmacological treatment for depression: a randomized controlled superiority trial</article-title><source>Eur Neuropsychopharmacol</source><year>2013</year><volume>23</volume><issue>(9)</issue><fpage>1057</fpage>&#8211;<lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.euroneuro.2012.11.006</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23219937/" ext-link-type="uri">23219937</ext-link></comment><pub-id pub-id-type="pmid">23219937</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aljumah</surname><given-names>K</given-names></name><name name-style="western"><surname>Hassali</surname><given-names>MA.</given-names></name></person-group><article-title>Impact of pharmacist intervention on adherence and measurable patient outcomes among depressed patients: a randomised controlled study</article-title><source>BMC Psychiatry</source><year>2015</year><volume>15</volume>:
<fpage>219</fpage><pub-id pub-id-type="doi">10.1186/s12888-015-0605-8</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26376830/" ext-link-type="uri">26376830</ext-link></comment> Central PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574071" ext-link-type="uri">PMC4574071</ext-link><pub-id pub-id-type="pmid">26376830</pub-id><pub-id pub-id-type="pmcid">PMC4574071</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silvia</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KC</given-names></name><name name-style="western"><surname>Bostwick</surname><given-names>JR</given-names></name><name name-style="western"><surname>Cobb</surname><given-names>CD</given-names></name><name name-style="western"><surname>Goldstone</surname><given-names>LW</given-names></name><name name-style="western"><surname>Moore</surname><given-names>TD</given-names></name><etal>et al.</etal></person-group><article-title>Assessment of the current practice of psychiatric pharmacists in the United States</article-title><source>Ment Health Clin</source><year>2020</year><volume>10</volume><issue>(6)</issue><fpage>346</fpage>&#8211;<lpage>53</lpage><pub-id pub-id-type="doi">10.9740/mhc.2020.11.346</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33224692/" ext-link-type="uri">33224692</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653732" ext-link-type="uri">PMC7653732</ext-link><pub-id pub-id-type="pmid">33224692</pub-id><pub-id pub-id-type="pmcid">PMC7653732</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorevitch</surname><given-names>A</given-names></name><name name-style="western"><surname>Perl</surname><given-names>E.</given-names></name></person-group><article-title>The impact of clinical pharmacy intervention in a psychiatric hospital</article-title><source>J Clin Pharm Ther</source><year>1996</year><volume>21</volume><issue>(1)</issue><fpage>45</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2710.1996.89575895.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8737183/" ext-link-type="uri">8737183</ext-link></comment><pub-id pub-id-type="pmid">8737183</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kennedy</surname><given-names>DT</given-names></name><name name-style="western"><surname>Giles</surname><given-names>JT</given-names></name><name name-style="western"><surname>Chang</surname><given-names>ZG</given-names></name><name name-style="western"><surname>Small</surname><given-names>RE</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JH.</given-names></name></person-group><article-title>Results of a smoking cessation clinic in community pharmacy practice</article-title><source>J Am Pharm Assoc (Wash)</source><year>2002</year><volume>42</volume><issue>(1)</issue><fpage>51</fpage>&#8211;<lpage>6</lpage><pub-id pub-id-type="doi">10.1331/108658002763538071</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11833517/" ext-link-type="uri">11833517</ext-link></comment><pub-id pub-id-type="pmid">11833517</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doescher</surname><given-names>M</given-names></name><name name-style="western"><surname>Whinston</surname><given-names>M</given-names></name><name name-style="western"><surname>Goo</surname><given-names>A</given-names></name><name name-style="western"><surname>Cummings</surname><given-names>D</given-names></name><name name-style="western"><surname>Huntington</surname><given-names>J</given-names></name><name name-style="western"><surname>Saver</surname><given-names>B.</given-names></name></person-group><article-title>Pilot study of enhanced tobacco-cessation services coverage for low-income smokers</article-title><source>Nicotine Tob Res</source><year>2002</year><volume>4</volume><issue>(1)</issue><fpage>19</fpage>&#8211;<lpage>24</lpage><pub-id pub-id-type="doi">10.1080/14622200210128045</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11945215/" ext-link-type="uri">11945215</ext-link></comment><pub-id pub-id-type="pmid">11945215</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khan</surname><given-names>N</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Du</surname><given-names>J</given-names></name><name name-style="western"><surname>Tinker</surname><given-names>D</given-names></name><name name-style="western"><surname>Bachyrycz</surname><given-names>AM</given-names></name><name name-style="western"><surname>Namdar</surname><given-names>R.</given-names></name></person-group><article-title>Smoking cessation and its predictors: results from a community-based pharmacy tobacco cessation program in New Mexico</article-title><source>Ann Pharmacother</source><year>2012</year><volume>46</volume><issue>(9)</issue><fpage>1198</fpage>&#8211;<lpage>204</lpage><pub-id pub-id-type="doi">10.1345/aph.1P146</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22911338/" ext-link-type="uri">22911338</ext-link></comment><pub-id pub-id-type="pmid">22911338</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomas</surname><given-names>D</given-names></name><name name-style="western"><surname>Abramson</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bonevski</surname><given-names>B</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S</given-names></name><name name-style="western"><surname>Poole</surname><given-names>SG</given-names></name><name name-style="western"><surname>Paul</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>Integrating smoking cessation into routine care in hospitals&#8212;a randomized controlled trial</article-title><source>Addiction</source><year>2016</year><volume>111</volume><issue>(4)</issue><fpage>714</fpage>&#8211;<lpage>23</lpage><pub-id pub-id-type="doi">10.1111/add.13239</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26597421/" ext-link-type="uri">26597421</ext-link></comment><pub-id pub-id-type="pmid">26597421</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watanabe</surname><given-names>F</given-names></name><name name-style="western"><surname>Shinohara</surname><given-names>K</given-names></name><name name-style="western"><surname>Dobashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Amagai</surname><given-names>K</given-names></name><name name-style="western"><surname>Hara</surname><given-names>K</given-names></name><name name-style="western"><surname>Kurata</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>Assessment of assistance in smoking cessation therapy by pharmacies in collaboration with medical institutions&#8212;implementation of a collaborative drug therapy management protocol based on a written agreement between physicians and pharmacists</article-title><source>Yakugaku Zasshi</source><year>2016</year><volume>136</volume><issue>(9)</issue><fpage>1243</fpage>&#8211;<lpage>54</lpage><pub-id pub-id-type="doi">10.1248/yakushi.16-00013</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27592827/" ext-link-type="uri">27592827</ext-link></comment><pub-id pub-id-type="pmid">27592827</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papastergiou</surname><given-names>J</given-names></name><name name-style="western"><surname>Quilty</surname><given-names>LC</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Thiruchselvam</surname><given-names>T</given-names></name><name name-style="western"><surname>Jain</surname><given-names>E</given-names></name><name name-style="western"><surname>Gove</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: a randomized controlled trial</article-title><source>Clin Transl Sci</source><year>2021</year><volume>14</volume><issue>(4)</issue><fpage>1359</fpage>&#8211;<lpage>68</lpage><pub-id pub-id-type="doi">10.1111/cts.12986</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33641259/" ext-link-type="uri">33641259</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301569" ext-link-type="uri">PMC8301569</ext-link><pub-id pub-id-type="pmid">33641259</pub-id><pub-id pub-id-type="pmcid">PMC8301569</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Saffar</surname><given-names>N</given-names></name><name name-style="western"><surname>Abdulkareem</surname><given-names>A</given-names></name><name name-style="western"><surname>Abdulhakeem</surname><given-names>A</given-names></name><name name-style="western"><surname>Salah</surname><given-names>A-Q</given-names></name><name name-style="western"><surname>Heba</surname><given-names>M.</given-names></name></person-group><article-title>Depressed patients&#8217; preferences for education about medications by pharmacists in Kuwait</article-title><source>Patient Educ Couns</source><year>2008</year><volume>72</volume><issue>(1)</issue><fpage>94</fpage>&#8211;<lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.pec.2008.01.027</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18337052/" ext-link-type="uri">18337052</ext-link></comment><pub-id pub-id-type="pmid">18337052</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alves</surname><given-names>L</given-names></name><name name-style="western"><surname>Carlos</surname><given-names>J</given-names></name><name name-style="western"><surname>Rosana</surname><given-names>M</given-names></name><name name-style="western"><surname>Carneiro</surname><given-names>C</given-names></name><name name-style="western"><surname>Alberto</surname><given-names>L</given-names></name><name name-style="western"><surname>Regina</surname><given-names>A.</given-names></name></person-group><article-title>Assessment of the effectiveness of pharmacotherapy follow-up in patients treated for depression</article-title><source>J Manag Care Pharm</source><year>2013</year><volume>19</volume><issue>(3)</issue><fpage>218</fpage>&#8211;<lpage>27</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2013.19.3.218</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23537456/" ext-link-type="uri">23537456</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438347" ext-link-type="uri">PMC10438347</ext-link><pub-id pub-id-type="pmid">23537456</pub-id><pub-id pub-id-type="pmcid">PMC10438347</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bultman</surname><given-names>DC</given-names></name><name name-style="western"><surname>Svarstad</surname><given-names>BL.</given-names></name></person-group><article-title>Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy</article-title><source>J Am Pharm Assoc (Wash)</source><year>2002</year><volume>42</volume><issue>(1)</issue><fpage>36</fpage>&#8211;<lpage>43</lpage><pub-id pub-id-type="doi">10.1331/108658002763538053</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11833513/" ext-link-type="uri">11833513</ext-link></comment><pub-id pub-id-type="pmid">11833513</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rickles</surname><given-names>NM</given-names></name><name name-style="western"><surname>Svarstad</surname><given-names>BL</given-names></name><name name-style="western"><surname>Statz-Paynter</surname><given-names>JL</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>LV</given-names></name><name name-style="western"><surname>Kobak</surname><given-names>KA.</given-names></name></person-group><article-title>Pharmacist telemonitoring of antidepressant use: effects on pharmacist&#8211;patient collaboration</article-title><source>J Am Pharm Assoc (2003)</source><year>2005</year><volume>45</volume><issue>(3)</issue><fpage>344</fpage>&#8211;<lpage>53</lpage><pub-id pub-id-type="doi">10.1331/1544345054003732</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15991756/" ext-link-type="uri">15991756</ext-link></comment><pub-id pub-id-type="pmid">15991756</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poon</surname><given-names>LH</given-names></name><name name-style="western"><surname>Lee</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Chiao</surname><given-names>TB</given-names></name><name name-style="western"><surname>Kang</surname><given-names>GA</given-names></name><name name-style="western"><surname>Heath</surname><given-names>S</given-names></name><name name-style="western"><surname>Glass</surname><given-names>GA.</given-names></name></person-group><article-title>Pharmacist&#8217;s role in a Parkinson&#8217;s disease and movement disorders clinic</article-title><source>Am J Health Syst Pharm</source><year>2012</year><volume>69</volume><issue>(6)</issue><fpage>518</fpage>&#8211;<lpage>20</lpage><pub-id pub-id-type="doi">10.2146/ajhp110127</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22382484/" ext-link-type="uri">22382484</ext-link></comment><pub-id pub-id-type="pmid">22382484</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swain</surname><given-names>LD.</given-names></name></person-group><article-title>A Pharmacist&#8217;s contribution to an ambulatory neurology clinic</article-title><source>Consult Pharm</source><year>2012</year><volume>27</volume><issue>(1)</issue><fpage>49</fpage>&#8211;<lpage>57</lpage><pub-id pub-id-type="doi">10.4140/TCP.n.2012.49</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22231998/" ext-link-type="uri">22231998</ext-link></comment><pub-id pub-id-type="pmid">22231998</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>Y</given-names></name><name name-style="western"><surname>Umegaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Shigeno</surname><given-names>K</given-names></name><name name-style="western"><surname>Matsushita</surname><given-names>R</given-names></name><name name-style="western"><surname>Sai</surname><given-names>Y</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist-based Donepezil Outpatient Consultation Service to improve medication persistence</article-title><source>Patient Prefer Adherence</source><year>2012</year><volume>6</volume>:
<fpage>605</fpage>&#8211;<lpage>11</lpage><pub-id pub-id-type="doi">10.2147/PPA.S34984</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22969291/" ext-link-type="uri">22969291</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437908" ext-link-type="uri">PMC3437908</ext-link><pub-id pub-id-type="pmid">22969291</pub-id><pub-id pub-id-type="pmcid">PMC3437908</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>B</given-names></name><name name-style="western"><surname>Dopheide</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gregerson</surname><given-names>P.</given-names></name></person-group><article-title>Psychiatric pharmacist and primary care collaboration at a skid-row safety-net clinic</article-title><source>J Natl Med Assoc</source><year>2011</year><volume>103</volume><issue>(7)</issue><fpage>567</fpage>&#8211;<lpage>75</lpage><pub-id pub-id-type="doi">10.1016/s0027-9684(15)30382-5</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21999031/" ext-link-type="uri">21999031</ext-link></comment><pub-id pub-id-type="pmid">21999031</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cobb</surname><given-names>CD.</given-names></name></person-group><article-title>Optimizing medication use with a pharmacist-provided comprehensive medication management service for patients with psychiatric disorders</article-title><source>Pharmacotherapy</source><year>2014</year><volume>34</volume><issue>(12)</issue><fpage>1336</fpage>&#8211;<lpage>40</lpage><pub-id pub-id-type="doi">10.1002/phar.1503</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25329409/" ext-link-type="uri">25329409</ext-link></comment><pub-id pub-id-type="pmid">25329409</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McMillan</surname><given-names>SS</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>F</given-names></name><name name-style="western"><surname>Hattingh</surname><given-names>HL</given-names></name><name name-style="western"><surname>Fowler</surname><given-names>JL</given-names></name><name name-style="western"><surname>Mihala</surname><given-names>G</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>AJ.</given-names></name></person-group><article-title>The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes</article-title><source>J Ment Health</source><year>2018</year><volume>27</volume><issue>(2)</issue><fpage>164</fpage>&#8211;<lpage>73</lpage><pub-id pub-id-type="doi">10.1080/09638237.2017.1340618</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28675321/" ext-link-type="uri">28675321</ext-link></comment><pub-id pub-id-type="pmid">28675321</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rojas&#8208;Fernandez</surname><given-names>CH</given-names></name><name name-style="western"><surname>Eng</surname><given-names>M</given-names></name><name name-style="western"><surname>Allie</surname><given-names>ND.</given-names></name></person-group><article-title>Pharmacologic management by clinical pharmacists of behavioral and psychological symptoms of dementia in nursing home residents: results from a pilot study</article-title><source>Pharmacotherapy</source><year>2003</year><volume>23</volume><issue>(2)</issue><fpage>217</fpage>&#8211;<lpage>21</lpage><pub-id pub-id-type="doi">10.1592/phco.23.2.217.32084</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/12587811/" ext-link-type="uri">12587811</ext-link></comment><pub-id pub-id-type="pmid">12587811</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuijt</surname><given-names>C</given-names></name><name name-style="western"><surname>Karapinar-&#199;arkit</surname><given-names>F</given-names></name><name name-style="western"><surname>van den Bemt</surname><given-names>B</given-names></name><name name-style="western"><surname>van Laar</surname><given-names>T.</given-names></name></person-group><article-title>Effect of pharmacist-led interventions on (non)motor symptoms, medication-related problems, and quality of life in Parkinson disease patients: a pilot study</article-title><source>Clin Neuropharmacol</source><year>2018</year><volume>41</volume><issue>(1)</issue><fpage>14</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1097/WNF.0000000000000260</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29300205/" ext-link-type="uri">29300205</ext-link></comment><pub-id pub-id-type="pmid">29300205</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ellenor</surname><given-names>GL</given-names></name><name name-style="western"><surname>Frisk</surname><given-names>PA.</given-names></name></person-group><article-title>Pharmacist impact on drug use in an institution for the mentally retarded</article-title><source>Am J Hosp Pharm</source><year>1977</year><volume>34</volume><issue>(6)</issue><fpage>604</fpage>&#8211;<lpage>8</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/879182/" ext-link-type="uri">879182</ext-link></comment><pub-id pub-id-type="pmid">879182</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>S.</given-names></name></person-group><article-title>Pharmacist&#8217;s impact on chronic psychiatric outpatients in community mental health</article-title><source>Am J Hosp Pharm</source><year>1978</year><volume>35</volume><issue>(6)</issue><fpage>704</fpage>&#8211;<lpage>8</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/665683/" ext-link-type="uri">665683</ext-link></comment><pub-id pub-id-type="pmid">665683</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Copp</surname><given-names>WM</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>S.</given-names></name></person-group><article-title>Effectiveness of a specially trained pharmacist in a rural community mental health center</article-title><source>Public Health Rep</source><year>1978</year><volume>93</volume><issue>(5)</issue><fpage>464</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="pmid">212774</pub-id><pub-id pub-id-type="pmcid">PMC1431929</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bond</surname><given-names>CA</given-names></name><name name-style="western"><surname>Salinger</surname><given-names>RJ.</given-names></name></person-group><article-title>Fluphenazine outpatient clinics: a pharmacist&#8217;s role</article-title><source>J Clin Psychiatry</source><year>1979</year><volume>40</volume><issue>(12)</issue><fpage>501</fpage>&#8211;<lpage>3</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/500572/" ext-link-type="uri">500572</ext-link></comment><pub-id pub-id-type="pmid">500572</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>DR</given-names></name><name name-style="western"><surname>Namikas</surname><given-names>EA</given-names></name><name name-style="western"><surname>Sax</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheung</surname><given-names>A</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Clinical pharmacists as allied health care providers to psychiatric patients</article-title><source>Contemp Pharm Pract</source><year>1979</year><volume>2</volume><issue>(3)</issue><fpage>108</fpage>&#8211;<lpage>16</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10242843/" ext-link-type="uri">10242843</ext-link></comment><pub-id pub-id-type="pmid">10242843</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardoni</surname><given-names>AA</given-names></name><name name-style="western"><surname>Gunning</surname><given-names>J.</given-names></name></person-group><article-title>Psychiatric pharmacy in a partial hospital program</article-title><source>Hosp Pharm</source><year>1983</year><volume>18</volume><issue>(10)</issue><fpage>543</fpage>&#8211;<lpage>9</lpage>,
<fpage>555</fpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10263894/" ext-link-type="uri">10263894</ext-link></comment><pub-id pub-id-type="pmid">10263894</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steineck</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Skoglund</surname><given-names>AK</given-names></name><name name-style="western"><surname>Carlson</surname><given-names>MK</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of a pharmacist-managed methadone taper*</article-title><source>Pediatr Crit Care Med</source><year>2014</year><volume>15</volume><issue>(3)</issue><fpage>206</fpage>&#8211;<lpage>10</lpage><pub-id pub-id-type="doi">10.1097/PCC.0000000000000048</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24448326/" ext-link-type="uri">24448326</ext-link></comment><pub-id pub-id-type="pmid">24448326</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paquin</surname><given-names>AM</given-names></name><name name-style="western"><surname>Salow</surname><given-names>M</given-names></name><name name-style="western"><surname>Rudolph</surname><given-names>JL.</given-names></name></person-group><article-title>pharmacist calls to older adults with cognitive difficulties after discharge in a tertiary veterans administration medical center: a quality improvement program</article-title><source>J Am Geriatrics Soc</source><year>2015</year><volume>63</volume><issue>(3)</issue><fpage>571</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="doi">10.1111/jgs.13315</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25732548/" ext-link-type="uri">25732548</ext-link></comment><pub-id pub-id-type="pmid">25732548</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeCaporale-Ryan</surname><given-names>LN</given-names></name><name name-style="western"><surname>Ahmed-Sarwar</surname><given-names>N</given-names></name><name name-style="western"><surname>Upham</surname><given-names>R</given-names></name><name name-style="western"><surname>Mahler</surname><given-names>K</given-names></name><name name-style="western"><surname>Lashway</surname><given-names>K.</given-names></name></person-group><article-title>Reducing hospital readmission through team-based primary care: a 7-week pilot study integrating behavioral health and pharmacy</article-title><source>Fam Syst Health</source><year>2017</year><volume>35</volume><issue>(2)</issue><fpage>217</fpage>&#8211;<lpage>26</lpage><pub-id pub-id-type="doi">10.1037/fsh0000269</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28617022/" ext-link-type="uri">28617022</ext-link></comment><pub-id pub-id-type="pmid">28617022</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafsson</surname><given-names>M</given-names></name><name name-style="western"><surname>Sj&#246;lander</surname><given-names>M</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>B</given-names></name><name name-style="western"><surname>Jonsson</surname><given-names>J</given-names></name><name name-style="western"><surname>Schneede</surname><given-names>J</given-names></name><name name-style="western"><surname>L&#246;vheim</surname><given-names>H.</given-names></name></person-group><article-title>Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial</article-title><source>Eur J Clin Pharmacol</source><year>2017</year><volume>73</volume><issue>(7)</issue><fpage>827</fpage>&#8211;<lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s00228-017-2249-8</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28391409/" ext-link-type="uri">28391409</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486919" ext-link-type="uri">PMC5486919</ext-link><pub-id pub-id-type="pmid">28391409</pub-id><pub-id pub-id-type="pmcid">PMC5486919</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Louzon</surname><given-names>P</given-names></name><name name-style="western"><surname>Jennings</surname><given-names>H</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M</given-names></name><name name-style="western"><surname>Kraisinger</surname><given-names>M.</given-names></name></person-group><article-title>Impact of pharmacist management of pain, agitation, and delirium in the intensive care unit through participation in multidisciplinary bundle rounds</article-title><source>Am J Health Syst Pharm</source><year>2017</year><volume>74</volume><issue>(4)</issue><fpage>253</fpage>&#8211;<lpage>62</lpage><pub-id pub-id-type="doi">10.2146/ajhp150942</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28179250/" ext-link-type="uri">28179250</ext-link></comment><pub-id pub-id-type="pmid">28179250</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salazar-Ospina</surname><given-names>A</given-names></name><name name-style="western"><surname>Amariles</surname><given-names>P</given-names></name><name name-style="western"><surname>Hincapi&#233;-Garc&#237;a</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Avenda&#241;o</surname><given-names>S</given-names></name><name name-style="western"><surname>Benjumea</surname><given-names>DM</given-names></name><name name-style="western"><surname>Faus</surname><given-names>MJ</given-names></name><etal>et al.</etal></person-group><article-title>Effectiveness of the Dader method for pharmaceutical care on patients with bipolar I disorder: results from the EMDADER-TAB study</article-title><source>J Manag Care Spec Pharm</source><year>2017</year><volume>23</volume><issue>(1)</issue><fpage>74</fpage>&#8211;<lpage>84</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2017.23.1.74</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28025928/" ext-link-type="uri">28025928</ext-link></comment><pub-id pub-id-type="pmid">28025928</pub-id><pub-id pub-id-type="pmcid">PMC10398179</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#228;ttig</surname><given-names>VAD</given-names></name><name name-style="western"><surname>Roll</surname><given-names>SC</given-names></name><name name-style="western"><surname>Hahn</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacogenetic testing in depressed patients and interdisciplinary exchange between a pharmacist and psychiatrists results in reduced hospitalization times</article-title><source>Pharmacopsychiatry</source><year>2020</year><volume>53</volume><issue>(4)</issue><fpage>185</fpage>&#8211;<lpage>92</lpage><pub-id pub-id-type="doi">10.1055/a-1096-1171</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32045941/" ext-link-type="uri">32045941</ext-link></comment><pub-id pub-id-type="pmid">32045941</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dorevitch</surname><given-names>A</given-names></name><name name-style="western"><surname>Aronzon</surname><given-names>R</given-names></name><name name-style="western"><surname>Zilberman</surname><given-names>L.</given-names></name></person-group><article-title>Medication maintenance of chronic schizophrenic out-patients by a psychiatric clinical pharmacist: 10-year follow-up study</article-title><source>J Clin Pharm Ther</source><year>1993</year><volume>18</volume><issue>(3)</issue><fpage>183</fpage>&#8211;<lpage>6</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2710.1993.tb00610.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/8102143/" ext-link-type="uri">8102143</ext-link></comment><pub-id pub-id-type="pmid">8102143</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoner</surname><given-names>SC</given-names></name><name name-style="western"><surname>Ott</surname><given-names>CA</given-names></name><name name-style="western"><surname>DiPaula</surname><given-names>BA.</given-names></name></person-group><article-title>Psychiatric pharmacy residency training*</article-title><source>Am J Pharm Educ</source><year>2010</year><volume>74</volume><issue>(9)</issue><fpage>163</fpage><pub-id pub-id-type="doi">10.5688/aj7409163</pub-id><pub-id pub-id-type="pmid">21301597</pub-id><pub-id pub-id-type="pmcid">PMC2996753</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suehs</surname><given-names>BT</given-names></name><name name-style="western"><surname>Mican</surname><given-names>LM</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>AH.</given-names></name></person-group><article-title>Retrospective evaluation of an inpatient psychiatric pharmacist consultation service</article-title><source>J Am Pharm Assoc (2003)</source><year>2011</year><volume>51</volume><issue>(5)</issue><fpage>599</fpage>&#8211;<lpage>604</lpage><pub-id pub-id-type="doi">10.1331/JAPhA.2011.10107</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21896457/" ext-link-type="uri">21896457</ext-link></comment><pub-id pub-id-type="pmid">21896457</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Valenstein</surname><given-names>M</given-names></name><name name-style="western"><surname>Kavanagh</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>T</given-names></name><name name-style="western"><surname>Reilly</surname><given-names>P</given-names></name><name name-style="western"><surname>Dalack</surname><given-names>GW</given-names></name><name name-style="western"><surname>Grabowski</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness</article-title><source>Schizophr Bull</source><year>2011</year><volume>37</volume><issue>(4)</issue><fpage>727</fpage>&#8211;<lpage>36</lpage><pub-id pub-id-type="doi">10.1093/schbul/sbp121</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19933540/" ext-link-type="uri">19933540</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3122282" ext-link-type="uri">PMC3122282</ext-link><pub-id pub-id-type="pmid">19933540</pub-id><pub-id pub-id-type="pmcid">PMC3122282</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>I</given-names></name><name name-style="western"><surname>Dopheide</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gregerson</surname><given-names>P.</given-names></name></person-group><article-title>Role of a psychiatric pharmacist in a Los Angeles &#8220;Skid-Row&#8221; safety-net clinic</article-title><source>J Urban Health</source><year>2011</year><volume>88</volume><issue>(4)</issue><fpage>718</fpage>&#8211;<lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s11524-011-9573-6</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21512832/" ext-link-type="uri">21512832</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157501" ext-link-type="uri">PMC3157501</ext-link><pub-id pub-id-type="pmid">21512832</pub-id><pub-id pub-id-type="pmcid">PMC3157501</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furbish</surname><given-names>SML</given-names></name><name name-style="western"><surname>Kroehl</surname><given-names>ME</given-names></name><name name-style="western"><surname>Loeb</surname><given-names>DF</given-names></name><name name-style="western"><surname>Lam</surname><given-names>HM</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>CL</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>A pharmacist-physician collaboration to optimize benzodiazepine use for anxiety and sleep symptom control in primary care</article-title><source>J Pharm Pract</source><year>2017</year><volume>30</volume><issue>(4)</issue><fpage>425</fpage>&#8211;<lpage>33</lpage><pub-id pub-id-type="doi">10.1177/0897190016660435</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27480874/" ext-link-type="uri">27480874</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511764" ext-link-type="uri">PMC5511764</ext-link><pub-id pub-id-type="pmid">27480874</pub-id><pub-id pub-id-type="pmcid">PMC5511764</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harms</surname><given-names>M</given-names></name><name name-style="western"><surname>Haas</surname><given-names>M</given-names></name><name name-style="western"><surname>Larew</surname><given-names>J</given-names></name><name name-style="western"><surname>DeJongh</surname><given-names>B.</given-names></name></person-group><article-title>Impact of a mental health clinical pharmacist on a primary care mental health integration team</article-title><source>Ment Health Clin</source><year>2017</year><volume>7</volume><issue>(3)</issue><fpage>101</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.9740/mhc.2017.05.101</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29955506/" ext-link-type="uri">29955506</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007568" ext-link-type="uri">PMC6007568</ext-link><pub-id pub-id-type="pmid">29955506</pub-id><pub-id pub-id-type="pmcid">PMC6007568</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herbert</surname><given-names>C</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>H.</given-names></name></person-group><article-title>Impact of a clinical pharmacist-managed clinic in primary care mental health integration at a Veterans Affairs health system</article-title><source>Ment Health Clin</source><year>2018</year><volume>8</volume><issue>(3)</issue><fpage>105</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.9740/mhc.2018.05.105</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29955554/" ext-link-type="uri">29955554</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007641" ext-link-type="uri">PMC6007641</ext-link><pub-id pub-id-type="pmid">29955554</pub-id><pub-id pub-id-type="pmcid">PMC6007641</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindell</surname><given-names>VA</given-names></name><name name-style="western"><surname>Stencel</surname><given-names>NL</given-names></name><name name-style="western"><surname>Ives</surname><given-names>RC</given-names></name><name name-style="western"><surname>Ward</surname><given-names>KM</given-names></name><name name-style="western"><surname>Fluent</surname><given-names>T</given-names></name><name name-style="western"><surname>Choe</surname><given-names>HM</given-names></name><etal>et al.</etal></person-group><article-title>A pilot evaluating clinical pharmacy services in an ambulatory psychiatry setting</article-title><source>Psychopharmacol Bull</source><year>2018</year><volume>48</volume><issue>(2)</issue><fpage>18</fpage>&#8211;<lpage>28</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29713097/" ext-link-type="uri">29713097</ext-link></comment><pub-id pub-id-type="pmid">29713097</pub-id><pub-id pub-id-type="pmcid">PMC5875359</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buist</surname><given-names>E</given-names></name><name name-style="western"><surname>McLelland</surname><given-names>R</given-names></name><name name-style="western"><surname>Rushworth</surname><given-names>GF</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>D</given-names></name><name name-style="western"><surname>Gibson-Smith</surname><given-names>K</given-names></name><name name-style="western"><surname>MacLure</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland</article-title><source>Int J Clin Pharm</source><year>2019</year><volume>41</volume><issue>(5)</issue><fpage>1138</fpage>&#8211;<lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s11096-019-00897-1</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31493208/" ext-link-type="uri">31493208</ext-link></comment><pub-id pub-id-type="pmid">31493208</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonzalvo</surname><given-names>JD</given-names></name><name name-style="western"><surname>Hamm</surname><given-names>JA</given-names></name><name name-style="western"><surname>Shan</surname><given-names>M.</given-names></name></person-group><article-title>A pharmacist-managed cardiovascular risk-reduction clinic for individuals experiencing serious mental illness</article-title><source>J Am Pharm Assoc (2003)</source><year>2019</year><volume>59</volume><issue>(5)</issue><fpage>698</fpage>&#8211;<lpage>703</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2019.06.012</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31324536/" ext-link-type="uri">31324536</ext-link></comment><pub-id pub-id-type="pmid">31324536</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perepelkin</surname><given-names>J</given-names></name><name name-style="western"><surname>Antunes</surname><given-names>K</given-names></name><name name-style="western"><surname>Boechler</surname><given-names>L</given-names></name><name name-style="western"><surname>Remillard</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Mildenberger</surname><given-names>L.</given-names></name></person-group><article-title>Providing mindfulness meditation for patients with depression and anxiety in a community pharmacy: a pilot study</article-title><source>J Am Pharm Assoc (2003)</source><year>2019</year><volume>59</volume><issue>(2)</issue><fpage>258</fpage>&#8211;<lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2018.10.017</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30552050/" ext-link-type="uri">30552050</ext-link></comment><pub-id pub-id-type="pmid">30552050</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>AbuNaba&#8217;a</surname><given-names>Y</given-names></name><name name-style="western"><surname>Basheti</surname><given-names>IA.</given-names></name></person-group><article-title>Assessing the impact of medication management review service for females diagnosed with depression and anxiety: a randomized control trial</article-title><source>J Eval Clin Pract</source><year>2020</year><volume>26</volume><issue>(5)</issue><fpage>1478</fpage>&#8211;<lpage>89</lpage><pub-id pub-id-type="doi">10.1111/jep.13314</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31692212/" ext-link-type="uri">31692212</ext-link></comment><pub-id pub-id-type="pmid">31692212</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkoudsi</surname><given-names>KT</given-names></name><name name-style="western"><surname>Basheti</surname><given-names>IA.</given-names></name></person-group><article-title>Prevalence of anxiety and depression among women with polycystic ovary syndrome living in war versus non-war zone countries: a randomized controlled trial assessing a pharmacist intervention</article-title><source>Res Soc Administrative Pharm</source><year>2020</year><volume>16</volume><issue>(5)</issue><fpage>689</fpage>&#8211;<lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.sapharm.2019.08.027</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31420190/" ext-link-type="uri">31420190</ext-link></comment><pub-id pub-id-type="pmid">31420190</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samaksha</surname><given-names>PB</given-names></name><name name-style="western"><surname>Kishor</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramesh</surname><given-names>M.</given-names></name></person-group><article-title>A novel study on clinical pharmacist and psychiatrist collaborative pharmacotherapy management services among elderly population with psychiatric illness</article-title><source>Indian J Psychiatry</source><year>2022</year><volume>64</volume><issue>(1)</issue><fpage>20</fpage>&#8211;<lpage>4</lpage><pub-id pub-id-type="doi">10.4103/indianjpsychiatry.indianjpsychiatry_379_21</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35400748/" ext-link-type="uri">35400748</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992754" ext-link-type="uri">PMC8992754</ext-link><pub-id pub-id-type="pmid">35400748</pub-id><pub-id pub-id-type="pmcid">PMC8992754</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>MR</given-names></name><name name-style="western"><surname>Nash</surname><given-names>DR</given-names></name><name name-style="western"><surname>Laird</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kiley</surname><given-names>RC</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>MA.</given-names></name></person-group><article-title>Development and implementation of a pharmacist-managed, neonatal and pediatric, opioid-weaning protocol</article-title><source>J Pediatric Pharmacol Ther</source><year>2014</year><volume>19</volume><issue>(3)</issue><fpage>165</fpage>&#8211;<lpage>73</lpage><pub-id pub-id-type="doi">10.5863/1551-6776-19.3.165</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25309146/" ext-link-type="uri">25309146</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187529" ext-link-type="uri">PMC4187529</ext-link><pub-id pub-id-type="pmcid">PMC4187529</pub-id><pub-id pub-id-type="pmid">25309146</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celestin</surname><given-names>G</given-names></name><name name-style="western"><surname>Balding</surname><given-names>M</given-names></name><name name-style="western"><surname>Para</surname><given-names>JL</given-names></name><name name-style="western"><surname>Utley</surname><given-names>A</given-names></name><name name-style="western"><surname>Shaddix</surname><given-names>BP.</given-names></name></person-group><article-title>A preliminary assessment of the effects of pharmacist-driven methadone stewardship for the treatment of neonatal abstinence syndrome at a tertiary children&#8217;s hospital</article-title><source>J Pediatric Pharmacol Ther</source><year>2022</year><volume>27</volume><issue>(8)</issue><fpage>720</fpage>&#8211;<lpage>4</lpage><pub-id pub-id-type="doi">10.5863/1551-6776-27.8.720</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36415769/" ext-link-type="uri">36415769</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674361" ext-link-type="uri">PMC9674361</ext-link><pub-id pub-id-type="pmcid">PMC9674361</pub-id><pub-id pub-id-type="pmid">36415769</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Casey</surname><given-names>T</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C</given-names></name><name name-style="western"><surname>Love</surname><given-names>D.</given-names></name></person-group><article-title>Adult attention deficit hyperactivity disorder clinic: An interprofessional collaboration</article-title><source>J Am Pharm Assoc (2003)</source><year>2020</year><volume>60</volume><issue>(5)</issue><fpage>S113</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2020.03.020</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32616446/" ext-link-type="uri">32616446</ext-link></comment><pub-id pub-id-type="pmid">32616446</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fortney</surname><given-names>JC</given-names></name><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Kimbrell</surname><given-names>TA</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>DE</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>R</given-names></name><etal>et al.</etal></person-group><article-title>Telemedicine-based collaborative care for posttraumatic stress disorder</article-title><source>JAMA Psychiatry</source><year>2015</year><volume>72</volume><issue>(1)</issue><fpage>58</fpage>&#8211;<lpage>67</lpage><pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.1575</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25409287/" ext-link-type="uri">25409287</ext-link></comment><pub-id pub-id-type="pmid">25409287</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mishra</surname><given-names>A</given-names></name><name name-style="western"><surname>Krishna</surname><given-names>GS</given-names></name><name name-style="western"><surname>Alla</surname><given-names>S</given-names></name><name name-style="western"><surname>Kurian</surname><given-names>TD</given-names></name><name name-style="western"><surname>Kurian</surname><given-names>J</given-names></name><name name-style="western"><surname>Ramesh</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Impact of pharmacist-psychiatrist collaborative patient education on medication adherence and quality of life (QOL) of bipolar affective disorder (BPAD) patients</article-title><source>Front Pharmacol</source><year>2017</year><volume>8</volume>:
<fpage>722</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00722</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29066976/" ext-link-type="uri">29066976</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641349" ext-link-type="uri">PMC5641349</ext-link><pub-id pub-id-type="pmid">29066976</pub-id><pub-id pub-id-type="pmcid">PMC5641349</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salazar-Ospina</surname><given-names>A</given-names></name><name name-style="western"><surname>Amariles</surname><given-names>P</given-names></name><name name-style="western"><surname>Hincapi&#233;-Garc&#237;a</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gonz&#225;lez-Avenda&#241;o</surname><given-names>S.</given-names></name></person-group><article-title>Long-term impact of pharmacist intervention in patients with bipolar disorder: extended follow-up to the EMDADER-TAB study</article-title><source>Heliyon</source><year>2020</year><volume>6</volume><issue>(2)</issue><fpage>e03333</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03333</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32072044/" ext-link-type="uri">32072044</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016228" ext-link-type="uri">PMC7016228</ext-link><pub-id pub-id-type="pmid">32072044</pub-id><pub-id pub-id-type="pmcid">PMC7016228</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakakibara</surname><given-names>M</given-names></name><name name-style="western"><surname>Igarashi</surname><given-names>A</given-names></name><name name-style="western"><surname>Takase</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kamei</surname><given-names>H</given-names></name><name name-style="western"><surname>Nabeshima</surname><given-names>T.</given-names></name></person-group><article-title>Effects of prescription drug reduction on quality of life in community-dwelling patients with dementia</article-title><source>J Pharm Pharm Sci</source><year>2015</year><volume>18</volume><issue>(5)</issue><fpage>705</fpage>&#8211;<lpage>12</lpage><pub-id pub-id-type="doi">10.18433/j37p5x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26670367/" ext-link-type="uri">26670367</ext-link></comment><pub-id pub-id-type="pmid">26670367</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gustafsson</surname><given-names>M</given-names></name><name name-style="western"><surname>Sj&#246;lander</surname><given-names>M</given-names></name><name name-style="western"><surname>Pfister</surname><given-names>B</given-names></name><name name-style="western"><surname>Schneede</surname><given-names>J</given-names></name><name name-style="western"><surname>L&#246;vheim</surname><given-names>H.</given-names></name></person-group><article-title>Effects of pharmacists&#8217; interventions on inappropriate drug use and drug-related readmissions in people with dementia&#8212;a secondary analysis of a randomized controlled trial</article-title><source>Pharmacy</source><year>2018</year><volume>6</volume><issue>(1)</issue><fpage>7</fpage><pub-id pub-id-type="doi">10.3390/pharmacy6010007</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29337859/" ext-link-type="uri">29337859</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874546" ext-link-type="uri">PMC5874546</ext-link><pub-id pub-id-type="pmid">29337859</pub-id><pub-id pub-id-type="pmcid">PMC5874546</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bravo-Jos&#233;</surname><given-names>P</given-names></name><name name-style="western"><surname>S&#225;ez-Lle&#243;</surname><given-names>CI</given-names></name><name name-style="western"><surname>Peris-Mart&#237;</surname><given-names>JF.</given-names></name></person-group><article-title>Deprescribing antipsychotics in long term care patients with dementia</article-title><source>Farm Hosp</source><year>2019</year><volume>43</volume><issue>(4)</issue><fpage>140</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.7399/fh.11217</pub-id><pub-id pub-id-type="pmid">31276444</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>L</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K</given-names></name><name name-style="western"><surname>Mi</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Q</given-names></name><etal>et al.</etal></person-group><article-title>The effects of a multi-disciplinary team on sleep quality assessment in mild-to-moderate Alzheimer&#8217;s disease patients with sleep disorders</article-title><source>Scott Med J</source><year>2021</year><volume>66</volume><issue>(3)</issue><fpage>134</fpage>&#8211;<lpage>41</lpage><pub-id pub-id-type="doi">10.1177/00369330211027450</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34225517/" ext-link-type="uri">34225517</ext-link></comment><pub-id pub-id-type="pmid">34225517</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elbeddini</surname><given-names>A</given-names></name><name name-style="western"><surname>Tayefehchamani</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yilmaz</surname><given-names>Z</given-names></name><name name-style="western"><surname>Villegas</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>EY.</given-names></name></person-group><article-title>Evaluation of a community-based memory clinic in collaboration with local hospitals to support patients with memory decline</article-title><source>J Taibah Univ Med Sci</source><year>2022</year><volume>17</volume><issue>(2)</issue><fpage>220</fpage>&#8211;<lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.jtumed.2021.05.013</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35592795/" ext-link-type="uri">35592795</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073869" ext-link-type="uri">PMC9073869</ext-link><pub-id pub-id-type="pmid">35592795</pub-id><pub-id pub-id-type="pmcid">PMC9073869</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kable</surname><given-names>A</given-names></name><name name-style="western"><surname>Hullick</surname><given-names>C</given-names></name><name name-style="western"><surname>Palazzi</surname><given-names>K</given-names></name><name name-style="western"><surname>Oldmeadow</surname><given-names>C</given-names></name><name name-style="western"><surname>Searles</surname><given-names>A</given-names></name><name name-style="western"><surname>Ling</surname><given-names>R</given-names></name><etal>et al.</etal></person-group><article-title>Evaluation of a safe medication strategy intervention for people with dementia with an unplanned admission: results from the Safe Medication Strategy Dementia Study</article-title><source>Australas J Ageing</source><year>2021</year><volume>40</volume><issue>(4)</issue><fpage>356</fpage>&#8211;<lpage>65</lpage><pub-id pub-id-type="doi">10.1111/ajag.12877</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33166034/" ext-link-type="uri">33166034</ext-link></comment><pub-id pub-id-type="pmid">33166034</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>C&#8208;Y</given-names></name><name name-style="western"><surname>Hu</surname><given-names>C&#8208;J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L&#8208;K</given-names></name><name name-style="western"><surname>Chang</surname><given-names>EH.</given-names></name></person-group><article-title>Effects of caregiver counselling on medication persistence and adherence in patients with dementia at a pharmacist&#8208;managed clinic: a pilot study</article-title><source>Clin Pharm Ther</source><year>2022</year><volume>47</volume><issue>(12)</issue><fpage>2074</fpage>&#8211;<lpage>82</lpage><pub-id pub-id-type="doi">10.1111/jcpt.13752</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36543253/" ext-link-type="uri">36543253</ext-link></comment><pub-id pub-id-type="pmid">36543253</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Summers</surname><given-names>B</given-names></name><name name-style="western"><surname>Summers</surname><given-names>RS</given-names></name><name name-style="western"><surname>Rom</surname><given-names>S.</given-names></name></person-group><article-title>The effect of a specialist clinic with pharmacist involvement on the management of epilepsy in paediatric patients</article-title><source>J Clin Pharm Ther</source><year>1986</year><volume>11</volume><issue>(3)</issue><fpage>207</fpage>&#8211;<lpage>14</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2710.1986.tb00846.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/3745470/" ext-link-type="uri">3745470</ext-link></comment><pub-id pub-id-type="pmid">3745470</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McFadyen</surname><given-names>ML</given-names></name><name name-style="western"><surname>Miller</surname><given-names>R</given-names></name><name name-style="western"><surname>Juta</surname><given-names>M</given-names></name><name name-style="western"><surname>Hodgson</surname><given-names>V.</given-names></name></person-group><article-title>The relevance of a First-World therapeutic drug monitoring service to the treatment of epilepsy in third-world conditions</article-title><source>S Afr Med J</source><year>1990</year><volume>78</volume><issue>(10)</issue><fpage>587</fpage>&#8211;<lpage>90</lpage><pub-id pub-id-type="pmid">2247792</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eshiet</surname><given-names>UI</given-names></name><name name-style="western"><surname>Okonta</surname><given-names>JM</given-names></name><name name-style="western"><surname>Ukwe</surname><given-names>CV.</given-names></name></person-group><article-title>Impact of a pharmacist-led education and counseling interventions on quality of life in epilepsy: a randomized controlled trial</article-title><source>Epilepsy Res</source><year>2021</year><volume>174</volume>:
<fpage>106648</fpage><pub-id pub-id-type="doi">10.1016/j.eplepsyres.2021.106648</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33945920/" ext-link-type="uri">33945920</ext-link></comment><pub-id pub-id-type="pmid">33945920</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marawar</surname><given-names>R</given-names></name><name name-style="western"><surname>Faraj</surname><given-names>M</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>K</given-names></name><name name-style="western"><surname>Burns</surname><given-names>CV</given-names></name><name name-style="western"><surname>Garwood</surname><given-names>CL.</given-names></name></person-group><article-title>Implementation of an older adult epilepsy clinic utilizing pharmacist services</article-title><source>J Am Pharm Assoc (2003)</source><year>2021</year><volume>61</volume><issue>(6)</issue><fpage>e93</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2021.07.003</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34330650/" ext-link-type="uri">34330650</ext-link></comment><pub-id pub-id-type="pmid">34330650</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pham</surname><given-names>HT</given-names></name><name name-style="western"><surname>Tran</surname><given-names>M-H</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>NQ</given-names></name><name name-style="western"><surname>Tan Vo</surname><given-names>V</given-names></name><name name-style="western"><surname>Tran</surname><given-names>MH.</given-names></name></person-group><article-title>Role of clinical pharmacists in epilepsy management at a general hospital in Vietnam: a before-and-after study</article-title><source>J Pharm Policy Pract</source><year>2021</year><volume>14</volume><issue>(1)</issue><fpage>109</fpage><pub-id pub-id-type="doi">10.1186/s40545-021-00394-9</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34930487/" ext-link-type="uri">34930487</ext-link></comment><pub-id pub-id-type="pmid">34930487</pub-id><pub-id pub-id-type="pmcid">PMC8686354</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berchou</surname><given-names>RC.</given-names></name></person-group><article-title>Effect of a consultant pharmacist on medication use in an institution for the mentally retarded</article-title><source>Am J Hosp Pharm</source><year>1982</year><volume>39</volume><issue>(10)</issue><fpage>1671</fpage>&#8211;<lpage>4</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/6128921/" ext-link-type="uri">6128921</ext-link></comment><pub-id pub-id-type="pmid">6128921</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKee</surname><given-names>JR.</given-names></name></person-group><article-title>Clinical pharmacy services in an intermediate care facility for the mentally retarded</article-title><source>Hosp Pharm</source><year>1994</year><volume>29</volume><issue>(3)</issue><fpage>228</fpage>&#8211;<lpage>230</lpage>,
<comment>233-234, 237</comment><pub-id pub-id-type="pmid">10132698</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thayer</surname><given-names>N</given-names></name><name name-style="western"><surname>White</surname><given-names>S</given-names></name><name name-style="western"><surname>Islam</surname><given-names>J</given-names></name><name name-style="western"><surname>Jones</surname><given-names>W</given-names></name><name name-style="western"><surname>Kenzie</surname><given-names>S</given-names></name><name name-style="western"><surname>Kullu</surname><given-names>R.</given-names></name></person-group><article-title>Reducing risks associated with medicines and lifestyle in a residential care population with intellectual disabilities: evaluation of a pharmacy review initiative in England</article-title><source>BMJ Open</source><year>2021</year><volume>11</volume><issue>(8)</issue><fpage>e046630</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-046630</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34404698/" ext-link-type="uri">34404698</ext-link></comment><pub-id pub-id-type="pmcid">PMC8372807</pub-id><pub-id pub-id-type="pmid">34404698</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boudreau</surname><given-names>DM</given-names></name><name name-style="western"><surname>Capoccia</surname><given-names>KL</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>SD</given-names></name><name name-style="western"><surname>Blough</surname><given-names>DK</given-names></name><name name-style="western"><surname>Ellsworth</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Clark</surname><given-names>DL</given-names></name><etal>et al.</etal></person-group><article-title>Collaborative care model to improve outcomes in major depression</article-title><source>Ann Pharmacother</source><year>2002</year><volume>36</volume><issue>(4)</issue><fpage>585</fpage>&#8211;<lpage>91</lpage><pub-id pub-id-type="doi">10.1345/aph.1A259</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11918503/" ext-link-type="uri">11918503</ext-link></comment><pub-id pub-id-type="pmid">11918503</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bungay</surname><given-names>KM</given-names></name><name name-style="western"><surname>Adler</surname><given-names>DA</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>WH</given-names></name><name name-style="western"><surname>McCoy</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaszuba</surname><given-names>M</given-names></name><name name-style="western"><surname>Supran</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>Description of a clinical pharmacist intervention administered to primary care patients with depression</article-title><source>Gen Hosp Psychiatry</source><year>2004</year><volume>26</volume><issue>(3)</issue><fpage>210</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2004.01.004</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15121349/" ext-link-type="uri">15121349</ext-link></comment><pub-id pub-id-type="pmid">15121349</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capoccia</surname><given-names>KL</given-names></name><name name-style="western"><surname>Boudreau</surname><given-names>DM</given-names></name><name name-style="western"><surname>Blough</surname><given-names>DK</given-names></name><name name-style="western"><surname>Ellsworth</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Clark</surname><given-names>DR</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>NG</given-names></name><etal>et al.</etal></person-group><article-title>Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care</article-title><source>Am J Health Syst Pharm</source><year>2004</year><volume>61</volume><issue>(4)</issue><fpage>364</fpage>&#8211;<lpage>72</lpage><pub-id pub-id-type="doi">10.1093/ajhp/61.4.364</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15011764/" ext-link-type="uri">15011764</ext-link></comment><pub-id pub-id-type="pmid">15011764</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Fortney</surname><given-names>JC</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>SP</given-names></name><name name-style="western"><surname>Maciejewski</surname><given-names>ML</given-names></name><name name-style="western"><surname>Edlund</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Williams</surname><given-names>DK.</given-names></name></person-group><article-title>Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression</article-title><source>Arch Gen Psychiatry</source><year>2010</year><volume>67</volume><issue>(8)</issue><fpage>812</fpage>&#8211;<lpage>21</lpage><pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2010.82</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20679589/" ext-link-type="uri">20679589</ext-link></comment><pub-id pub-id-type="pmid">20679589</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fortney</surname><given-names>JC</given-names></name><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Mouden</surname><given-names>SB</given-names></name><name name-style="western"><surname>Mittal</surname><given-names>D</given-names></name><name name-style="western"><surname>Hudson</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Schroeder</surname><given-names>GW</given-names></name><etal>et al.</etal></person-group><article-title>Practice-based versus telemedicine-based collaborative care for depression in rural federally qualified health centers: a pragmatic randomized comparative effectiveness trial</article-title><source>Am J Psychiatry</source><year>2013</year><volume>170</volume><issue>(4)</issue><fpage>414</fpage>&#8211;<lpage>25</lpage><pub-id pub-id-type="doi">10.1176/appi.ajp.2012.12050696</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23429924/" ext-link-type="uri">23429924</ext-link></comment><pub-id pub-id-type="pmid">23429924</pub-id><pub-id pub-id-type="pmcid">PMC3816374</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>JM</given-names></name><name name-style="western"><surname>Shartle</surname><given-names>D</given-names></name><name name-style="western"><surname>Faudskar</surname><given-names>L</given-names></name><name name-style="western"><surname>Matlin</surname><given-names>OS</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>TA.</given-names></name></person-group><article-title>Impact of a patient-centered pharmacy program and intervention in a high-risk group</article-title><source>J Manag Care Pharm</source><year>2013</year><volume>19</volume><issue>(3)</issue><fpage>228</fpage>&#8211;<lpage>36</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2013.19.3.228</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23537457/" ext-link-type="uri">23537457</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438107" ext-link-type="uri">PMC10438107</ext-link><pub-id pub-id-type="pmid">23537457</pub-id><pub-id pub-id-type="pmcid">PMC10438107</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silvia</surname><given-names>R</given-names></name><name name-style="western"><surname>Plum</surname><given-names>M</given-names></name><name name-style="western"><surname>Dufresne</surname><given-names>R.</given-names></name></person-group><article-title>Efficiencies and outcomes of depression treatment by a psychiatric pharmacist in a primary care clinic compared with treatment within a behavioral health clinic</article-title><source>J Am Pharm Assoc (2003)</source><year>2020</year><volume>60</volume><issue>(5)</issue><fpage>S98</fpage>&#8211;<lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2020.05.015</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32665098/" ext-link-type="uri">32665098</ext-link></comment><pub-id pub-id-type="pmid">32665098</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marasine</surname><given-names>NR</given-names></name><name name-style="western"><surname>Sankhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Lamichhane</surname><given-names>R.</given-names></name></person-group><article-title>Impact of pharmacist intervention on medication adherence and patient-reported outcomes among depressed patients in a private psychiatric hospital of Nepal: a randomised controlled trial</article-title><source>Hosp Pharm</source><year>2022</year><volume>57</volume><issue>(1)</issue><fpage>26</fpage>&#8211;<lpage>31</lpage><pub-id pub-id-type="doi">10.1177/0018578720970465</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35521002/" ext-link-type="uri">35521002</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065529" ext-link-type="uri">PMC9065529</ext-link><pub-id pub-id-type="pmid">35521002</pub-id><pub-id pub-id-type="pmcid">PMC9065529</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schr&#246;der</surname><given-names>S</given-names></name><name name-style="western"><surname>Martus</surname><given-names>P</given-names></name><name name-style="western"><surname>Odin</surname><given-names>P</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>M.</given-names></name></person-group><article-title>Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson&#8217;s disease</article-title><source>Int J Clin Pharm</source><year>2012</year><volume>34</volume><issue>(5)</issue><fpage>746</fpage>&#8211;<lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s11096-012-9672-9</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22810890/" ext-link-type="uri">22810890</ext-link></comment><pub-id pub-id-type="pmid">22810890</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oonk</surname><given-names>NGM</given-names></name><name name-style="western"><surname>Dorresteijn</surname><given-names>LDA</given-names></name><name name-style="western"><surname>van den Berg</surname><given-names>AD</given-names></name><name name-style="western"><surname>van der Palen</surname><given-names>J</given-names></name><name name-style="western"><surname>Movig</surname><given-names>KLL</given-names></name><name name-style="western"><surname>Nijmeijer</surname><given-names>HW</given-names></name><etal>et al.</etal></person-group><article-title>Cost-utility analysis of a structured medication review compared to usual care in Parkinson&#8217;s disease</article-title><source>Eur J Clin Pharmacol</source><year>2023</year><volume>79</volume><issue>(2)</issue><fpage>289</fpage>&#8211;<lpage>97</lpage><pub-id pub-id-type="doi">10.1007/s00228-022-03438-4</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36562830/" ext-link-type="uri">36562830</ext-link></comment><pub-id pub-id-type="pmid">36562830</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hoffmann</surname><given-names>RP</given-names></name><name name-style="western"><surname>Moore</surname><given-names>WE</given-names></name><name name-style="western"><surname>O&#8217;Dea</surname><given-names>LF.</given-names></name></person-group><article-title>Medication problems confronted by the schizophrenic outpatient</article-title><source>J Am Pharm Assoc (1961)</source><year>1974</year><volume>14</volume><issue>(5)</issue><fpage>252</fpage>&#8211;<lpage>6</lpage><pub-id pub-id-type="doi">10.1016/s0003-0465(16)32982-2</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/4831215/" ext-link-type="uri">4831215</ext-link></comment><pub-id pub-id-type="pmid">4831215</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathienluckana</surname><given-names>T</given-names></name><name name-style="western"><surname>Unaharassamee</surname><given-names>W</given-names></name><name name-style="western"><surname>Suthisisang</surname><given-names>C</given-names></name><name name-style="western"><surname>Suanchang</surname><given-names>O</given-names></name><name name-style="western"><surname>Suansanae</surname><given-names>T.</given-names></name></person-group><article-title>Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist-physician collaboration in the outpatient department</article-title><source>Integr Pharm Res Pract</source><year>2018</year><volume>7</volume>:
<fpage>161</fpage>&#8211;<lpage>71</lpage><pub-id pub-id-type="doi">10.2147/IPRP.S176653</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30464898/" ext-link-type="uri">30464898</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208936" ext-link-type="uri">PMC6208936</ext-link><pub-id pub-id-type="pmid">30464898</pub-id><pub-id pub-id-type="pmcid">PMC6208936</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Spann</surname><given-names>G</given-names></name><name name-style="western"><surname>Austin</surname><given-names>L</given-names></name><name name-style="western"><surname>King</surname><given-names>E.</given-names></name></person-group><article-title>Pharmacists in clozapine clinics improving physical health monitoring</article-title><source>Ment Health Clin</source><year>2022</year><volume>12</volume><issue>(3)</issue><fpage>193</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.9740/mhc.2022.06.193</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35801163/" ext-link-type="uri">35801163</ext-link></comment><pub-id pub-id-type="pmid">35801163</pub-id><pub-id pub-id-type="pmcid">PMC9190272</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lui</surname><given-names>E</given-names></name><name name-style="western"><surname>Wintemute</surname><given-names>K</given-names></name><name name-style="western"><surname>Muraca</surname><given-names>M</given-names></name><name name-style="western"><surname>Truong</surname><given-names>C</given-names></name><name name-style="western"><surname>Ha</surname><given-names>R</given-names></name><name name-style="western"><surname>Choe</surname><given-names>AKB</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice</article-title><source>Can Pharm J (Ott)</source><year>2021</year><volume>154</volume><issue>(4)</issue><fpage>278</fpage>&#8211;<lpage>84</lpage><pub-id pub-id-type="doi">10.1177/17151635211014918</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34345321/" ext-link-type="uri">34345321</ext-link></comment><pub-id pub-id-type="pmid">34345321</pub-id><pub-id pub-id-type="pmcid">PMC8282922</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masse</surname><given-names>M</given-names></name><name name-style="western"><surname>Henry</surname><given-names>H</given-names></name><name name-style="western"><surname>Cuvelier</surname><given-names>E</given-names></name><name name-style="western"><surname>Pin&#231;on</surname><given-names>C</given-names></name><name name-style="western"><surname>Pavy</surname><given-names>M</given-names></name><name name-style="western"><surname>Beeuwsaert</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Sleep medication in older adults: identifying the need for support by a community pharmacist</article-title><source>Healthcare (Basel)</source><year>2022</year><volume>10</volume><issue>(1)</issue><fpage>147</fpage><pub-id pub-id-type="doi">10.3390/healthcare10010147</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35052310/" ext-link-type="uri">35052310</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775744" ext-link-type="uri">PMC8775744</ext-link><pub-id pub-id-type="pmid">35052310</pub-id><pub-id pub-id-type="pmcid">PMC8775744</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hutchinson</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>A</given-names></name><name name-style="western"><surname>Gruer</surname><given-names>L</given-names></name><name name-style="western"><surname>Barr</surname><given-names>C</given-names></name><name name-style="western"><surname>Mills</surname><given-names>C</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>L.</given-names></name></person-group><article-title>One&#8208;year follow&#8208;up of opiate injectors treated with oral methadone in a GP&#8208;centred programme</article-title><source>Addiction</source><year>2000</year><volume>95</volume><issue>(7)</issue><fpage>1055</fpage>&#8211;<lpage>68</lpage><pub-id pub-id-type="doi">10.1046/j.1360-0443.2000.95710557.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10962770/" ext-link-type="uri">10962770</ext-link></comment><pub-id pub-id-type="pmid">10962770</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaffray</surname><given-names>M</given-names></name><name name-style="western"><surname>Matheson</surname><given-names>C</given-names></name><name name-style="western"><surname>Bond</surname><given-names>CM</given-names></name><name name-style="western"><surname>Lee</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McLernon</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Johnstone</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial</article-title><source>Int J Pharm Pract</source><year>2013</year><volume>22</volume><issue>(1)</issue><fpage>4</fpage>&#8211;<lpage>12</lpage><pub-id pub-id-type="doi">10.1111/ijpp.12049</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23822820/" ext-link-type="uri">23822820</ext-link></comment><pub-id pub-id-type="pmid">23822820</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>J</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>ML</given-names></name><name name-style="western"><surname>Brick</surname><given-names>D</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>M-T</given-names></name><name name-style="western"><surname>Wasan</surname><given-names>AD</given-names></name><name name-style="western"><surname>Jamison</surname><given-names>RN</given-names></name><etal>et al.</etal></person-group><article-title>Implementation of a collaborative care management program with buprenorphine in primary care: a comparison between opioid-dependent patients and patients with chronic pain using opioids nonmedically</article-title><source>J Opioid Manag</source><year>2014</year><volume>10</volume><issue>(3)</issue><fpage>159</fpage>&#8211;<lpage>68</lpage><pub-id pub-id-type="doi">10.5055/jom.2014.0204</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24944066/" ext-link-type="uri">24944066</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085743" ext-link-type="uri">PMC4085743</ext-link><pub-id pub-id-type="pmid">24944066</pub-id><pub-id pub-id-type="pmcid">PMC4085743</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>J</given-names></name><name name-style="western"><surname>Colvard</surname><given-names>M.</given-names></name></person-group><article-title>Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention</article-title><source>J Subst Abus Treat</source><year>2021</year><volume>130</volume><issue>(1)</issue><fpage>108440</fpage><pub-id pub-id-type="doi">10.1016/j.jsat.2021.108440</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34118708/" ext-link-type="uri">34118708</ext-link></comment><pub-id pub-id-type="pmid">34118708</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yasin</surname><given-names>H</given-names></name><name name-style="western"><surname>Bulatova</surname><given-names>N</given-names></name><name name-style="western"><surname>Wazaify</surname><given-names>M.</given-names></name></person-group><article-title>Pharmaceutical care in the treatment of substance use disorders in Jordan: a randomized controlled trial</article-title><source>Subst Use Misuse</source><year>2021</year><volume>56</volume><issue>(12)</issue><fpage>1846</fpage>&#8211;<lpage>59</lpage><pub-id pub-id-type="doi">10.1080/10826084.2021.1958852</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34348564/" ext-link-type="uri">34348564</ext-link></comment><pub-id pub-id-type="pmid">34348564</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Binswanger</surname><given-names>IA</given-names></name><name name-style="western"><surname>Rinehart</surname><given-names>D</given-names></name><name name-style="western"><surname>Mueller</surname><given-names>SR</given-names></name><name name-style="western"><surname>Narwaney</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Stowell</surname><given-names>M</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>N</given-names></name><etal>et al.</etal></person-group><article-title>Naloxone co-dispensing with opioids: a cluster randomized pragmatic trial</article-title><source>J Gen Intern Med</source><year>2022</year><volume>37</volume><issue>(11)</issue><fpage>2624</fpage>&#8211;<lpage>33</lpage><pub-id pub-id-type="doi">10.1007/s11606-021-07356-6</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35132556/" ext-link-type="uri">35132556</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411391" ext-link-type="uri">PMC9411391</ext-link><pub-id pub-id-type="pmid">35132556</pub-id><pub-id pub-id-type="pmcid">PMC9411391</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehrhard</surname><given-names>K</given-names></name><name name-style="western"><surname>Colvard</surname><given-names>M</given-names></name><name name-style="western"><surname>Brabson</surname><given-names>J.</given-names></name></person-group><article-title>Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes</article-title><source>Ment Health Clin</source><year>2022</year><volume>12</volume><issue>(4)</issue><fpage>219</fpage>&#8211;<lpage>24</lpage><pub-id pub-id-type="doi">10.9740/mhc.2022.08.219</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36071740/" ext-link-type="uri">36071740</ext-link></comment><pub-id pub-id-type="pmid">36071740</pub-id><pub-id pub-id-type="pmcid">PMC9405629</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skoy</surname><given-names>E</given-names></name><name name-style="western"><surname>Frenzel</surname><given-names>O</given-names></name><name name-style="western"><surname>Eukel</surname><given-names>H</given-names></name><name name-style="western"><surname>Lothspeich</surname><given-names>E</given-names></name><name name-style="western"><surname>Steig</surname><given-names>J</given-names></name><name name-style="western"><surname>Strand</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Evaluation of a program to screen patients in community pharmacies for opioid misuse and accidental overdose</article-title><source>Prev Chronic Dis</source><year>2022</year><volume>19</volume>:
<fpage>E41</fpage><pub-id pub-id-type="doi">10.5888/pcd19.220028</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35834737/" ext-link-type="uri">35834737</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336191" ext-link-type="uri">PMC9336191</ext-link><pub-id pub-id-type="pmid">35834737</pub-id><pub-id pub-id-type="pmcid">PMC9336191</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sze</surname><given-names>J</given-names></name><name name-style="western"><surname>Chan</surname><given-names>T</given-names></name><name name-style="western"><surname>Dalpoas</surname><given-names>S</given-names></name><name name-style="western"><surname>Kiruthi</surname><given-names>C</given-names></name><name name-style="western"><surname>Harris</surname><given-names>CM</given-names></name><name name-style="western"><surname>Gundareddy</surname><given-names>V</given-names></name><etal>et al.</etal></person-group><article-title>Implementation of a pharmacist-led, multidisciplinary naloxone patient education program at an academic medical center</article-title><source>J Pharm Pract</source><year>2023</year><volume>36</volume><issue>(5)</issue><fpage>1201</fpage>&#8211;<lpage>10</lpage><pub-id pub-id-type="doi">10.1177/08971900221094268</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35484711/" ext-link-type="uri">35484711</ext-link></comment><pub-id pub-id-type="pmid">35484711</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maguire</surname><given-names>TA</given-names></name><name name-style="western"><surname>McElnay</surname><given-names>JC</given-names></name><name name-style="western"><surname>Drummond</surname><given-names>A.</given-names></name></person-group><article-title>A randomized controlled trial of a smoking cessation intervention based in community pharmacies</article-title><source>Addiction</source><year>2001</year><volume>96</volume><issue>(2)</issue><fpage>325</fpage>&#8211;<lpage>31</lpage><pub-id pub-id-type="doi">10.1046/j.1360-0443.2001.96232516.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11182878/" ext-link-type="uri">11182878</ext-link></comment><pub-id pub-id-type="pmid">11182878</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauld</surname><given-names>L</given-names></name><name name-style="western"><surname>Chesterman</surname><given-names>J</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>J</given-names></name><name name-style="western"><surname>Judge</surname><given-names>K.</given-names></name></person-group><article-title>A comparison of the effectiveness of group&#8208;based and pharmacy&#8208;led smoking cessation treatment in Glasgow</article-title><source>Addiction</source><year>2009</year><volume>104</volume><issue>(2)</issue><fpage>308</fpage>&#8211;<lpage>16</lpage><pub-id pub-id-type="doi">10.1111/j.1360-0443.2008.02446.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19149828/" ext-link-type="uri">19149828</ext-link></comment><pub-id pub-id-type="pmid">19149828</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dent</surname><given-names>LA</given-names></name><name name-style="western"><surname>Harris</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Noonan</surname><given-names>CW.</given-names></name></person-group><article-title>Randomized trial assessing the effectiveness of a pharmacist-delivered program for smoking cessation</article-title><source>Ann Pharmacother</source><year>2009</year><volume>43</volume><issue>(2)</issue><fpage>194</fpage>&#8211;<lpage>201</lpage><pub-id pub-id-type="doi">10.1345/aph.1L556</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19193572/" ext-link-type="uri">19193572</ext-link></comment><pub-id pub-id-type="pmid">19193572</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capoccia</surname><given-names>KL</given-names></name><name name-style="western"><surname>Boudreau</surname><given-names>DM</given-names></name><name name-style="western"><surname>Blough</surname><given-names>DK</given-names></name><name name-style="western"><surname>Ellsworth</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Clark</surname><given-names>DR</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>NG</given-names></name><etal>et al.</etal></person-group><article-title>Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care</article-title><source>Am J Health Syst Pharm</source><year>2004</year><volume>61</volume><issue>(4)</issue><fpage>364</fpage>&#8211;<lpage>72</lpage><pub-id pub-id-type="doi">10.1093/ajhp/61.4.364</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15011764/" ext-link-type="uri">15011764</ext-link></comment><pub-id pub-id-type="pmid">15011764</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauld</surname><given-names>L</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>KA</given-names></name><name name-style="western"><surname>Briggs</surname><given-names>AH</given-names></name><name name-style="western"><surname>Chesterman</surname><given-names>J</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>J</given-names></name><name name-style="western"><surname>Judge</surname><given-names>K</given-names></name><etal>et al.</etal></person-group><article-title>One-year outcomes and a cost-effectiveness analysis for smokers accessing group-based and pharmacy-led cessation services</article-title><source>Nicotine Tob Res</source><year>2011</year><volume>13</volume><issue>(2)</issue><fpage>135</fpage>&#8211;<lpage>45</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntq222</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21196451/" ext-link-type="uri">21196451</ext-link></comment><pub-id pub-id-type="pmid">21196451</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costello</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sproule</surname><given-names>B</given-names></name><name name-style="western"><surname>Victor</surname><given-names>JC</given-names></name><name name-style="western"><surname>Leatherdale</surname><given-names>ST</given-names></name><name name-style="western"><surname>Zawertailo</surname><given-names>L</given-names></name><name name-style="western"><surname>Selby</surname><given-names>P.</given-names></name></person-group><article-title>Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers</article-title><source>Cancer Causes Control</source><year>2011</year><volume>22</volume><issue>(2)</issue><fpage>167</fpage>&#8211;<lpage>80</lpage><pub-id pub-id-type="doi">10.1007/s10552-010-9672-9</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21153694/" ext-link-type="uri">21153694</ext-link></comment><pub-id pub-id-type="pmid">21153694</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mardle</surname><given-names>T</given-names></name><name name-style="western"><surname>Merrett</surname><given-names>S</given-names></name><name name-style="western"><surname>Wright</surname><given-names>J</given-names></name><name name-style="western"><surname>Percival</surname><given-names>F</given-names></name><name name-style="western"><surname>Lockhart</surname><given-names>I.</given-names></name></person-group><article-title>Real world evaluation of three models of NHS smoking cessation service in England</article-title><source>BMC Res Notes</source><year>2012</year><volume>5</volume><issue>(1)</issue>.
<pub-id pub-id-type="doi">10.1186/1756-0500-5-9</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22226240/" ext-link-type="uri">22226240</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309947" ext-link-type="uri">PMC3309947</ext-link><pub-id pub-id-type="pmcid">PMC3309947</pub-id><pub-id pub-id-type="pmid">22226240</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>TD</given-names></name><name name-style="western"><surname>Deen</surname><given-names>T</given-names></name><name name-style="western"><surname>Bryant-Bedell</surname><given-names>K</given-names></name><name name-style="western"><surname>Tate</surname><given-names>V</given-names></name><name name-style="western"><surname>Fortney</surname><given-names>J.</given-names></name></person-group><article-title>Does minority racial-ethnic status moderate outcomes of collaborative care for depression?</article-title><source>Psychiatr Serv</source><year>2011</year><volume>62</volume><issue>(11)</issue><fpage>1282</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1176/ps.62.11.pss6211_1282</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22211206/" ext-link-type="uri">22211206</ext-link></comment><pub-id pub-id-type="pmid">22211206</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>X</given-names></name><name name-style="western"><surname>Bachyrycz</surname><given-names>A</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Tinker</surname><given-names>D</given-names></name><name name-style="western"><surname>Raisch</surname><given-names>DW.</given-names></name></person-group><article-title>Quitting patterns and predictors of success among participants in a tobacco cessation program provided by pharmacists in New Mexico</article-title><source>J Manag Care Spec Pharm</source><year>2014</year><volume>20</volume><issue>(6)</issue><fpage>579</fpage>&#8211;<lpage>87</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2014.20.6.579</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/24856596/" ext-link-type="uri">24856596</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437766" ext-link-type="uri">PMC10437766</ext-link><pub-id pub-id-type="pmid">24856596</pub-id><pub-id pub-id-type="pmcid">PMC10437766</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Augustine</surname><given-names>JM</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>AM</given-names></name><name name-style="western"><surname>Pelger</surname><given-names>M</given-names></name><name name-style="western"><surname>Schiefer</surname><given-names>D</given-names></name><name name-style="western"><surname>Warholak</surname><given-names>TL.</given-names></name></person-group><article-title>Smoking quit rates among patients receiving pharmacist-provided pharmacotherapy and telephonic smoking cessation counseling</article-title><source>J Am Pharm Assoc (2003)</source><year>2016</year><volume>56</volume><issue>(2)</issue><fpage>129</fpage>&#8211;<lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2016.02.001</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27000162/" ext-link-type="uri">27000162</ext-link></comment><pub-id pub-id-type="pmid">27000162</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fai</surname><given-names>SC</given-names></name><name name-style="western"><surname>Yen</surname><given-names>GK</given-names></name><name name-style="western"><surname>Malik</surname><given-names>N.</given-names></name></person-group><article-title>Quit rates at 6 months in a pharmacist-led smoking cessation service in Malaysia</article-title><source>Can Pharm J</source><year>2016</year><volume>149</volume><issue>(5)</issue><fpage>303</fpage>&#8211;<lpage>12</lpage><pub-id pub-id-type="doi">10.1177/1715163516662894</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27708676/" ext-link-type="uri">27708676</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032936" ext-link-type="uri">PMC5032936</ext-link><pub-id pub-id-type="pmcid">PMC5032936</pub-id><pub-id pub-id-type="pmid">27708676</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gong</surname><given-names>J</given-names></name><name name-style="western"><surname>Baker</surname><given-names>CL</given-names></name><name name-style="western"><surname>Zou</surname><given-names>KH</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>M</given-names></name><name name-style="western"><surname>Jumadilova</surname><given-names>Z</given-names></name><name name-style="western"><surname>Lawrence</surname><given-names>D</given-names></name><etal>et al.</etal></person-group><article-title>A pragmatic randomized trial comparing telephone-based enhanced pharmacy care and usual care to support smoking cessation</article-title><source>J Manag Care Spec Pharm</source><year>2016</year><volume>22</volume><issue>(12)</issue><fpage>1417</fpage>&#8211;<lpage>25</lpage><pub-id pub-id-type="doi">10.18553/jmcp.2016.22.12.1417</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27882838/" ext-link-type="uri">27882838</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397624" ext-link-type="uri">PMC10397624</ext-link><pub-id pub-id-type="pmid">27882838</pub-id><pub-id pub-id-type="pmcid">PMC10397624</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El Hajj</surname><given-names>MS</given-names></name><name name-style="western"><surname>Kheir</surname><given-names>N</given-names></name><name name-style="western"><surname>Al Mulla</surname><given-names>AM</given-names></name><name name-style="western"><surname>Shami</surname><given-names>R</given-names></name><name name-style="western"><surname>Fanous</surname><given-names>N</given-names></name><name name-style="western"><surname>Mahfoud</surname><given-names>ZR.</given-names></name></person-group><article-title>Effectiveness of a pharmacist-delivered smoking cessation program in the state of Qatar: a randomized controlled trial</article-title><source>BMC Public Health</source><year>2017</year><volume>17</volume><issue>(1)</issue>.
<pub-id pub-id-type="doi">10.1186/s12889-017-4103-4</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28219367/" ext-link-type="uri">28219367</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319062" ext-link-type="uri">PMC5319062</ext-link><pub-id pub-id-type="pmcid">PMC5319062</pub-id><pub-id pub-id-type="pmid">28219367</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forinash</surname><given-names>AB</given-names></name><name name-style="western"><surname>Yancey</surname><given-names>A</given-names></name><name name-style="western"><surname>Chamness</surname><given-names>D</given-names></name><name name-style="western"><surname>Koerner</surname><given-names>J</given-names></name><name name-style="western"><surname>Inteso</surname><given-names>C</given-names></name><name name-style="western"><surname>Miller</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>Smoking cessation following text message intervention in pregnant women</article-title><source>Ann Pharmacother</source><year>2018</year><volume>52</volume><issue>(11)</issue><fpage>1109</fpage>&#8211;<lpage>16</lpage><pub-id pub-id-type="doi">10.1177/1060028018780448</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29857773/" ext-link-type="uri">29857773</ext-link></comment><pub-id pub-id-type="pmid">29857773</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>VW</given-names></name><name name-style="western"><surname>Lam</surname><given-names>J</given-names></name><name name-style="western"><surname>Heise</surname><given-names>P</given-names></name><name name-style="western"><surname>Reid</surname><given-names>RD</given-names></name><name name-style="western"><surname>Mullen</surname><given-names>KA.</given-names></name></person-group><article-title>Implementation of a pharmacist-led inpatient tobacco cessation intervention in a rehabilitation hospital: a before-and-after pilot study</article-title><source>Can J Hosp Pharm</source><year>2018</year><volume>71</volume><issue>(3)</issue><fpage>180</fpage>&#8211;<lpage>6</lpage><pub-id pub-id-type="pmid">29955191</pub-id><pub-id pub-id-type="pmcid">PMC6019087</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litke</surname><given-names>J</given-names></name><name name-style="western"><surname>Spoutz</surname><given-names>L</given-names></name><name name-style="western"><surname>Ahlstrom</surname><given-names>D</given-names></name><name name-style="western"><surname>Perdew</surname><given-names>C</given-names></name><name name-style="western"><surname>Llamas</surname><given-names>W</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>K.</given-names></name></person-group><article-title>Impact of the clinical pharmacy specialist in telehealth primary care</article-title><source>Am J Health Syst Pharm</source><year>2018</year><volume>75</volume><issue>(13)</issue><fpage>982</fpage>&#8211;<lpage>6</lpage><pub-id pub-id-type="doi">10.2146/ajhp170633</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29941537/" ext-link-type="uri">29941537</ext-link></comment><pub-id pub-id-type="pmid">29941537</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>HM</given-names></name><name name-style="western"><surname>Liu</surname><given-names>WC</given-names></name><name name-style="western"><surname>Chua</surname><given-names>G</given-names></name><name name-style="western"><surname>Liew</surname><given-names>CF</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Choo</surname><given-names>W</given-names></name><etal>et al.</etal></person-group><article-title>Impact of a pharmacy-led smoking cessation clinic in a dermatology centre</article-title><source>Singapore Med J</source><year>2019</year><volume>60</volume><issue>(1)</issue><fpage>31</fpage>&#8211;<lpage>3</lpage><pub-id pub-id-type="doi">10.11622/smedj.2018063</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29774362/" ext-link-type="uri">29774362</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351693" ext-link-type="uri">PMC6351693</ext-link><pub-id pub-id-type="pmid">29774362</pub-id><pub-id pub-id-type="pmcid">PMC6351693</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beaupre</surname><given-names>L</given-names></name><name name-style="western"><surname>Hammal</surname><given-names>F</given-names></name><name name-style="western"><surname>Stiegelmar</surname><given-names>R</given-names></name><name name-style="western"><surname>Masson</surname><given-names>E</given-names></name><name name-style="western"><surname>Finegan</surname><given-names>B.</given-names></name></person-group><article-title>A community-based pharmacist-led smoking cessation program, before elective total joint replacement surgery, markedly enhances smoking cessation rates</article-title><source>Tob Induc Dis</source><year>2020</year><volume>18</volume>:
<fpage>1</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="doi">10.18332/tid/126405</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33013274/" ext-link-type="uri">33013274</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528266" ext-link-type="uri">PMC7528266</ext-link><pub-id pub-id-type="pmcid">PMC7528266</pub-id><pub-id pub-id-type="pmid">33013274</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Condinho</surname><given-names>M</given-names></name><name name-style="western"><surname>Ramalhinho</surname><given-names>I</given-names></name><name name-style="western"><surname>Sinogas</surname><given-names>C.</given-names></name></person-group><article-title>Smoking cessation at the community pharmacy: determinants of success from a real-life practice</article-title><source>Pharmacy (Basel)</source><year>2021</year><volume>9</volume><issue>(3)</issue><fpage>143</fpage><pub-id pub-id-type="doi">10.3390/pharmacy9030143</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34449711/" ext-link-type="uri">34449711</ext-link></comment><pub-id pub-id-type="pmid">34449711</pub-id><pub-id pub-id-type="pmcid">PMC8396305</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gobarani</surname><given-names>RK</given-names></name><name name-style="western"><surname>Zwar</surname><given-names>NA</given-names></name><name name-style="western"><surname>Russell</surname><given-names>G</given-names></name><name name-style="western"><surname>Abramson</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Bonevski</surname><given-names>B</given-names></name><name name-style="western"><surname>Holland</surname><given-names>AE</given-names></name><etal>et al.</etal></person-group><article-title>Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial</article-title><source>Br J Gen Pract</source><year>2021</year><volume>71</volume><issue>(707)</issue><fpage>e458-64</fpage><pub-id pub-id-type="doi">10.3399/BJGP.2020.0906</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33947668/" ext-link-type="uri">33947668</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103929" ext-link-type="uri">PMC8103929</ext-link><pub-id pub-id-type="pmid">33947668</pub-id><pub-id pub-id-type="pmcid">PMC8103929</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lertsinudom</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaewketthong</surname><given-names>P</given-names></name><name name-style="western"><surname>Chankaew</surname><given-names>T</given-names></name><name name-style="western"><surname>Chinwong</surname><given-names>D</given-names></name><name name-style="western"><surname>Chinwong</surname><given-names>S.</given-names></name></person-group><article-title>Smoking cessation services by community pharmacists: real-world practice in Thailand</article-title><source>Int J Environ Res Public Health</source><year>2021</year><volume>18</volume><issue>(22)</issue><fpage>11890</fpage><pub-id pub-id-type="doi">10.3390/ijerph182211890</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34831660/" ext-link-type="uri">34831660</ext-link></comment><pub-id pub-id-type="pmid">34831660</pub-id><pub-id pub-id-type="pmcid">PMC8620368</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Onda</surname><given-names>M</given-names></name><name name-style="western"><surname>Horiguchi</surname><given-names>M</given-names></name><name name-style="western"><surname>Domichi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakane</surname><given-names>N.</given-names></name></person-group><article-title>A pragmatic pilot cluster-randomized study of tobacco screening and smoking cessation program for community pharmacies in Japan: FINE program</article-title><source>J Smok Cessat</source><year>2021</year><volume>2021</volume>:
<fpage>9983515</fpage><pub-id pub-id-type="doi">10.1155/2021/9983515</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34956405/" ext-link-type="uri">34956405</ext-link></comment><pub-id pub-id-type="pmid">34956405</pub-id><pub-id pub-id-type="pmcid">PMC8664521</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tse</surname><given-names>SS</given-names></name><name name-style="western"><surname>Sands</surname><given-names>BE</given-names></name><name name-style="western"><surname>Keefer</surname><given-names>L</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>BL</given-names></name><name name-style="western"><surname>Maser</surname><given-names>E</given-names></name><name name-style="western"><surname>Ungaro</surname><given-names>RC</given-names></name><etal>et al.</etal></person-group><article-title>Improved smoking cessation rates in a pharmacist-led program embedded in an inflammatory bowel disease specialty medical home</article-title><source>J Pharm Pract</source><year>2022</year><volume>35</volume><issue>(6)</issue><fpage>827</fpage>&#8211;<lpage>35</lpage><pub-id pub-id-type="doi">10.1177/08971900211000682</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33827316/" ext-link-type="uri">33827316</ext-link></comment><pub-id pub-id-type="pmid">33827316</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asayut</surname><given-names>N</given-names></name><name name-style="western"><surname>Olson</surname><given-names>PS</given-names></name><name name-style="western"><surname>Kanjanasilp</surname><given-names>J</given-names></name><name name-style="western"><surname>Thanarat</surname><given-names>P</given-names></name><name name-style="western"><surname>Senkraigul</surname><given-names>B</given-names></name><name name-style="western"><surname>Sittisarn</surname><given-names>C</given-names></name><etal>et al.</etal></person-group><article-title>A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): a randomized controlled trial</article-title><source>Taheri S. PLoS One</source><year>2022</year><volume>17</volume><issue>(3)</issue><fpage>e0265483</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0265483</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35349576/" ext-link-type="uri">35349576</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963551" ext-link-type="uri">PMC8963551</ext-link><pub-id pub-id-type="pmcid">PMC8963551</pub-id><pub-id pub-id-type="pmid">35349576</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cameron</surname><given-names>CR</given-names></name><name name-style="western"><surname>Ewachiw</surname><given-names>B</given-names></name><name name-style="western"><surname>Chasler</surname><given-names>JE</given-names></name><name name-style="western"><surname>Dalpoas</surname><given-names>SE</given-names></name><name name-style="western"><surname>V&#225;zquez</surname><given-names>J</given-names></name><name name-style="western"><surname>Burdalski</surname><given-names>C.</given-names></name></person-group><article-title>Assisted versus referred pharmacy smoking interventions for patients with thoracic malignancies or pulmonary nodules</article-title><source>Drug Alcohol Depend</source><year>2022</year><volume>236</volume><issue>(2)</issue><fpage>109465</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2022.109465</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35490592/" ext-link-type="uri">35490592</ext-link></comment><pub-id pub-id-type="pmid">35490592</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guthrie</surname><given-names>AR.</given-names></name></person-group><article-title>Pharmacist-assisted varenicline tobacco cessation treatment for veterans</article-title><source>Fed Pract</source><year>2022</year><volume>39</volume><issue>(7)</issue><fpage>304</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.12788/fp.0290</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36425350/" ext-link-type="uri">36425350</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9648582" ext-link-type="uri">PMC9648582</ext-link><pub-id pub-id-type="pmid">36425350</pub-id><pub-id pub-id-type="pmcid">PMC9648582</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hartman-Filson</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>P</given-names></name><name name-style="western"><surname>Phan</surname><given-names>M</given-names></name><name name-style="western"><surname>Apollonio</surname><given-names>DE</given-names></name><name name-style="western"><surname>Kroon</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>A community-based tobacco cessation program for individuals experiencing homelessness</article-title><source>Addict Behav</source><year>2022</year><volume>129</volume><issue>(10)</issue><fpage>107282</fpage><pub-id pub-id-type="doi">10.1016/j.addbeh.2022.107282</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35184003/" ext-link-type="uri">35184003</ext-link></comment><pub-id pub-id-type="pmid">35184003</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>S-K</given-names></name><name name-style="western"><surname>Kang</surname><given-names>D-W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>E-K.</given-names></name></person-group><article-title>Cost-effectiveness analysis of smoking cessation interventions with behavioral support: a study based on the benefits of smoking cessation on outcomes (BENESCO) model</article-title><source>Nicotine Tob Res</source><year>2022</year><volume>24</volume><issue>(12)</issue><fpage>2011</fpage>&#8211;<lpage>17</lpage><pub-id pub-id-type="doi">10.1093/ntr/ntac172</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35862219/" ext-link-type="uri">35862219</ext-link></comment><pub-id pub-id-type="pmid">35862219</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>LCE</given-names></name><name name-style="western"><surname>Nguyen</surname><given-names>H</given-names></name><name name-style="western"><surname>Genge</surname><given-names>TL</given-names></name><name name-style="western"><surname>Maddigan</surname><given-names>WJ.</given-names></name></person-group><article-title>Effectiveness and cost-effectiveness of an intensive and abbreviated individualized smoking cessation program delivered by pharmacists: a pragmatic, mixed-method, randomized trial</article-title><source>Can Pharm J</source><year>2022</year><volume>155</volume><issue>(6)</issue><fpage>334</fpage>&#8211;<lpage>44</lpage><pub-id pub-id-type="doi">10.1177/17151635221128263</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36386606/" ext-link-type="uri">36386606</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647399" ext-link-type="uri">PMC9647399</ext-link><pub-id pub-id-type="pmcid">PMC9647399</pub-id><pub-id pub-id-type="pmid">36386606</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malone</surname><given-names>M</given-names></name><name name-style="western"><surname>Alger-Mayer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>DA.</given-names></name></person-group><article-title>the lifestyle challenge program: a multidisciplinary approach to weight management</article-title><source>Ann Pharmacother</source><year>2005</year><volume>39</volume><issue>(12)</issue><fpage>2015</fpage>&#8211;<lpage>20</lpage><pub-id pub-id-type="doi">10.1345/aph.1G287</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/16288070/" ext-link-type="uri">16288070</ext-link></comment><pub-id pub-id-type="pmid">16288070</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taveira</surname><given-names>TH</given-names></name><name name-style="western"><surname>Pirraglia</surname><given-names>PA</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>LB</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W&#8208;C.</given-names></name></person-group><article-title>Efficacy of a pharmacist&#8208;led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions</article-title><source>Prev Cardiol</source><year>2008</year><volume>11</volume><issue>(4)</issue><fpage>195</fpage>&#8211;<lpage>200</lpage><pub-id pub-id-type="doi">10.1111/j.1751-7141.2008.00008.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19476571/" ext-link-type="uri">19476571</ext-link></comment><pub-id pub-id-type="pmid">19476571</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansen</surname><given-names>RA</given-names></name><name name-style="western"><surname>Dusetzina</surname><given-names>SB</given-names></name><name name-style="western"><surname>Song</surname><given-names>L</given-names></name><name name-style="western"><surname>Gaynes</surname><given-names>BN</given-names></name><name name-style="western"><surname>Tu</surname><given-names>W</given-names></name><name name-style="western"><surname>Murray</surname><given-names>MD.</given-names></name></person-group><article-title>Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients</article-title><source>J Am Pharm Assoc (2003)</source><year>2009</year><volume>49</volume><issue>(6)</issue><fpage>760</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1331/JAPhA.2009.08184</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19926556/" ext-link-type="uri">19926556</ext-link></comment><pub-id pub-id-type="pmid">19926556</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hohmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Klotz</surname><given-names>JM</given-names></name><name name-style="western"><surname>Radziwill</surname><given-names>R</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>AH</given-names></name><name name-style="western"><surname>Kissel</surname><given-names>T.</given-names></name></person-group><article-title>Pharmaceutical care for patients with ischemic stroke: improving the patients quality of life</article-title><source>Pharm World Sci</source><year>2009</year><volume>31</volume><issue>(5)</issue><fpage>550</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1007/s11096-009-9315-y</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/19633917/" ext-link-type="uri">19633917</ext-link></comment><pub-id pub-id-type="pmid">19633917</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hohmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Radziwill</surname><given-names>R</given-names></name><name name-style="western"><surname>Klotz</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>AH.</given-names></name></person-group><article-title>Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (Pharmaceutical Care Concept)</article-title><source>Health Qual Life Outcomes</source><year>2010</year><volume>8</volume><issue>(1)</issue><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/1477-7525-8-59</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20565872/" ext-link-type="uri">20565872</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894785" ext-link-type="uri">PMC2894785</ext-link><pub-id pub-id-type="pmid">20565872</pub-id><pub-id pub-id-type="pmcid">PMC2894785</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Fortney</surname><given-names>JC</given-names></name><name name-style="western"><surname>Curran</surname><given-names>GM</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>S</given-names></name><name name-style="western"><surname>Atkinson</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kilbourne</surname><given-names>AM</given-names></name><etal>et al.</etal></person-group><article-title>Effectiveness of collaborative care for depression in human immunodeficiency virus clinics</article-title><source>Arch Intern Med</source><year>2010</year><volume>171</volume><issue>(1)</issue><fpage>23</fpage>&#8211;<lpage>31</lpage><pub-id pub-id-type="doi">10.1001/archinternmed.2010.395</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/21220657/" ext-link-type="uri">21220657</ext-link></comment><pub-id pub-id-type="pmid">21220657</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taveira</surname><given-names>TH</given-names></name><name name-style="western"><surname>Dooley</surname><given-names>AG</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>LB</given-names></name><name name-style="western"><surname>Khatana</surname><given-names>SAM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>W-C.</given-names></name></person-group><article-title>Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults</article-title><source>Ann Pharmacother</source><year>2011</year><volume>45</volume><issue>(11)</issue><fpage>1346</fpage>&#8211;<lpage>55</lpage><pub-id pub-id-type="doi">10.1345/aph.1Q212</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22028418/" ext-link-type="uri">22028418</ext-link></comment><pub-id pub-id-type="pmid">22028418</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carri&#243;n</surname><given-names>JA</given-names></name><name name-style="western"><surname>Gonzalez-Colominas</surname><given-names>E</given-names></name><name name-style="western"><surname>Garc&#237;a-Retortillo</surname><given-names>M</given-names></name><name name-style="western"><surname>Ca&#241;ete</surname><given-names>N</given-names></name><name name-style="western"><surname>Cirera</surname><given-names>I</given-names></name><name name-style="western"><surname>Coll</surname><given-names>S</given-names></name><etal>et al.</etal></person-group><article-title>A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C</article-title><source>J Hepatol</source><year>2013</year><volume>59</volume><issue>(5)</issue><fpage>926</fpage>&#8211;<lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2013.06.019</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23811030/" ext-link-type="uri">23811030</ext-link></comment><pub-id pub-id-type="pmid">23811030</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ummavathy</surname><given-names>P</given-names></name><name name-style="western"><surname>Sherina</surname><given-names>MS</given-names></name><name name-style="western"><surname>Rampal</surname><given-names>L</given-names></name><name name-style="western"><surname>Siti Irma Fadhilah</surname><given-names>I.</given-names></name></person-group><article-title>Outcome of chemotherapy counseling by pharmacists on psychological effects and self esteem among oncology patients in a government hospital in Malaysia</article-title><source>Med J Malaysia</source><year>2015</year><volume>70</volume><issue>(3)</issue><fpage>131</fpage>&#8211;<lpage>41</lpage><pub-id pub-id-type="pmid">26248774</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milkovich</surname><given-names>SA</given-names></name><name name-style="western"><surname>Rychel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Pascuzzi</surname><given-names>KM</given-names></name><etal>et al.</etal></person-group><article-title>Serious mental illness and its impact on diabetes care in a VA nurse/pharmacist-managed population</article-title><source>Fed Pract</source><year>2017</year><volume>34</volume><issue>(Suppl 8)</issue>:
<fpage>S32</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="pmid">30766314</pub-id><pub-id pub-id-type="pmcid">PMC6375526</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanwal</surname><given-names>F</given-names></name><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Tavakoli-Tabasi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>S</given-names></name><name name-style="western"><surname>Dieckgraefe</surname><given-names>B</given-names></name><name name-style="western"><surname>Storay</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>A randomized trial of off-site collaborative care for depression in chronic hepatitis C virus</article-title><source>Health Serv Res</source><year>2018</year><volume>53</volume><issue>(4)</issue><fpage>2547</fpage>&#8211;<lpage>66</lpage><pub-id pub-id-type="doi">10.1111/1475-6773.12758</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28891153/" ext-link-type="uri">28891153</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6051980" ext-link-type="uri">PMC6051980</ext-link><pub-id pub-id-type="pmid">28891153</pub-id><pub-id pub-id-type="pmcid">PMC6051980</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Byrd</surname><given-names>KK</given-names></name><name name-style="western"><surname>Hardnett</surname><given-names>F</given-names></name><name name-style="western"><surname>Hou</surname><given-names>JG</given-names></name><name name-style="western"><surname>Clay</surname><given-names>PG</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>S</given-names></name><name name-style="western"><surname>Camp</surname><given-names>NM</given-names></name><etal>et al.</etal></person-group><article-title>Improvements in retention in care and HIV viral suppression among persons with HIV and comorbid mental health conditions: patient-centered HIV care model</article-title><source>AIDS Behav</source><year>2020</year><volume>24</volume><issue>(12)</issue><fpage>3522</fpage>&#8211;<lpage>32</lpage><pub-id pub-id-type="doi">10.1007/s10461-020-02913-2</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32415615/" ext-link-type="uri">32415615</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666642" ext-link-type="uri">PMC7666642</ext-link><pub-id pub-id-type="pmid">32415615</pub-id><pub-id pub-id-type="pmcid">PMC7666642</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Foster</surname><given-names>MG</given-names></name><name name-style="western"><surname>Toll</surname><given-names>BA</given-names></name><name name-style="western"><surname>Ware</surname><given-names>E</given-names></name><name name-style="western"><surname>Eckard</surname><given-names>AR</given-names></name><name name-style="western"><surname>Sterba</surname><given-names>KR</given-names></name><name name-style="western"><surname>Rojewski</surname><given-names>AM.</given-names></name></person-group><article-title>Optimizing the implementation of tobacco treatment for people with HIV: a pilot study</article-title><source>Int J Environ Res Public Health</source><year>2022</year><volume>19</volume><issue>(19)</issue><fpage>12896</fpage><pub-id pub-id-type="doi">10.3390/ijerph191912896</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36232195/" ext-link-type="uri">36232195</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566573" ext-link-type="uri">PMC9566573</ext-link><pub-id pub-id-type="pmid">36232195</pub-id><pub-id pub-id-type="pmcid">PMC9566573</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Losada-Camacho</surname><given-names>M.</given-names></name></person-group><article-title>Effect of pharmaceutical care program on depression among women with epilepsy: a randomized controlled trial (IPHIWWE study)</article-title><source>Epilepsy Behav</source><year>2022</year><volume>129</volume><issue>(4)</issue><fpage>108559</fpage><pub-id pub-id-type="doi">10.1016/j.yebeh.2022.108559</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35180569/" ext-link-type="uri">35180569</ext-link></comment><pub-id pub-id-type="pmid">35180569</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans</surname><given-names>RL</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>RF</given-names></name><name name-style="western"><surname>Walker</surname><given-names>PW</given-names></name><name name-style="western"><surname>Rosenbluth</surname><given-names>SA</given-names></name><name name-style="western"><surname>McDonald</surname><given-names>J.</given-names></name></person-group><article-title>Medication maintenance of mentally ill patients by a pharmacist in a community setting</article-title><source>Am J Hosp Pharm</source><year>1976</year><volume>33</volume><issue>(7)</issue><fpage>635</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="pmid">941914</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dugas</surname><given-names>JE</given-names></name><name name-style="western"><surname>Brown</surname><given-names>S.</given-names></name></person-group><article-title>Community mental health centers: a milieu for expansion of pharmacist services</article-title><source>Hosp Pharm</source><year>1978</year><volume>13</volume><issue>(2)</issue><fpage>78, 81</fpage>&#8211;<lpage>82, 84</lpage><comment>passim</comment><pub-id pub-id-type="pmid">10306348</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dobbs</surname><given-names>JH.</given-names></name></person-group><article-title>Drug histories obtained by pharmacists from psychiatric inpatients</article-title><source>Hosp Community Psychiatry</source><year>1981</year><volume>32</volume><issue>(9)</issue><fpage>639</fpage>&#8211;<lpage>40</lpage><pub-id pub-id-type="doi">10.1176/ps.32.9.639</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/7275041/" ext-link-type="uri">7275041</ext-link></comment><pub-id pub-id-type="pmid">7275041</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stimmel</surname><given-names>GL</given-names></name><name name-style="western"><surname>McGhan</surname><given-names>WF</given-names></name><name name-style="western"><surname>Wincor</surname><given-names>MZ</given-names></name><name name-style="western"><surname>Deandrea</surname><given-names>DM.</given-names></name></person-group><article-title>Comparison of pharmacist and physician prescribing for psychiatric inpatients</article-title><source>Am J Hosp Pharm</source><year>1982</year><volume>39</volume><issue>(9)</issue><fpage>1483</fpage>&#8211;<lpage>6</lpage><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/6127948/" ext-link-type="uri">6127948</ext-link></comment><pub-id pub-id-type="pmid">6127948</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saklad</surname><given-names>SR</given-names></name><name name-style="western"><surname>Ereshefsky</surname><given-names>L</given-names></name><name name-style="western"><surname>Jann</surname><given-names>MW</given-names></name><name name-style="western"><surname>Crismon</surname><given-names>ML.</given-names></name></person-group><article-title>Clinical pharmacists&#8217; impact on prescribing in an acute adult psychiatric facility</article-title><source>Drug Intell Clin Pharm</source><year>1984</year><volume>18</volume><issue>(7-8)</issue><fpage>632</fpage>&#8211;<lpage>4</lpage><pub-id pub-id-type="doi">10.1177/106002808401800718</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/6745092/" ext-link-type="uri">6745092</ext-link></comment><pub-id pub-id-type="pmid">6745092</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahrens</surname><given-names>TN</given-names></name><name name-style="western"><surname>Sramek</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Herrera</surname><given-names>JM</given-names></name><name name-style="western"><surname>Jewett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Alcorn</surname><given-names>VE.</given-names></name></person-group><article-title>Pharmacy-based screening program for tardive dyskinesia</article-title><source>Drug Intell Clin Pharm</source><year>1988</year><volume>22</volume><issue>(3)</issue><fpage>205</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1177/106002808802200305</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2896586/" ext-link-type="uri">2896586</ext-link></comment><pub-id pub-id-type="pmid">2896586</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolf-Klein</surname><given-names>GP</given-names></name><name name-style="western"><surname>Levy</surname><given-names>AP</given-names></name><name name-style="western"><surname>Silverstone</surname><given-names>FA</given-names></name><name name-style="western"><surname>Smith</surname><given-names>H</given-names></name><name name-style="western"><surname>Papain</surname><given-names>P</given-names></name><name name-style="western"><surname>Foley</surname><given-names>CJ.</given-names></name></person-group><article-title>Psychiatric profile of the noncompliant geriatric patient in the community</article-title><source>Int Psychogeriatr</source><year>1989</year><volume>1</volume><issue>(2)</issue><fpage>177</fpage>&#8211;<lpage>84</lpage><pub-id pub-id-type="doi">10.1017/s1041610289000189</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/2491144/" ext-link-type="uri">2491144</ext-link></comment><pub-id pub-id-type="pmid">2491144</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bransgrove</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>MW.</given-names></name></person-group><article-title>Movement disorders in patients treated with long-acting injectable antipsychotic drugs</article-title><source>Am J Health Syst Pharm</source><year>1994</year><volume>51</volume><issue>(7)</issue><fpage>895</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1093/ajhp/51.7.895</pub-id><pub-id pub-id-type="pmid">7912473</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furniss</surname><given-names>L</given-names></name><name name-style="western"><surname>Burns</surname><given-names>A</given-names></name><name name-style="western"><surname>Craig</surname><given-names>SKL</given-names></name><name name-style="western"><surname>Scobie</surname><given-names>S</given-names></name><name name-style="western"><surname>Cooke</surname><given-names>J</given-names></name><name name-style="western"><surname>Faragher</surname><given-names>B.</given-names></name></person-group><article-title>Effects of a pharmacist&#8217;s medication review in nursing homes</article-title><source>Br J Psychiatry</source><year>2000</year><volume>176</volume><issue>(6)</issue><fpage>563</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="doi">10.1192/bjp.176.6.563</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10974963/" ext-link-type="uri">10974963</ext-link></comment><pub-id pub-id-type="pmid">10974963</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoner</surname><given-names>SC</given-names></name><name name-style="western"><surname>Worrel</surname><given-names>JA</given-names></name><name name-style="western"><surname>Jones</surname><given-names>MT</given-names></name><name name-style="western"><surname>Farrar</surname><given-names>CA</given-names></name><name name-style="western"><surname>Ramlatchman</surname><given-names>LV.</given-names></name></person-group><article-title>Pharmacist&#8208;designed and &#8208;implemented pharmaceutical care plan for antipsychotic&#8208;induced movement disorders</article-title><source>Pharmacotherapy</source><year>2000</year><volume>20</volume><issue>(5)</issue><fpage>583</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1592/phco.20.6.583.35159</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/10809346/" ext-link-type="uri">10809346</ext-link></comment><pub-id pub-id-type="pmid">10809346</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Eijk</surname><given-names>MEC.</given-names></name></person-group><article-title>Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic</article-title><source>BMJ</source><year>2001</year><volume>322</volume><issue>(7287)</issue><fpage>654</fpage><pub-id pub-id-type="doi">10.1136/bmj.322.7287.654</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11250852/" ext-link-type="uri">11250852</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC26547" ext-link-type="uri">PMC26547</ext-link><pub-id pub-id-type="pmid">11250852</pub-id><pub-id pub-id-type="pmcid">PMC26547</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brophy</surname><given-names>GM</given-names></name><name name-style="western"><surname>Tesoro</surname><given-names>EP</given-names></name><name name-style="western"><surname>Schrote</surname><given-names>GL</given-names></name><name name-style="western"><surname>Garnett</surname><given-names>WR.</given-names></name></person-group><article-title>Pharmacist impact on posttraumatic seizure prophylaxis in patients with head injury</article-title><source>Pharmacotherapy</source><year>2002</year><volume>22</volume><issue>(2)</issue><fpage>251</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.1592/phco.22.3.251.33547</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/11837562/" ext-link-type="uri">11837562</ext-link></comment><pub-id pub-id-type="pmid">11837562</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adler</surname><given-names>DA</given-names></name><name name-style="western"><surname>Bungay</surname><given-names>KM</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>IB</given-names></name><name name-style="western"><surname>Pei</surname><given-names>Y</given-names></name><name name-style="western"><surname>Supran</surname><given-names>S</given-names></name><name name-style="western"><surname>Peckham</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients</article-title><source>Gen Hosp Psychiatry</source><year>2004</year><volume>26</volume><issue>(3)</issue><fpage>199</fpage>&#8211;<lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.genhosppsych.2003.08.005</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/15121348/" ext-link-type="uri">15121348</ext-link></comment><pub-id pub-id-type="pmid">15121348</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crockett</surname><given-names>J</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>S</given-names></name><name name-style="western"><surname>Grabham</surname><given-names>A</given-names></name><name name-style="western"><surname>Stanford</surname><given-names>P.</given-names></name></person-group><article-title>Patient outcomes following an intervention involving community pharmacists in the management of depression</article-title><source>Aust J Rural Health</source><year>2006</year><volume>14</volume><issue>(6)</issue><fpage>263</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1584.2006.00827.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/17121506/" ext-link-type="uri">17121506</ext-link></comment><pub-id pub-id-type="pmid">17121506</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caballero</surname><given-names>J</given-names></name><name name-style="western"><surname>Souffrant</surname><given-names>G</given-names></name><name name-style="western"><surname>Heffernan</surname><given-names>E.</given-names></name></person-group><article-title>Development and outcomes of a psychiatric pharmacy clinic for indigent patients</article-title><source>Am J Health Syst Pharm</source><year>2008</year><volume>65</volume><issue>(3)</issue><fpage>229</fpage>&#8211;<lpage>33</lpage><pub-id pub-id-type="doi">10.2146/ajhp070266</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/18216008/" ext-link-type="uri">18216008</ext-link></comment><pub-id pub-id-type="pmid">18216008</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patterson</surname><given-names>SM</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>CM</given-names></name><name name-style="western"><surname>Crealey</surname><given-names>G</given-names></name><name name-style="western"><surname>Cardwell</surname><given-names>C</given-names></name><name name-style="western"><surname>Lapane</surname><given-names>KL.</given-names></name></person-group><article-title>An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland Study)</article-title><source>J Am Geriatrics Soc</source><year>2010</year><volume>58</volume><issue>(1)</issue><fpage>44</fpage>&#8211;<lpage>53</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2009.02617.x</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/20002510/" ext-link-type="uri">20002510</ext-link></comment><pub-id pub-id-type="pmid">20002510</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Davis</surname><given-names>TD</given-names></name><name name-style="western"><surname>Deen</surname><given-names>T</given-names></name><name name-style="western"><surname>Bryant-Bedell</surname><given-names>K</given-names></name><name name-style="western"><surname>Tate</surname><given-names>V</given-names></name><name name-style="western"><surname>Fortney</surname><given-names>J.</given-names></name></person-group><article-title>Does minority racial-ethnic status moderate outcomes of collaborative care for depression?</article-title><source>Psychiatr Serv</source><year>2011</year><volume>62</volume><issue>(11)</issue><fpage>1282</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1176/ps.62.11.pss6211_1282</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22211206/" ext-link-type="uri">22211206</ext-link></comment><pub-id pub-id-type="pmid">22211206</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litzer</surname><given-names>MH.</given-names></name></person-group><article-title>The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients</article-title><source>Ment Health Clin</source><year>2013</year><volume>2</volume><issue>(8)</issue><fpage>236</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.9740/mhc.n133114</pub-id><pub-id pub-id-type="pmcid">PMC3870170</pub-id><pub-id pub-id-type="pmid">24367465</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruhn</surname><given-names>H</given-names></name><name name-style="western"><surname>Bond</surname><given-names>CM</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>AM</given-names></name><name name-style="western"><surname>Hannaford</surname><given-names>PC</given-names></name><name name-style="western"><surname>Lee</surname><given-names>AJ</given-names></name><name name-style="western"><surname>McNamee</surname><given-names>P</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist-led management of chronic pain in primary care: results from a randomised controlled exploratory trial</article-title><source>BMJ Open</source><year>2013</year><volume>3</volume><issue>(4)</issue><fpage>e002361</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2012-002361</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/23562814/" ext-link-type="uri">23562814</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641445" ext-link-type="uri">PMC3641445</ext-link><pub-id pub-id-type="pmcid">PMC3641445</pub-id><pub-id pub-id-type="pmid">23562814</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kersten</surname><given-names>H</given-names></name><name name-style="western"><surname>Molden</surname><given-names>E</given-names></name><name name-style="western"><surname>Tolo</surname><given-names>IK</given-names></name><name name-style="western"><surname>Skovlund</surname><given-names>E</given-names></name><name name-style="western"><surname>Engedal</surname><given-names>K</given-names></name><name name-style="western"><surname>Wyller</surname><given-names>TB.</given-names></name></person-group><article-title>Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2013</year><volume>68</volume><issue>(3)</issue><fpage>271</fpage>&#8211;<lpage>8</lpage><pub-id pub-id-type="doi">10.1093/gerona/gls176</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/22982689/" ext-link-type="uri">22982689</ext-link></comment><pub-id pub-id-type="pmid">22982689</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneiderhan</surname><given-names>ME</given-names></name><name name-style="western"><surname>Shuster</surname><given-names>SM</given-names></name><name name-style="western"><surname>Davey</surname><given-names>CS.</given-names></name></person-group><article-title>Twelve-month prospective randomized study of pharmacists utilizing point-of-care testing for metabolic syndrome and related conditions in subjects prescribed antipsychotics</article-title><source>Prim Care Companion CNS Disord</source><year>2014</year><volume>16</volume><issue>(5)</issue>.
<pub-id pub-id-type="doi">10.4088/PCC.14m01669</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25667811/" ext-link-type="uri">25667811</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321016" ext-link-type="uri">PMC4321016</ext-link><pub-id pub-id-type="pmcid">PMC4321016</pub-id><pub-id pub-id-type="pmid">25667811</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhital</surname><given-names>R</given-names></name><name name-style="western"><surname>Norman</surname><given-names>I</given-names></name><name name-style="western"><surname>Whittlesea</surname><given-names>C</given-names></name><name name-style="western"><surname>Murrells</surname><given-names>T</given-names></name><name name-style="western"><surname>McCambridge</surname><given-names>J.</given-names></name></person-group><article-title>The effectiveness of brief alcohol interventions delivered by community pharmacists: randomized controlled trial</article-title><source>Addiction</source><year>2015</year><volume>110</volume><issue>(10)</issue><fpage>1586</fpage>&#8211;<lpage>94</lpage><pub-id pub-id-type="doi">10.1111/add.12994</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25988589/" ext-link-type="uri">25988589</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765086" ext-link-type="uri">PMC4765086</ext-link><pub-id pub-id-type="pmid">25988589</pub-id><pub-id pub-id-type="pmcid">PMC4765086</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dipaula</surname><given-names>BA</given-names></name><name name-style="western"><surname>Menachery</surname><given-names>E.</given-names></name></person-group><article-title>Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients</article-title><source>J Am Pharm Assoc (2003)</source><year>2015</year><volume>55</volume><issue>(2)</issue><fpage>187</fpage>&#8211;<lpage>92</lpage><pub-id pub-id-type="doi">10.1331/JAPhA.2015.14177</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/25749264/" ext-link-type="uri">25749264</ext-link></comment><pub-id pub-id-type="pmid">25749264</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phimarn</surname><given-names>W</given-names></name><name name-style="western"><surname>Kaewphila</surname><given-names>P</given-names></name><name name-style="western"><surname>Suttajit</surname><given-names>S</given-names></name><name name-style="western"><surname>Saramunee</surname><given-names>K.</given-names></name></person-group><article-title>Depression screening and advisory service provided by community pharmacist for depressive students in university</article-title><source>Springerplus</source><year>2015</year><volume>4</volume>:
<fpage>470</fpage><pub-id pub-id-type="doi">10.1186/s40064-015-1259-1</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26357601/" ext-link-type="uri">26357601</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556723" ext-link-type="uri">PMC4556723</ext-link><pub-id pub-id-type="pmid">26357601</pub-id><pub-id pub-id-type="pmcid">PMC4556723</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>D</given-names></name><name name-style="western"><surname>Emmett</surname><given-names>M</given-names></name><name name-style="western"><surname>Crist</surname><given-names>A</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>C</given-names></name><name name-style="western"><surname>Grome</surname><given-names>M.</given-names></name></person-group><article-title>Improving the care of dual eligible patients in rural federally qualified health centers: the impact of care coordinators and clinical pharmacists</article-title><source>J Prim Care Community Health</source><year>2016</year><volume>7</volume><issue>(2)</issue><fpage>118</fpage>&#8211;<lpage>21</lpage><pub-id pub-id-type="doi">10.1177/2150131915617297</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26582045/" ext-link-type="uri">26582045</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794360" ext-link-type="uri">PMC4794360</ext-link><pub-id pub-id-type="pmid">26582045</pub-id><pub-id pub-id-type="pmcid">PMC4794360</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanwal</surname><given-names>F</given-names></name><name name-style="western"><surname>Pyne</surname><given-names>JM</given-names></name><name name-style="western"><surname>Tavakoli-Tabasi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nicholson</surname><given-names>S</given-names></name><name name-style="western"><surname>Dieckgraefe</surname><given-names>B</given-names></name><name name-style="western"><surname>Storay</surname><given-names>E</given-names></name><etal>et al.</etal></person-group><article-title>Collaborative care for depression in chronic hepatitis C clinics</article-title><source>Psychiatr Serv</source><year>2016</year><volume>67</volume><issue>(10)</issue><fpage>1076</fpage>&#8211;<lpage>82</lpage><pub-id pub-id-type="doi">10.1176/appi.ps.201400474</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/27364808/" ext-link-type="uri">27364808</ext-link></comment><pub-id pub-id-type="pmid">27364808</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parikh</surname><given-names>M</given-names></name><name name-style="western"><surname>Ebong</surname><given-names>EE</given-names></name><name name-style="western"><surname>Harris</surname><given-names>E</given-names></name><name name-style="western"><surname>Barnes</surname><given-names>B.</given-names></name></person-group><article-title>Evaluation of clinical pharmacy services within the primary care-mental health integration model at the Tuscaloosa Veterans Affairs Medical Center</article-title><source>Ment Health Clin</source><year>2016</year><volume>6</volume><issue>(5)</issue><fpage>260</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.9740/mhc.2016.09.260</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29955480/" ext-link-type="uri">29955480</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007590" ext-link-type="uri">PMC6007590</ext-link><pub-id pub-id-type="pmid">29955480</pub-id><pub-id pub-id-type="pmcid">PMC6007590</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moga</surname><given-names>DC</given-names></name><name name-style="western"><surname>Abner</surname><given-names>EL</given-names></name><name name-style="western"><surname>Rigsby</surname><given-names>DN</given-names></name><name name-style="western"><surname>Eckmann</surname><given-names>L</given-names></name><name name-style="western"><surname>Huffmyer</surname><given-names>M</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>RR</given-names></name><etal>et al.</etal></person-group><article-title>Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden</article-title><source>Alz Res Ther</source><year>2017</year><volume>9</volume><issue>(1)</issue><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s13195-017-0263-9</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28535785/" ext-link-type="uri">28535785</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442667" ext-link-type="uri">PMC5442667</ext-link><pub-id pub-id-type="pmcid">PMC5442667</pub-id><pub-id pub-id-type="pmid">28535785</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pardo</surname><given-names>D</given-names></name><name name-style="western"><surname>Miller</surname><given-names>L</given-names></name><name name-style="western"><surname>Chiulli</surname><given-names>D.</given-names></name></person-group><article-title>Implementation of a pharmacy consult to reduce co-prescribing of opioids and benzodiazepines in a veteran population</article-title><source>Subst Abus</source><year>2017</year><volume>38</volume><issue>(2)</issue><fpage>157</fpage>&#8211;<lpage>60</lpage><pub-id pub-id-type="doi">10.1080/08897077.2017.1290011</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/28166464/" ext-link-type="uri">28166464</ext-link></comment><pub-id pub-id-type="pmid">28166464</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badr</surname><given-names>AF</given-names></name><name name-style="western"><surname>Kurdi</surname><given-names>S</given-names></name><name name-style="western"><surname>Alshehri</surname><given-names>S</given-names></name><name name-style="western"><surname>McManus</surname><given-names>C</given-names></name><name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name></person-group><article-title>Pharmacists&#8217; interventions to reduce sedative/hypnotic use for insomnia in hospitalized patients</article-title><source>Saudi Pharm J</source><year>2018</year><volume>26</volume><issue>(8)</issue><fpage>1204</fpage>&#8211;<lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2018.07.010</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30510473/" ext-link-type="uri">30510473</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257887" ext-link-type="uri">PMC6257887</ext-link><pub-id pub-id-type="pmid">30510473</pub-id><pub-id pub-id-type="pmcid">PMC6257887</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bingham</surname><given-names>J</given-names></name><name name-style="western"><surname>Axon</surname><given-names>D</given-names></name><name name-style="western"><surname>Scovis</surname><given-names>N</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>A.</given-names></name></person-group><article-title>Evaluating the effectiveness of clinical pharmacy consultations on nutrition, physical activity, and sleep in improving patient-reported psychiatric outcomes for individuals with mental illnesses</article-title><source>Pharmacy</source><year>2018</year><volume>7</volume><issue>(1)</issue><fpage>2</fpage><pub-id pub-id-type="doi">10.3390/pharmacy7010002</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30583547/" ext-link-type="uri">30583547</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473796" ext-link-type="uri">PMC6473796</ext-link><pub-id pub-id-type="pmid">30583547</pub-id><pub-id pub-id-type="pmcid">PMC6473796</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gibu</surname><given-names>M</given-names></name><name name-style="western"><surname>Clark</surname><given-names>J</given-names></name><name name-style="western"><surname>Gold</surname><given-names>J.</given-names></name></person-group><article-title>Mental health pharmacists as interim prescribers</article-title><source>Ment Health Clin</source><year>2017</year><volume>7</volume><issue>(3)</issue><fpage>111</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.9740/mhc.2017.05.111</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/29955508/" ext-link-type="uri">29955508</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007566" ext-link-type="uri">PMC6007566</ext-link><pub-id pub-id-type="pmid">29955508</pub-id><pub-id pub-id-type="pmcid">PMC6007566</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mooney</surname><given-names>EV</given-names></name><name name-style="western"><surname>Hamper</surname><given-names>JG</given-names></name><name name-style="western"><surname>Willis</surname><given-names>RT</given-names></name><name name-style="western"><surname>Farinha</surname><given-names>TL</given-names></name><name name-style="western"><surname>Ricchetti</surname><given-names>CA.</given-names></name></person-group><article-title>Evaluating patient satisfaction with pharmacist-administered long-acting injectable antipsychotics in the community pharmacy</article-title><source>J Am Pharm Assoc (2003)</source><year>2018</year><volume>58</volume><issue>(4S)</issue><fpage>S24</fpage>&#8211;<lpage>9.e2</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2018.04.035</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30006184/" ext-link-type="uri">30006184</ext-link></comment><pub-id pub-id-type="pmid">30006184</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chavez</surname><given-names>B</given-names></name><name name-style="western"><surname>Kosirog</surname><given-names>E.</given-names></name></person-group><article-title>Impact on an integrated psychiatric pharmacy service in a primary care clinic</article-title><source>Ment Health Clin</source><year>2019</year><volume>9</volume><issue>(4)</issue><fpage>269</fpage>&#8211;<lpage>74</lpage><pub-id pub-id-type="doi">10.9740/mhc.2019.07.269</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31293846/" ext-link-type="uri">31293846</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607947" ext-link-type="uri">PMC6607947</ext-link><pub-id pub-id-type="pmid">31293846</pub-id><pub-id pub-id-type="pmcid">PMC6607947</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heins</surname><given-names>K.</given-names></name></person-group><article-title>Fairview Pharmacy Services clozapine monitoring program: description and evaluation of a clinical pharmacy service</article-title><source>Ment Health Clin</source><year>2019</year><volume>9</volume><issue>(3)</issue><fpage>138</fpage>&#8211;<lpage>40</lpage><pub-id pub-id-type="doi">10.9740/mhc.2019.05.138</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31123662/" ext-link-type="uri">31123662</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513055" ext-link-type="uri">PMC6513055</ext-link><pub-id pub-id-type="pmid">31123662</pub-id><pub-id pub-id-type="pmcid">PMC6513055</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maryan</surname><given-names>S</given-names></name><name name-style="western"><surname>Harms</surname><given-names>M</given-names></name><name name-style="western"><surname>McAllister</surname><given-names>E</given-names></name><name name-style="western"><surname>DeJongh</surname><given-names>B.</given-names></name></person-group><article-title>Comparison of clozapine monitoring and adverse event management in a psychiatrist-only and a clinical pharmacist-psychiatrist collaborative clinic</article-title><source>Ment Health Clin</source><year>2019</year><volume>9</volume><issue>(2)</issue><fpage>70</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.9740/mhc.2019.03.070</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/30842913/" ext-link-type="uri">30842913</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398353" ext-link-type="uri">PMC6398353</ext-link><pub-id pub-id-type="pmid">30842913</pub-id><pub-id pub-id-type="pmcid">PMC6398353</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shilpa</surname><given-names>HSS</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>NN</given-names></name><name name-style="western"><surname>Maheswari</surname><given-names>E</given-names></name><name name-style="western"><surname>Virupaksha</surname><given-names>HS</given-names></name><name name-style="western"><surname>Subeesh</surname><given-names>V</given-names></name><name name-style="western"><surname>Saraswathy</surname><given-names>GR</given-names></name><etal>et al.</etal></person-group><article-title>Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care Hospital</article-title><source>Asian J Psychiatr</source><year>2019</year><volume>44</volume><issue>(1)</issue><fpage>189</fpage>&#8211;<lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.ajp.2019.07.041</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31408799/" ext-link-type="uri">31408799</ext-link></comment><pub-id pub-id-type="pmid">31408799</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuhec</surname><given-names>M</given-names></name><name name-style="western"><surname>Bratovi&#263;</surname><given-names>N</given-names></name><name name-style="western"><surname>Mrhar</surname><given-names>A.</given-names></name></person-group><article-title>Impact of clinical pharmacist&#8217;s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><issue>(1)</issue><fpage>16856</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-53057-w</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31728029/" ext-link-type="uri">31728029</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856189" ext-link-type="uri">PMC6856189</ext-link><pub-id pub-id-type="pmid">31728029</pub-id><pub-id pub-id-type="pmcid">PMC6856189</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Raynsford</surname><given-names>J</given-names></name><name name-style="western"><surname>Dada</surname><given-names>C</given-names></name><name name-style="western"><surname>Stansfield</surname><given-names>D</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>T.</given-names></name></person-group><article-title>Impact of a specialist mental health pharmacy team on medicines optimisation in primary care for patients on a severe mental illness register: a pilot study</article-title><source>Eur J Hosp Pharm</source><year>2018</year><volume>27</volume><issue>(1)</issue><fpage>31</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.1136/ejhpharm-2018-001514</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32064086/" ext-link-type="uri">32064086</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992977" ext-link-type="uri">PMC6992977</ext-link><pub-id pub-id-type="pmid">32064086</pub-id><pub-id pub-id-type="pmcid">PMC6992977</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Watkins</surname><given-names>VA</given-names></name><name name-style="western"><surname>Michaels</surname><given-names>NM</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>DL</given-names></name><name name-style="western"><surname>Rhodes</surname><given-names>LA</given-names></name><name name-style="western"><surname>Marciniak</surname><given-names>MW.</given-names></name></person-group><article-title>The effect of community pharmacist&#8211;led health coaching on clinical outcomes</article-title><source>J Am Pharm Assoc (2003)</source><year>2020</year><volume>60</volume><issue>(3)</issue><fpage>S65</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2020.03.021</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32439280/" ext-link-type="uri">32439280</ext-link></comment><pub-id pub-id-type="pmid">32439280</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ahmed</surname><given-names>S</given-names></name><name name-style="western"><surname>Tahir</surname><given-names>R</given-names></name><name name-style="western"><surname>Akhtar</surname><given-names>U</given-names></name><name name-style="western"><surname>Faiz</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacogenomics guided prescription changes improved medication effectiveness in patients with mental health-related disability: a retrospective cohort analyses</article-title><source>Front Genet</source><year>2021</year><volume>12</volume>:
<fpage>644694</fpage><pub-id pub-id-type="doi">10.3389/fgene.2021.644694</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34413872/" ext-link-type="uri">34413872</ext-link></comment><pub-id pub-id-type="pmid">34413872</pub-id><pub-id pub-id-type="pmcid">PMC8370841</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Butala</surname><given-names>N</given-names></name><name name-style="western"><surname>Williams</surname><given-names>A</given-names></name><name name-style="western"><surname>Kneebusch</surname><given-names>J</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>M.</given-names></name></person-group><article-title>Impact of a pharmacist-driven tardive dyskinesia screening service</article-title><source>Ment Health Clin</source><year>2021</year><volume>11</volume><issue>(4)</issue><fpage>248</fpage>&#8211;<lpage>53</lpage><pub-id pub-id-type="doi">10.9740/mhc.2021.07.248</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34316421/" ext-link-type="uri">34316421</ext-link></comment><pub-id pub-id-type="pmid">34316421</pub-id><pub-id pub-id-type="pmcid">PMC8287863</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hefazi</surname><given-names>E</given-names></name><name name-style="western"><surname>Boggie</surname><given-names>D</given-names></name><name name-style="western"><surname>Huynh</surname><given-names>T</given-names></name><name name-style="western"><surname>Lee</surname><given-names>KC.</given-names></name></person-group><article-title>Influence of psychotropic medications on readmission rates of patients receiving a pharmacist discharge medication reconciliation</article-title><source>J Pharm Pract</source><year>2021</year><volume>34</volume><issue>(5)</issue><fpage>741</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.1177/0897190020904466</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/32067567/" ext-link-type="uri">32067567</ext-link></comment><pub-id pub-id-type="pmid">32067567</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lowrie</surname><given-names>R</given-names></name><name name-style="western"><surname>Stock</surname><given-names>K</given-names></name><name name-style="western"><surname>Lucey</surname><given-names>S</given-names></name><name name-style="western"><surname>Knapp</surname><given-names>M</given-names></name><name name-style="western"><surname>Williamson</surname><given-names>A</given-names></name><name name-style="western"><surname>Montgomery</surname><given-names>M</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist led homeless outreach engagement and non-medical independent prescribing (Rx) (PHOENIx) intervention for people experiencing homelessness: a non-randomised feasibility study</article-title><source>Int J Equity Health</source><year>2021</year><volume>20</volume><issue>(1)</issue><fpage>19</fpage><pub-id pub-id-type="doi">10.1186/s12939-020-01337-7</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33413396/" ext-link-type="uri">33413396</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789612" ext-link-type="uri">PMC7789612</ext-link><pub-id pub-id-type="pmid">33413396</pub-id><pub-id pub-id-type="pmcid">PMC7789612</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Margulis</surname><given-names>A</given-names></name><name name-style="western"><surname>Uhlyar</surname><given-names>S</given-names></name><name name-style="western"><surname>Chin-Beckford</surname><given-names>N</given-names></name><name name-style="western"><surname>DeRonde</surname><given-names>K</given-names></name><name name-style="western"><surname>Salazar</surname><given-names>V</given-names></name><name name-style="western"><surname>Abbo</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Clinical pharmacist input on HIV management may improve antiretroviral prescribing for psychiatric patients</article-title><source>Am J Health Syst Pharm</source><year>2020</year><volume>78</volume><issue>(Supplement_1)</issue>:
<fpage>S10</fpage>&#8211;<lpage>5</lpage><pub-id pub-id-type="doi">10.1093/ajhp/zxaa310</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33037816/" ext-link-type="uri">33037816</ext-link></comment><pub-id pub-id-type="pmid">33037816</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sahr</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelsh</surname><given-names>S</given-names></name><name name-style="western"><surname>Blower</surname><given-names>N</given-names></name><name name-style="western"><surname>Sohn</surname><given-names>M.</given-names></name></person-group><article-title>Pilot Study of Electronic Nicotine Delivery Systems (ENDS) cessation methods</article-title><source>Pharmacy</source><year>2021</year><volume>9</volume><issue>(1)</issue><fpage>21</fpage><pub-id pub-id-type="doi">10.3390/pharmacy9010021</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33466912/" ext-link-type="uri">33466912</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838991" ext-link-type="uri">PMC7838991</ext-link><pub-id pub-id-type="pmid">33466912</pub-id><pub-id pub-id-type="pmcid">PMC7838991</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stuhec</surname><given-names>M</given-names></name><name name-style="western"><surname>Tement</surname><given-names>V.</given-names></name></person-group><article-title>Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>(1)</issue><fpage>13641</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-92909-2</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34211019/" ext-link-type="uri">34211019</ext-link></comment><pub-id pub-id-type="pmid">34211019</pub-id><pub-id pub-id-type="pmcid">PMC8249606</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Accomando</surname><given-names>M</given-names></name><name name-style="western"><surname>DeWitt</surname><given-names>K</given-names></name><name name-style="western"><surname>Porter</surname><given-names>B.</given-names></name></person-group><article-title>Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department</article-title><source>Ment Health Clin</source><year>2022</year><volume>12</volume><issue>(3)</issue><fpage>187</fpage>&#8211;<lpage>92</lpage><pub-id pub-id-type="doi">10.9740/mhc.2022.06.187</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35801158/" ext-link-type="uri">35801158</ext-link></comment><pub-id pub-id-type="pmid">35801158</pub-id><pub-id pub-id-type="pmcid">PMC9190267</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bawazeer</surname><given-names>G</given-names></name><name name-style="western"><surname>Alsaad</surname><given-names>S</given-names></name><name name-style="western"><surname>Almalag</surname><given-names>H</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>A</given-names></name><name name-style="western"><surname>Altulaihi</surname><given-names>N</given-names></name><name name-style="western"><surname>Alodhayani</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Impact of specialized clinics on medications deprescribing in older adults: a pilot study in ambulatory care clinics in a teaching hospital</article-title><source>Saudi Pharm J</source><year>2022</year><month>Jul</month>;
<volume>30</volume><issue>(7)</issue><fpage>1027</fpage>&#8211;<lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.jsps.2022.04.012</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35903532/" ext-link-type="uri">35903532</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315319" ext-link-type="uri">PMC9315319</ext-link><pub-id pub-id-type="pmid">35903532</pub-id><pub-id pub-id-type="pmcid">PMC9315319</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chulasai</surname><given-names>P</given-names></name><name name-style="western"><surname>Chinwong</surname><given-names>D</given-names></name><name name-style="western"><surname>Vientong</surname><given-names>P</given-names></name><name name-style="western"><surname>Lertsinudom</surname><given-names>S</given-names></name><name name-style="western"><surname>Kanjanarat</surname><given-names>P</given-names></name><name name-style="western"><surname>Hall</surname><given-names>JJ</given-names></name><etal>et al.</etal></person-group><article-title>Smartphone application for smoking cessation (Quit with US): a randomized controlled trial among young adult light smokers in Thailand</article-title><source>Int J Environ Res Public Health</source><year>2022</year><volume>19</volume><issue>(14)</issue><fpage>8265</fpage><pub-id pub-id-type="doi">10.3390/ijerph19148265</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35886120/" ext-link-type="uri">35886120</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321212" ext-link-type="uri">PMC9321212</ext-link><pub-id pub-id-type="pmid">35886120</pub-id><pub-id pub-id-type="pmcid">PMC9321212</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farag</surname><given-names>M</given-names></name><name name-style="western"><surname>Hoti</surname><given-names>K</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>J</given-names></name><name name-style="western"><surname>Chalmers</surname><given-names>L.</given-names></name></person-group><article-title>Impact of a clinical pharmacist on medication safety in mental health hospital-in-the-home: a retrospective analysis</article-title><source>Int J Clin Pharm</source><year>2022</year><volume>44</volume><issue>(4)</issue><fpage>947</fpage>&#8211;<lpage>55</lpage><pub-id pub-id-type="doi">10.1007/s11096-022-01409-4</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35438472/" ext-link-type="uri">35438472</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016122" ext-link-type="uri">PMC9016122</ext-link><pub-id pub-id-type="pmid">35438472</pub-id><pub-id pub-id-type="pmcid">PMC9016122</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Light</surname><given-names>J</given-names></name><name name-style="western"><surname>Ruh</surname><given-names>C</given-names></name><name name-style="western"><surname>Ott</surname><given-names>M</given-names></name><name name-style="western"><surname>Banker</surname><given-names>C</given-names></name><name name-style="western"><surname>Meaney</surname><given-names>D</given-names></name><name name-style="western"><surname>Doloresco</surname><given-names>F</given-names></name><etal>et al.</etal></person-group><article-title>The effect of pharmacy-led medication reconciliation on odds of psychiatric relapse at a community hospital</article-title><source>J Pharm Pract</source><year>2022</year><volume>9</volume><issue>(5)</issue><comment>089719002211371. </comment><pub-id pub-id-type="doi">10.1177/08971900221137100</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36314582/" ext-link-type="uri">36314582</ext-link></comment><pub-id pub-id-type="pmid">36314582</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDuffie</surname><given-names>AC</given-names></name><name name-style="western"><surname>Varughese</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Duffy</surname><given-names>AR</given-names></name><name name-style="western"><surname>Faiella</surname><given-names>AS</given-names></name><name name-style="western"><surname>Wegener</surname><given-names>LF</given-names></name><name name-style="western"><surname>Singer</surname><given-names>KA</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist-led telehealth tobacco cessation services compared with usual care in a community health center</article-title><source>J Am Pharm Assoc (2003)</source><year>2022</year><volume>62</volume><issue>(6)</issue><fpage>1891</fpage>&#8211;<lpage>6.e2</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2022.07.004</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35970728/" ext-link-type="uri">35970728</ext-link></comment><pub-id pub-id-type="pmid">35970728</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mertens</surname><given-names>V</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>L</given-names></name><name name-style="western"><surname>Knops</surname><given-names>N</given-names></name><name name-style="western"><surname>Alemzadeh</surname><given-names>SM</given-names></name><name name-style="western"><surname>Vandeven</surname><given-names>K</given-names></name><name name-style="western"><surname>Swartenbroekx</surname><given-names>J</given-names></name><etal>et al.</etal></person-group><article-title>Bedside medication review with cognitive and depression screening by a clinical pharmacist as part of a comprehensive geriatric assessment in hospitalized older patients with polypharmacy: a pilot study</article-title><source>Alotaibi NH. PLoS One</source><year>2022</year><volume>17</volume><issue>(10)</issue><fpage>e0276402</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0276402</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36269748/" ext-link-type="uri">36269748</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586415" ext-link-type="uri">PMC9586415</ext-link><pub-id pub-id-type="pmcid">PMC9586415</pub-id><pub-id pub-id-type="pmid">36269748</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>J</given-names></name><name name-style="western"><surname>Costa E Silva</surname><given-names>T</given-names></name><name name-style="western"><surname>Cabral</surname><given-names>A</given-names></name><name name-style="western"><surname>Lavrador</surname><given-names>M</given-names></name><name name-style="western"><surname>Almeida</surname><given-names>F</given-names></name><name name-style="western"><surname>Macedo</surname><given-names>A</given-names></name><etal>et al.</etal></person-group><article-title>Pharmacist-led medication reconciliation on admission to an acute psychiatric hospital unit</article-title><source>Pharm Pract</source><year>2022</year><volume>20</volume><issue>(2)</issue><fpage>2650</fpage><pub-id pub-id-type="doi">10.18549/PharmPract.2022.2.2650</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35919807/" ext-link-type="uri">35919807</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296076" ext-link-type="uri">PMC9296076</ext-link><pub-id pub-id-type="pmcid">PMC9296076</pub-id><pub-id pub-id-type="pmid">35919807</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pals</surname><given-names>H</given-names></name><name name-style="western"><surname>Bratberg</surname><given-names>J.</given-names></name></person-group><article-title>Improving access to care via psychiatric clinical pharmacist practitioner collaborative management of buprenorphine for opioid use disorder</article-title><source>J Am Pharm Assoc (2003)</source><year>2022</year><volume>62</volume><issue>(4)</issue><fpage>1422</fpage>&#8211;<lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.japh.2022.03.006</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35365405/" ext-link-type="uri">35365405</ext-link></comment><pub-id pub-id-type="pmid">35365405</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sacarny</surname><given-names>A</given-names></name><name name-style="western"><surname>Safran</surname><given-names>E</given-names></name><name name-style="western"><surname>Steffel</surname><given-names>M</given-names></name><name name-style="western"><surname>Dunham</surname><given-names>JR</given-names></name><name name-style="western"><surname>Abili</surname><given-names>OD</given-names></name><name name-style="western"><surname>Mohajeri</surname><given-names>L</given-names></name><etal>et al.</etal></person-group><article-title>Effect of pharmacist email alerts on concurrent prescribing of opioids and benzodiazepines by prescribers and primary care managers</article-title><source>JAMA Health Forum</source><year>2022</year><volume>3</volume><issue>(9)</issue><fpage>e223378</fpage><pub-id pub-id-type="doi">10.1001/jamahealthforum.2022.3378</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/36218952/" ext-link-type="uri">36218952</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526090" ext-link-type="uri">PMC9526090</ext-link><pub-id pub-id-type="pmid">36218952</pub-id><pub-id pub-id-type="pmcid">PMC9526090</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steel</surname><given-names>A</given-names></name><name name-style="western"><surname>Hopwood</surname><given-names>H</given-names></name><name name-style="western"><surname>Goodwin</surname><given-names>E</given-names></name><name name-style="western"><surname>Sampson</surname><given-names>EL.</given-names></name></person-group><article-title>Multidisciplinary residential home intervention to improve outcomes for frail residents</article-title><source>BMC Health Serv Res</source><year>2022</year><volume>22</volume><issue>(1)</issue><fpage>58</fpage><pub-id pub-id-type="doi">10.1186/s12913-021-07407-y</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35022056/" ext-link-type="uri">35022056</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756619" ext-link-type="uri">PMC8756619</ext-link><pub-id pub-id-type="pmid">35022056</pub-id><pub-id pub-id-type="pmcid">PMC8756619</pub-id></mixed-citation></ref><ref id="i2168-9709-14-1-33-b211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vaillancourt</surname><given-names>R</given-names></name><name name-style="western"><surname>Gallagher</surname><given-names>S</given-names></name><name name-style="western"><surname>Cameron</surname><given-names>JD</given-names></name><name name-style="western"><surname>Dhalla</surname><given-names>R.</given-names></name></person-group><article-title>Cannabis use in patients with insomnia and sleep disorders: retrospective chart review</article-title><source>Can Pharm J</source><year>2022</year><volume>155</volume><issue>(3)</issue><fpage>175</fpage>&#8211;<lpage>80</lpage><pub-id pub-id-type="doi">10.1177/17151635221089617</pub-id><comment>PMID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35519083/" ext-link-type="uri">35519083</ext-link></comment> PMCID: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067069" ext-link-type="uri">PMC9067069</ext-link><pub-id pub-id-type="pmcid">PMC9067069</pub-id><pub-id pub-id-type="pmid">35519083</pub-id></mixed-citation></ref></ref-list><app-group><app id="app1"><title>APPENDIX: Included studies sorted by disease state, year, and first author</title><table-wrap position="anchor" id="i2168-9709-14-1-33-t03" orientation="portrait"><caption><p>Multiple disease states</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb3col1" align="left" charoff="0" char="" span="1"/><col id="tb3col2" align="char" charoff="0" char="." span="1"/><col id="tb3col3" align="char" charoff="0" char="." span="1"/><col id="tb3col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Chung B, 2011,<xref rid="i2168-9709-14-1-33-b32" ref-type="bibr">32</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 34</td><td rowspan="1" colspan="1">Unknown, limited data Pharmacist-provided medication management MDD, anxiety, schizoaffective disorder</td><td rowspan="1" colspan="1">Self-reported satisfaction with pharmacist services</td></tr><tr><td align="left" rowspan="1" colspan="1">Suehs BT, 2011,<xref rid="i2168-9709-14-1-33-b52" ref-type="bibr">52</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 105</td><td rowspan="1" colspan="1">Retrospective, chart review Pharmacist interventions in state hospital Schizoaffective disorder, bipolar disorder, schizophrenia, MDD</td><td rowspan="1" colspan="1">Reduced CGI-severity if implementation of recommendation rate was 80% or more (CGI-S) score (<italic toggle="yes">P</italic> = .036)</td></tr><tr><td align="left" rowspan="1" colspan="1">Valenstein M, 2011,<xref rid="i2168-9709-14-1-33-b53" ref-type="bibr">53</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 118</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist interventions in patients with schizophrenia Schizophrenia, schizoaffective disorder, bipolar disorder</td><td rowspan="1" colspan="1">Increased medication persistence rate compared with usual care (0.86 vs 0.62) Failed to show differences in secondary outcomes measures, including PANSS, QWB, and CSQ-8</td></tr><tr><td align="left" rowspan="1" colspan="1">Wang I, 2011,<xref rid="i2168-9709-14-1-33-b54" ref-type="bibr">54</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 48</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist medication recommendations Homeless patients with myocardial infarction MDD, bipolar disorder, anxiety</td><td rowspan="1" colspan="1">Identified 41 drug therapy problems Reduced mean PHQ-9 score from baseline to end of study (&#8722;5.7, <italic toggle="yes">P</italic> = .02)</td></tr><tr><td align="left" rowspan="1" colspan="1">Furbish SML, 2017,<xref rid="i2168-9709-14-1-33-b55" ref-type="bibr">55</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 29</td><td rowspan="1" colspan="1">Pharmacist interventions for patients taking BZD Anxiety, sleep disorder</td><td rowspan="1" colspan="1">Optimized BZDs during visit (46%) Optimized non-BZDs during visit (59%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Harms M, 2018,<xref rid="i2168-9709-14-1-33-b56" ref-type="bibr">56</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Retrospective, chart review Anxiety, SUD, MDD</td><td rowspan="1" colspan="1">Improved change in PHQ-9 at 12 weeks compared with baseline (10; 95% CI = 6.2, 13.8; <italic toggle="yes">P</italic> &lt; .001) Improved change in GAD-7 (8, 95% CI = 3.1-12.9, <italic toggle="yes">P</italic> = 0.006) Improved change in PCL-7 (14.5; 95% CI = 17.3, 46.3; <italic toggle="yes">P</italic> = .109) Completed interventions (336)</td></tr><tr><td align="left" rowspan="1" colspan="1">Herbert C, 2018,<xref rid="i2168-9709-14-1-33-b57" ref-type="bibr">57</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 172</td><td rowspan="1" colspan="1">Pharmacist-provided medication management in primary care mental health integration MDD, anxiety</td><td rowspan="1" colspan="1">Decreased average PHQ-9 scores (14.5-8.5) Achieved response (46%) Achieved remission (31%) Observed average M-P-R for antidepressant therapy of 0.93 for all patients included</td></tr><tr><td align="left" rowspan="1" colspan="1">Lindell VA, 2018,<xref rid="i2168-9709-14-1-33-b58" ref-type="bibr">58</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 217</td><td rowspan="1" colspan="1">Retrospective cohort study Psychiatric clinical pharmacist-provided clinical services vs provider care alone Anxiety, MDD</td><td rowspan="1" colspan="1">Failed to observe a statistical difference in the primary outcome<xref rid="T3n1" ref-type="table-fn">a</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Buist E, 2019,<xref rid="i2168-9709-14-1-33-b59" ref-type="bibr">59</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 75</td><td rowspan="1" colspan="1">Pilot program Pharmacist-led medication management MDD, anxiety</td><td rowspan="1" colspan="1">Reduced PHQ-9 or GAD-7 score by 50% (45.3%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gonzalvo JD, 2019,<xref rid="i2168-9709-14-1-33-b60" ref-type="bibr">60</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 81</td><td rowspan="1" colspan="1">Retrospective, open, pre/post, nonrandomized Pharmacist-provided cardiovascular risk reduction clinic for those with serious mental illness Schizophrenia, bipolar disorder, MDD, anxiety</td><td rowspan="1" colspan="1">Decreased HbA<sub>1c</sub> (0.06% per month of follow-up, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Perepelkin J, 2019,<xref rid="i2168-9709-14-1-33-b61" ref-type="bibr">61</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 12</td><td rowspan="1" colspan="1">Prospective, pre/post comparison Community pharmacist-led mindfulness meditation class Anxiety, MDD</td><td rowspan="1" colspan="1">Improved PHQ-9 and GAD-7 scores (9/12 participants) Reduced severity of depression or anxiety (75% of participants)</td></tr><tr><td align="left" rowspan="1" colspan="1">AbuNaba&#8217;a Y, 2020,<xref rid="i2168-9709-14-1-33-b62" ref-type="bibr">62</xref> Jordan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 73</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist medication review Anxiety, MDD</td><td rowspan="1" colspan="1">Showed a significant decline in the number of treatment-related problems for the active group vs control group (0.58 [SD = 0.64], vs 1.78 [SD = 1.13]; <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Alkoudsi KT, 2020,<xref rid="i2168-9709-14-1-33-b63" ref-type="bibr">63</xref> Syria, Jordan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 118</td><td rowspan="1" colspan="1">Retrospective Pharmacist-provided management of anxiety and depression in patients with polycystic ovary syndrome Anxiety, MDD</td><td rowspan="1" colspan="1">Showed improvements in anxiety and depression mean scores in both groups<xref rid="T3n2" ref-type="table-fn">b</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Samaksha PB, 2022,<xref rid="i2168-9709-14-1-33-b64" ref-type="bibr">64</xref> India</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 84</td><td rowspan="1" colspan="1">Prospective interventional study Pharmacist-led management of geriatric patients newly diagnosed with depression, bipolar affective disorder, and alcohol dependency syndrome</td><td rowspan="1" colspan="1">Provided 155 medication information services to 84 patients Completed counseling (100%) Completed interventions (96%) Provided medication information (83%) Achieved a high rate of acceptance on interventions (95.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Johnson MR, 2014,<xref rid="i2168-9709-14-1-33-b65" ref-type="bibr">65</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 107</td><td rowspan="1" colspan="1">Prospective, controlled, nonrandomized, single-center Pharmacist based methadone weaning protocol Neonatal abstinence syndrome</td><td rowspan="1" colspan="1">Reduced wean time in pharmacist group vs physician group when exposed in utero (<italic toggle="yes">P</italic> &lt; .001) Reduced wean time in pharmacist group when iatrogenic (<italic toggle="yes">P</italic> = .096)</td></tr><tr><td align="left" rowspan="1" colspan="1">Celestin G, 2022,<xref rid="i2168-9709-14-1-33-b66" ref-type="bibr">66</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 21</td><td rowspan="1" colspan="1">Retrospective, pre/post comparison Pharmacist-driven neonatal abstinence syndrome management program evaluated</td><td rowspan="1" colspan="1">Decreased median duration of treatment (34%, 29 vs 19 days, <italic toggle="yes">P</italic> = .84) Decreased number of titrations (15%) Decreased length of stay (24%) Achieved average cost savings of $60 020 per patient</td></tr></tbody></table><table-wrap-foot><fn><p>BZD = benzodiazepine; CGI = Clinical Global Impression Scale; CSQ-8 = Client Satisfaction Questionnaire; GAD-7 = Generalized Anxiety Disorder 7-item; HbA<sub>1c</sub> = hemoglobin A<sub>1c</sub>; M-P-R = Merrill-Palmer-Revised Scales of Development; PANSS = Positive and Negative Syndrome Scale; PCL-7 = Posttraumatic Stress Disorder Checklist; PHQ-9&#160;= Patient Health Questionnaire-9; QWB = Quality of Well-Being; SUD = substance use disorder; US = United States.</p></fn><fn id="T3n1"><label>a</label><p>Patients in the case group had higher baseline PHQ-9/GAD-7 scores, and the frequency of measure values was lower than anticipated, limiting the ability to detect a difference.</p></fn><fn id="T3n2"><label>b</label><p>Limited detail was provided in the paper.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t04" orientation="portrait"><caption><p>Attention-Deficit/Hyperactivity Disorder (ADHD)</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb4col1" align="left" charoff="0" char="" span="1"/><col id="tb4col2" align="char" charoff="0" char="." span="1"/><col id="tb4col3" align="char" charoff="0" char="." span="1"/><col id="tb4col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Casey T, 2020,<xref rid="i2168-9709-14-1-33-b67" ref-type="bibr">67</xref> United States</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 914</td><td rowspan="1" colspan="1">Prospective study Pharmacist-provided collaborative drug therapy management</td><td rowspan="1" colspan="1">Achieved stabilization through the ADHD clinic pharmacists (610 patients)</td></tr></tbody></table></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t05" orientation="portrait"><caption><p>Anxiety</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb5col1" align="left" charoff="0" char="" span="1"/><col id="tb5col2" align="char" charoff="0" char="." span="1"/><col id="tb5col3" align="char" charoff="0" char="." span="1"/><col id="tb5col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Fortney JC, 2015,<xref rid="i2168-9709-14-1-33-b68" ref-type="bibr">68</xref> United States</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 225</td><td rowspan="1" colspan="1">Multisite, pragmatic, randomized effectiveness trial Pharmacist-provided posttraumatic stress disorder management</td><td rowspan="1" colspan="1">Reduced scores in the Posttraumatic Diagnostic Scale at 6 and 12 months more in the telemedicine outreach group compared with the usual care group</td></tr></tbody></table></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t06" orientation="portrait"><caption><p>Bipolar Disorder</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb6col1" align="left" charoff="0" char="" span="1"/><col id="tb6col2" align="char" charoff="0" char="." span="1"/><col id="tb6col3" align="char" charoff="0" char="." span="1"/><col id="tb6col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Mishra A, 2017,<xref rid="i2168-9709-14-1-33-b69" ref-type="bibr">69</xref> India</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 75</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided education</td><td rowspan="1" colspan="1">Improved medication adherence and quality of life in pharmacist group vs control group (2.06 + 0.15, <italic toggle="yes">P</italic> = .001; vs 13.8 + 0.5, <italic toggle="yes">P</italic> &lt; .05)</td></tr><tr><td align="left" rowspan="1" colspan="1">Salazar-Ospina A, 2017,<xref rid="i2168-9709-14-1-33-b48" ref-type="bibr">48</xref> Colombia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 92</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided pharmaceutical care using Dader Method</td><td rowspan="1" colspan="1">Observed increased risk of hospitalization in control group vs intervention group (HR = 9.03, <italic toggle="yes">P</italic> = .042) Observed increased risk of emergencies in control group vs intervention group (HR = 3.38, <italic toggle="yes">P</italic> = .034)</td></tr><tr><td align="left" rowspan="1" colspan="1">Salazar-Ospina A, 2020,<xref rid="i2168-9709-14-1-33-b70" ref-type="bibr">70</xref> Colombia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 92</td><td rowspan="1" colspan="1">Retrospective, observational, controlled, comparison group, nonrandomized Telephone-based pharmaceutical care program for adults</td><td rowspan="1" colspan="1">Failed to show a difference between the intervention group and control in hospitalization rates after discontinuation of the program (11/43 vs 19/49, <italic toggle="yes">P</italic> = .261)<xref rid="T6n1" ref-type="table-fn">a</xref> Failed to show a difference between intervention group and control in ED visits (14/43 vs 24/49, <italic toggle="yes">P</italic> = .212)<xref rid="T6n1" ref-type="table-fn">a</xref></td></tr></tbody></table><table-wrap-foot><fn><p>ED = emergency department; HR = hazard ratio.</p></fn><fn id="T6n1"><label>a</label><p>Limited detail was provided in the paper.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t07" orientation="portrait"><caption><p>Dementia</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb7col1" align="left" charoff="0" char="" span="1"/><col id="tb7col2" align="char" charoff="0" char="." span="1"/><col id="tb7col3" align="char" charoff="0" char="." span="1"/><col id="tb7col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Rojas-Fernandez CH, 2003,<xref rid="i2168-9709-14-1-33-b35" ref-type="bibr">35</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 11</td><td rowspan="1" colspan="1">Nonrandomized, unblinded study Pharmacist-based consultation service</td><td rowspan="1" colspan="1">Demonstrated satisfactory treatment responses as shown by a decreased BEHAVE-AD score of 30% or more (9 patients)</td></tr><tr><td align="left" rowspan="1" colspan="1">Watanabe N, 2012,<xref rid="i2168-9709-14-1-33-b31" ref-type="bibr">31</xref> Japan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 111</td><td rowspan="1" colspan="1">Retrospective, controlled, pre/post, nonrandomized Medication adherence in patients with Alzheimer&#8217;s disease</td><td rowspan="1" colspan="1">Increased medication persistence rate in intervention vs control group (73.1% vs 48.2%, <italic toggle="yes">P</italic> = .08)</td></tr><tr><td align="left" rowspan="1" colspan="1">Sakakibara M, 2015,<xref rid="i2168-9709-14-1-33-b71" ref-type="bibr">71</xref> Japan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 32</td><td rowspan="1" colspan="1">Pharmacist proposed reduction in medications versus control Outpatient mental health conditions Benzodiazepines</td><td rowspan="1" colspan="1">Showed no difference in QOL measures between groups Increased ADL scores in intervention group Decreased ADL scores in control group</td></tr><tr><td align="left" rowspan="1" colspan="1">Gustafsson M, 2017,<xref rid="i2168-9709-14-1-33-b46" ref-type="bibr">46</xref> Sweden</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 429</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist medication review</td><td rowspan="1" colspan="1">Reduced drug-related readmissions (18.9% vs 23.0%, <italic toggle="yes">P</italic> = .28)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gustafsson M, 2018,<xref rid="i2168-9709-14-1-33-b72" ref-type="bibr">72</xref> Sweden</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 429</td><td rowspan="1" colspan="1">Prospective, comparison group, secondary analysis of randomized controlled trial Clinical pharmacist performed comprehensive medication reviews</td><td rowspan="1" colspan="1">Decreased potentially inappropriate medications (<italic toggle="yes">P</italic> = .011) Failed to show a difference in time to first all-cause emergency department visits (HR = 0.994, <italic toggle="yes">P</italic> = .963) Failed to show a difference in time to institutionalization (HR = 0.761, <italic toggle="yes">P</italic> = .389)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bravo-Jos&#233; P, 2019,<xref rid="i2168-9709-14-1-33-b73" ref-type="bibr">73</xref> Spain</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 35</td><td rowspan="1" colspan="1">Prospective, open, pre/post, single-center, nonrandomized Interdisciplinary team created protocol for antipsychotic use</td><td rowspan="1" colspan="1">Decreased antipsychotic use (80%) Decreased antipsychotic dose (20%) Observed no change in neuropsychiatric symptoms</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen Z, 2021,<xref rid="i2168-9709-14-1-33-b74" ref-type="bibr">74</xref> China</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 60</td><td rowspan="1" colspan="1">Randomized controlled trial Clinical pharmacist participation as part of a multidisciplinary team to address sleep problems in patients with Alzheimer&#8217;s disease vs routine care</td><td rowspan="1" colspan="1">Decreased drowsiness in the multidisciplinary team group compared to that in the routine treatment group (&#967;<bold><sup>2</sup></bold> = 4.320, <italic toggle="yes">P</italic> = .038) Improved sleep quality during the follow-up in the multidisciplinary treatment group (<italic toggle="yes">t</italic> = 6.098, <italic toggle="yes">P</italic> &lt; .001) Improved HAM-D and HAM-A results among family caregivers vs routine treatment (<italic toggle="yes">t</italic> = &#8722;2.867, <italic toggle="yes">P</italic> = .042 vs <italic toggle="yes">t</italic> = 3.258, <italic toggle="yes">P</italic> = .003)</td></tr><tr><td align="left" rowspan="1" colspan="1">Elbeddini A, 2021,<xref rid="i2168-9709-14-1-33-b75" ref-type="bibr">75</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 102</td><td rowspan="1" colspan="1">Chart review Medication reconciliation in patients in geriatric and memory clinic</td><td rowspan="1" colspan="1">Deprescribed medications (712, <italic toggle="yes">P</italic> = .001) Improved ADL performance after 3 and 6 months (43 patients) Improved ADL performance after 12 months (68 patients)</td></tr><tr><td align="left" rowspan="1" colspan="1">Kable A, 2021,<xref rid="i2168-9709-14-1-33-b76" ref-type="bibr">76</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 526</td><td rowspan="1" colspan="1">Prospective, unrandomized, controlled, pre/post comparison study Pharmacist-provided evidence-based bundle of care</td><td rowspan="1" colspan="1">Reduced readmission or re-presentation within 3 months in both phases Achieved compliance with 6 strategies applicable for participants in the intervention phase (58%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Huang CY, 2022,<xref rid="i2168-9709-14-1-33-b77" ref-type="bibr">77</xref> Taiwan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 40</td><td rowspan="1" colspan="1">Prospective, randomized, controlled Pharmacists managed patients in an Alzheimer&#8217;s disease clinic via counseling and education sheets vs usual care</td><td rowspan="1" colspan="1">Improved dementia knowledge score in intervention group (77.5 vs 95.8, <italic toggle="yes">P</italic> &lt; .01) Observed nonsignificant changes in caregiver burden, medication persistence, or adherence</td></tr></tbody></table><table-wrap-foot><fn><p>ADL = activities of daily living; BEHAVE-AD = Behavioral Pathology in Alzheimer&#8217;s Disease Rating Scale; HAM-A = Hamilton Anxiety Rating Scale; HAM-D = Hamilton Rating Scale for Depression; HR = hazard ratio; QOL = quality of life; US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t08" orientation="portrait"><caption><p>Epilepsy</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb8col1" align="left" charoff="0" char="" span="1"/><col id="tb8col2" align="char" charoff="0" char="." span="1"/><col id="tb8col3" align="char" charoff="0" char="." span="1"/><col id="tb8col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Summers B, 1986,<xref rid="i2168-9709-14-1-33-b78" ref-type="bibr">78</xref> South Africa</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 150</td><td rowspan="1" colspan="1">Retrospective study Pharmacist-provided care in outpatient neurology clinic</td><td rowspan="1" colspan="1">Increased carbamazepine prescriptions with ethosuximide (23% to 39%) Increased carbamazepine prescriptions with sodium valproate (2% to 4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">McFadyen ML, 1990,<xref rid="i2168-9709-14-1-33-b79" ref-type="bibr">79</xref> South Africa</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 280</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist provided monitoring of antiepileptic drugs</td><td rowspan="1" colspan="1">Increased number of well-controlled patients in the first cycle compared with the last cycle (36% vs 60%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Eshiet UI, 2021,<xref rid="i2168-9709-14-1-33-b80" ref-type="bibr">80</xref> Nigeria</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 46</td><td rowspan="1" colspan="1">Open, randomized, controlled, single-blinded, longitudinal and 2-arm parallel prospective study Pharmacist education and counseling</td><td rowspan="1" colspan="1">Improved quality of life in epilepsy scores at 3 months (<italic toggle="yes">P</italic> = .001) Improved quality of life in epilepsy scores at 6 months (<italic toggle="yes">P</italic> = .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Marawar R, 2021,<xref rid="i2168-9709-14-1-33-b81" ref-type="bibr">81</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 58</td><td rowspan="1" colspan="1">Retrospective evaluation Medication review with collaboration with a physician</td><td rowspan="1" colspan="1">Performed medication reconciliation requiring adding medications (55.3% of encounters) Performed medication reconciliation requiring removing medications (53.2% of encounters)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pham HT, 2021,<xref rid="i2168-9709-14-1-33-b82" ref-type="bibr">82</xref> Vietnam</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 116</td><td rowspan="1" colspan="1">Retrospective, open, pre/post comparison Pharmacist-provided therapeutic drug monitoring for antiepileptic drugs</td><td rowspan="1" colspan="1">Patients:Received intervention (52.5%)Experienced adverse drug reactions (&gt; 56%) Pharmacist intervention:Increased effectiveness of therapy (25%, <italic toggle="yes">P</italic> &lt; .001)Increased optimized drug concentrations (14.6%, <italic toggle="yes">P</italic> = .018)</td></tr></tbody></table><table-wrap-foot><fn><p>US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t09" orientation="portrait"><caption><p>Intellectual Disabilities</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb9col1" align="left" charoff="0" char="" span="1"/><col id="tb9col2" align="char" charoff="0" char="." span="1"/><col id="tb9col3" align="char" charoff="0" char="." span="1"/><col id="tb9col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Ellenor GL, 1977,<xref rid="i2168-9709-14-1-33-b37" ref-type="bibr">37</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 208</td><td rowspan="1" colspan="1">Retrospective pre/post comparison chart review Pharmacist reviewed patients&#8217; charts and pharmacy records and visited patient to evaluate regimen</td><td rowspan="1" colspan="1">Reduced antipsychotic use (18%) Reduced antianxiety-antidepressant drug use (50%) Reduced sedative-hypnotic use (58%) Reduced miscellaneous agents (65%) Achieved net savings in drug expenditures of $19 363.25 per year</td></tr><tr><td align="left" rowspan="1" colspan="1">Berchou RC, 1982,<xref rid="i2168-9709-14-1-33-b83" ref-type="bibr">83</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 715</td><td rowspan="1" colspan="1">Retrospective chart review at 2 institutions Consultant pharmacist-provided medication use services</td><td rowspan="1" colspan="1">Increased single drug antipsychotic regimens (4.9% vs 9.1%) Increased single drug anticonvulsant regimens (2.7% vs 15.1%) Decreased long-term medications (76.1% to 56.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">McKee JR, 1994,<xref rid="i2168-9709-14-1-33-b84" ref-type="bibr">84</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 446</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist-conducted drug regimen reviews</td><td rowspan="1" colspan="1">Decreased medication doses per patient day (16.1 doses/d to 9.8 doses/d) Decreased pharmacy cost per patient day ($2.87 to $2.39) Decreased doses packaged per month by pharmacy (38 162 to 18 139) Saved 1057 hours of nursing time/month</td></tr><tr><td align="left" rowspan="1" colspan="1">Thayer N, 2021,<xref rid="i2168-9709-14-1-33-b85" ref-type="bibr">85</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 160</td><td rowspan="1" colspan="1">Pharmacist-provided medication reviews for care home residents</td><td rowspan="1" colspan="1">Completed 507 interventions including lifestyle risk-related (30.4%), changing medications (17.9%), and stopping medications (12.8%)</td></tr></tbody></table><table-wrap-foot><fn><p>US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t10" orientation="portrait"><caption><p>Major Depressive Disorder</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb10col1" align="left" charoff="0" char="" span="1"/><col id="tb10col2" align="char" charoff="0" char="." span="1"/><col id="tb10col3" align="char" charoff="0" char="." span="1"/><col id="tb10col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Boudreau DM, 2002,<xref rid="i2168-9709-14-1-33-b86" ref-type="bibr">86</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 74</td><td rowspan="1" colspan="1">Pragmatic, randomized, controlled trial Clinical pharmacist collaborative care intervention vs usual care</td><td rowspan="1" colspan="1">Improved diagnosis of major depression with a structured clinical interview for DSM-IV (53% vs 28%, <italic toggle="yes">P</italic> = .04) Failed to show statistical differences in counseling/psychotherapy, hospitalization, ED visits, and missed work/school</td></tr><tr><td align="left" rowspan="1" colspan="1">Finley PR, 2002,<xref rid="i2168-9709-14-1-33-b13" ref-type="bibr">13</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 220</td><td rowspan="1" colspan="1">Nonrandomized allocation pilot program Pharmacist-led management of outpatient psychiatric conditions</td><td rowspan="1" colspan="1">Increased adherence rates in intervention compared with control (medication possession ratio 0.81 vs 0.66) Increased medication switch rates (24% vs 5%) Reduced a higher number of PCP visits more than control (39% vs 12%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Finley PR, 2003,<xref rid="i2168-9709-14-1-33-b14" ref-type="bibr">14</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 125</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided management of outpatient psychiatric conditions</td><td rowspan="1" colspan="1">Achieved a higher adherence rate compared with control (67% vs 48%, OR 2.17)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bungay KM, 2004,<xref rid="i2168-9709-14-1-33-b87" ref-type="bibr">87</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 268</td><td rowspan="1" colspan="1">Randomized, controlled Pharmacists intervened on depressed patients in an outpatient setting</td><td rowspan="1" colspan="1">Achieved 978 encounters for 268 patients in 6 months Increased encounter time (70.3 min/patient over 6 months)</td></tr><tr><td align="left" rowspan="1" colspan="1">Capoccia KL, 2004,<xref rid="i2168-9709-14-1-33-b88" ref-type="bibr">88</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 74</td><td rowspan="1" colspan="1">Randomized, controlled Pharmacists or residents followed up with patients via phone vs usual care</td><td rowspan="1" colspan="1">Increased depression scores and QOL at 3 months maintained for 1 year in both groups</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyne JM, 2010,<xref rid="i2168-9709-14-1-33-b89" ref-type="bibr">89</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 395</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided medication management</td><td rowspan="1" colspan="1">Failed to show a difference in primary outcomes of DFDs Improved QOL outpatient on SF-12 (<italic toggle="yes">P</italic> = .04)</td></tr><tr><td align="left" rowspan="1" colspan="1">Fortney JC, 2013,<xref rid="i2168-9709-14-1-33-b90" ref-type="bibr">90</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 364</td><td rowspan="1" colspan="1">Prospective, randomized, controlled, comparative effectiveness trial Pharmacist-provided depression management</td><td rowspan="1" colspan="1">Improved response and remission across all times (6, 12, and 18 months)</td></tr><tr><td align="left" rowspan="1" colspan="1">Marques LA, 2013,<xref rid="i2168-9709-14-1-33-b26" ref-type="bibr">26</xref> Brazil</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 48</td><td rowspan="1" colspan="1">Prospective, randomized, controlled comparative trial Clinical pharmacist-provided intervention with pharmacotherapy follow-up</td><td rowspan="1" colspan="1">Decreased Modified Beck Depression Inventory scores more in the intervention group vs in the control group (13.5 vs 2.5, <italic toggle="yes">P</italic> = .0275) Decreased Anxiety Inventory scores more in the intervention group than the control group (13 vs 3.5, <italic toggle="yes">P</italic> = .0194) Reduced severe depression more in the intervention group (80% vs 60%) Increased number of patients with only minimal symptoms of depression at 3 months (7 vs 4 patients)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moore JM, 2013,<xref rid="i2168-9709-14-1-33-b91" ref-type="bibr">91</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 4500</td><td rowspan="1" colspan="1">Prospective, controlled, randomized matched, pre/post Pharmacist-driven MTM appointments for high-risk patients</td><td rowspan="1" colspan="1">Improved cost in intervention group compared to control group (&#8722;10.3% or $977 vs 0.7% or $62, <italic toggle="yes">P</italic> = .048) Increased total day supply of medications (73 additional days) Reduced inpatient visits (18.6%) Observed no change in ED visits or adherence</td></tr><tr><td align="left" rowspan="1" colspan="1">Rubio-Valera M, 2013,<xref rid="i2168-9709-14-1-33-b15" ref-type="bibr">15</xref> Spain</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 179</td><td rowspan="1" colspan="1">Prospective, parallel group, randomized, controlled Community pharmacist-driven educational intervention to improve antidepressant knowledge and adherence awareness</td><td rowspan="1" colspan="1">Increased probability of adherence at 3 months (78.4% vs 61.9%) Increased probability of adherence at 6 months (60.1% vs 40.2%) Improved quality of life scores (<italic toggle="yes">P</italic> = .038) Failed to improve patient satisfaction or symptom severity</td></tr><tr><td align="left" rowspan="1" colspan="1">Aljumah K, 2015,<xref rid="i2168-9709-14-1-33-b16" ref-type="bibr">16</xref> Saudi Arabia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 220</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist consults General outpatient conditions</td><td rowspan="1" colspan="1">Improved medication adherence, treatment satisfaction, general overuse beliefs, and specific concern beliefs</td></tr><tr><td align="left" rowspan="1" colspan="1">DeCaporale-Ryan LN, 2017,<xref rid="i2168-9709-14-1-33-b45" ref-type="bibr">45</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 17</td><td rowspan="1" colspan="1">Team-based hospital follow-up, including a pharmacist and student pharmacist, in a family medicine practice</td><td rowspan="1" colspan="1">Reduced average number of prescribed medications (15.5 to 13.1, <italic toggle="yes">P</italic> &lt; .01). Identified patients meeting the criteria for depression on CES-D (70.6%) Referred to therapy (23.5%) Identified as having cognitive deficits (41.2%) Completed full neuropsychiatric evaluations (11.8%) Avoided readmission at 30 and 90 days (88.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">B&#228;ttig VAD, 2020,<xref rid="i2168-9709-14-1-33-b49" ref-type="bibr">49</xref> Germany</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 143</td><td rowspan="1" colspan="1">Naturalistic retrospective cohort study Pharmacist-led pilot implementation of pharmacogenomic testing</td><td rowspan="1" colspan="1">Demonstrated significantly shorter stays than the control, after correction of the length of hospital stay and the time to genotyping results (36.3 vs 46.6 days; <italic toggle="yes">P</italic> = .003) Reduced length of stay the most in antidepressant-na&#239;ve patients (24.7 vs 50.2 days; <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Silvia R, 2020,<xref rid="i2168-9709-14-1-33-b92" ref-type="bibr">92</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 141</td><td rowspan="1" colspan="1">Retrospective, nonrandomized trial Pharmacist provided management</td><td rowspan="1" colspan="1">Decreased PHQ-9 score from baseline to follow-up (17.9 to 14.7, <italic toggle="yes">P</italic> &lt; .001) Reduced time from referral to assessment (31.3 vs. 104.5 days) Observed high patient satisfaction scores in 39 patients in the intervention group (26.8/28)</td></tr><tr><td align="left" rowspan="1" colspan="1">Marasine NR, 2022,<xref rid="i2168-9709-14-1-33-b93" ref-type="bibr">93</xref> Nepal</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 190</td><td rowspan="1" colspan="1">Single-center, open-label, parallel design Pharmaceutical service intervention vs usual care</td><td rowspan="1" colspan="1">Improved medication adherence compared with control at 2 and 4 months (<italic toggle="yes">P</italic> &lt; .001) Failed to show a difference in depression severity or health-related QOL</td></tr></tbody></table><table-wrap-foot><fn><p>CES-D = Center for Epidemiologic Studies Depression Scale; DFDs = depression-free days; DSM-IV = <italic toggle="yes">Diagnostic and Statistical Manual of Mental Health</italic>, 4<sup>th</sup> edition; ED = emergency department; PHQ-9 = Patient Health Questionnaire-9; MTM = medication therapy management; OR = odds ratio; PCP = primary care physician; QOL = quality of life; SF-12 = 12-Item Short Form Survey; US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t11" orientation="portrait"><caption><p>Parkinson Disease</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb11col1" align="left" charoff="0" char="" span="1"/><col id="tb11col2" align="char" charoff="0" char="." span="1"/><col id="tb11col3" align="char" charoff="0" char="." span="1"/><col id="tb11col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Schr&#246;der S, 2012,<xref rid="i2168-9709-14-1-33-b94" ref-type="bibr">94</xref> Germany</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 235</td><td rowspan="1" colspan="1">Open, multicenter, parallel group Community pharmacist-provided care</td><td rowspan="1" colspan="1">Improved Parkinson&#8217;s scale sub scores (<italic toggle="yes">P</italic> &lt; .05) Improved EuroQol 5-Dimension Questionnaire Index Score (<italic toggle="yes">P</italic> &lt; .001) Failed to show improvement in prescribers&#8217; guideline adherence Reduced inappropriate medications based on Beers List criteria (&lt; 0.01)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stuijt C, 2018,<xref rid="i2168-9709-14-1-33-b36" ref-type="bibr">36</xref> The Netherlands</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 23</td><td rowspan="1" colspan="1">Prospective pilot study Pharmacist-led medication review</td><td rowspan="1" colspan="1">Improved medication adherence after the combined unit dose packaging, Parkinson KinetiGraph, and medication review intervention in nonadherent patients Increased medications filled on time (56% to 68%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Oonk NGM, 2023,<xref rid="i2168-9709-14-1-33-b95" ref-type="bibr">95</xref> The Netherlands</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 152</td><td rowspan="1" colspan="1">Cost-utility analysis Community pharmacist-led medication review</td><td rowspan="1" colspan="1">Implemented 161 of 260 interventions (62%) Failed to show difference between Parkinson&#8217;s Disease Questionaire-39 scores</td></tr></tbody></table></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t12" orientation="portrait"><caption><p>Schizophrenia</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb12col1" align="left" charoff="0" char="" span="1"/><col id="tb12col2" align="char" charoff="0" char="." span="1"/><col id="tb12col3" align="char" charoff="0" char="." span="1"/><col id="tb12col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Hoffmann RP, 1974,<xref rid="i2168-9709-14-1-33-b96" ref-type="bibr">96</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist conducted interview</td><td rowspan="1" colspan="1">Self-reported misuse of at least 1 medication (56%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bond CA, 1979,<xref rid="i2168-9709-14-1-33-b40" ref-type="bibr">40</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 25</td><td rowspan="1" colspan="1">Unspecified study design Pharmacist-provided fluphenazine clinic</td><td rowspan="1" colspan="1">Reduced average dose of fluphenazine decanoate (32.8 to 20.05 mg) Improved rehospitalization rates Decreased medication-related side effects (1.52/patient vs 0.2/patient) Improved functional capacity</td></tr><tr><td align="left" rowspan="1" colspan="1">Dorevitch A, 1993,<xref rid="i2168-9709-14-1-33-b50" ref-type="bibr">50</xref> Israel</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 14</td><td rowspan="1" colspan="1">Open-label study Pharmacist-led medication management</td><td rowspan="1" colspan="1">Decreased rate of rehospitalization Reduced length of stay Decreased total neuroleptic dosage Reduced medication-related side effects Improved compliance</td></tr><tr><td align="left" rowspan="1" colspan="1">Sathienluckana T, 2018,<xref rid="i2168-9709-14-1-33-b97" ref-type="bibr">97</xref> Thailand</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 30</td><td rowspan="1" colspan="1">Prospective, open-label, randomized trial Pharmacist-provided medication management</td><td rowspan="1" colspan="1">Improved Wisconsin Card Sorting Test perseverative errors at the end of the study compared with baseline (<italic toggle="yes">P</italic> = .003)</td></tr><tr><td align="left" rowspan="1" colspan="1">Spann G, 2022,<xref rid="i2168-9709-14-1-33-b98" ref-type="bibr">98</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 61</td><td rowspan="1" colspan="1">Retrospective observational study Pharmacist-provided clozapine adverse effect monitoring</td><td rowspan="1" colspan="1">Achieved higher rates of metabolic and ECG monitoring compared with a clinic without a pharmacist (glucose 48% vs. 11%, <italic toggle="yes">P</italic> = 0.001; lipids 61% vs 7.1%, <italic toggle="yes">P</italic> = .001; ECG 15% vs 0%, <italic toggle="yes">P</italic> = .001) Achieved positive trends in weight</td></tr></tbody></table><table-wrap-foot><fn><p>ECG = electrocardiogram; US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t13" orientation="portrait"><caption><p>Sleep Disorder</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb13col1" align="left" charoff="0" char="" span="1"/><col id="tb13col2" align="char" charoff="0" char="." span="1"/><col id="tb13col3" align="char" charoff="0" char="." span="1"/><col id="tb13col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Lui E, 2021,<xref rid="i2168-9709-14-1-33-b99" ref-type="bibr">99</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 121</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist-provided insomnia management</td><td rowspan="1" colspan="1">Achieved complete abstinence (32%) Observed reduction in dose by &#8805; 50% (32%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Masse M, 2022,<xref rid="i2168-9709-14-1-33-b100" ref-type="bibr">100</xref> France</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 960</td><td rowspan="1" colspan="1">Prospective, observational Community pharmacist and pharmacy student-conducted interviews on sleep habits and medication</td><td rowspan="1" colspan="1">Performed 960 interviews Self-reported at least 1 poor sleep habit (75%) Self-reported 2 or more poor sleep habits (41%) Self-reported getting up at night (77%) Self-reported openness to discontinuing medication (35%)</td></tr></tbody></table></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t14" orientation="portrait"><caption><p>Substance Use Disorder</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb14col1" align="left" charoff="0" char="" span="1"/><col id="tb14col2" align="char" charoff="0" char="." span="1"/><col id="tb14col3" align="char" charoff="0" char="." span="1"/><col id="tb14col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Hutchinson SJ, 2000,<xref rid="i2168-9709-14-1-33-b101" ref-type="bibr">101</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 204</td><td rowspan="1" colspan="1">Cohort Community pharmacist supervised oral methadone use</td><td rowspan="1" colspan="1">Tracked continuous methadone treatment (29%) Reduced self-reported daily opiate injecting (78% to 2%) Reduced overdose (24% to 2%) Reduced drug spending (50 to 4 pounds) Reduced acquisition crimes (13 to 3) Attributed discontinuation of treatment to imprisonment (39%) or sanctions by the prescriber (33%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jaffray M, 2014,<xref rid="i2168-9709-14-1-33-b102" ref-type="bibr">102</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 335</td><td rowspan="1" colspan="1">Prospective, comparison group, randomized clinical trial Community pharmacist motivational interviewing of heroin users</td><td rowspan="1" colspan="1">Reduced heroin use in both groups (<italic toggle="yes">P</italic> &lt; .001) Observed larger decline in physical health in the intervention group (<italic toggle="yes">P</italic> = .046) Reported motivational interviewing was useful (<italic toggle="yes">P</italic> = .047)</td></tr><tr><td align="left" rowspan="1" colspan="1">Steineck KJ, 2014,<xref rid="i2168-9709-14-1-33-b43" ref-type="bibr">43</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 52</td><td rowspan="1" colspan="1">Retrospective, controlled, nonblinded, nonrandomized, case-control chart review Pharmacist intervention and management of methadone taper on opioid withdrawal Pediatric ICU patients</td><td rowspan="1" colspan="1">Decreased taper length from 24.7 to 15.0 days (<italic toggle="yes">P</italic> = .003) Reduced opioid infusion duration (3.32 days vs. 1.78 days; <italic toggle="yes">P</italic> = .004) Reduced number of additional opioid doses required (<italic toggle="yes">P</italic> = .24) Decreased length of stay (<italic toggle="yes">P</italic> = .023)</td></tr><tr><td align="left" rowspan="1" colspan="1">Suzuki J, 2014,<xref rid="i2168-9709-14-1-33-b103" ref-type="bibr">103</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 45</td><td rowspan="1" colspan="1">Prospective, open, nonrandomized single-group Pharmacist-provided buprenorphine in primary care</td><td rowspan="1" colspan="1">Achieved treatment retention at 6 months (55.6%) Improved aberrant urine toxicology results (69.2% vs 31.8%; <italic toggle="yes">P</italic> &lt; .01) Improved craving scores (4.1 vs 0.9; <italic toggle="yes">P</italic> &lt; .01) Improved confidence of PCPs treating opioid dependence (5.3% vs 25.0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Smith A, 2021,<xref rid="i2168-9709-14-1-33-b104" ref-type="bibr">104</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 150</td><td rowspan="1" colspan="1">Single-center, multisite, retrospective, observational cohort study Pharmacist-led substance use disorder management</td><td rowspan="1" colspan="1">Combined retention rates as measured by a certified medical assistance for buprenorphine/naloxone and extended-release naltrexone were significant for the intervention group compared to the control group at 1 and 3 months</td></tr><tr><td align="left" rowspan="1" colspan="1">Yasin H, 2021,<xref rid="i2168-9709-14-1-33-b105" ref-type="bibr">105</xref> Jordan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 93</td><td rowspan="1" colspan="1">Randomized, controlled trial Pharmacist identified treatment-related problems and provided recommendations to treatment team</td><td rowspan="1" colspan="1">Identified treatment-related problems (392)<xref rid="T14n1" ref-type="table-fn">a</xref> Reduced mean number of treatment-related problems at discharge by 2.2 &#177; 0.85 (<italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Binswanger IA, 2022,<xref rid="i2168-9709-14-1-33-b106" ref-type="bibr">106</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 325</td><td rowspan="1" colspan="1">Multisite, cluster, randomized Community pharmacists intervened in naloxone co-dispensing Naloxone, opioids</td><td rowspan="1" colspan="1">Reduced self-reported opioid risk behaviors at 4 months Failed to show reduction in self-reported opioid risk behaviors at 8 months (<italic toggle="yes">P</italic> = .052) Increased patient knowledge</td></tr><tr><td align="left" rowspan="1" colspan="1">Ehrhard K, 2022,<xref rid="i2168-9709-14-1-33-b107" ref-type="bibr">107</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 274</td><td rowspan="1" colspan="1">Single-center, retrospective, observational cohort study Pharmacist inclusion on addiction triage team</td><td rowspan="1" colspan="1">Improved MAUD/MOUD initiation rates with pharmacist addition vs control (26.3% vs 4%, <italic toggle="yes">P</italic> &lt; .0001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Skoy E, 2022,<xref rid="i2168-9709-14-1-33-b108" ref-type="bibr">108</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 8217</td><td rowspan="1" colspan="1">Validation study of Opioid and Naloxone Education Program Community pharmacist-provided preventive screening for opioid misuse and accidental overdose before dispensing prescribed opioid</td><td rowspan="1" colspan="1">Identified patients at high risk for opioid misuse (3.9%) Identified patients at risk for accidental overdose (18.3%) Indicated opioid medication use in the past 60 days (31.7%) Delivered 1 or more risk-factor&#8211;dependent interventions to 41.1% of patients Dispensed naloxone in pharmacies increased to 6 times the national average</td></tr><tr><td align="left" rowspan="1" colspan="1">Sze J, 2022,<xref rid="i2168-9709-14-1-33-b109" ref-type="bibr">109</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 44</td><td rowspan="1" colspan="1">Prospective, unblinded pilot study Pharmacist-driven inpatient naloxone education program</td><td rowspan="1" colspan="1">Improved accuracy of completed assessments, indicating enhanced knowledge about naloxone use and administration, following the naloxone education (4.68 vs 3.42, <italic toggle="yes">P</italic> = .0016)</td></tr></tbody></table><table-wrap-foot><fn><p>ICU = intensive care unit; MAUD/MOUD = medications for alcohol use disorder/medications for opioid use disorder; PCP = primary care physician; US = United States.</p></fn><fn id="T14n1"><label>a</label><p>Improved physical health (<italic toggle="yes">P</italic> = .035) and overall sleep status (<italic toggle="yes">P</italic> = .048) in the intervention vs control group.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t15" orientation="portrait"><caption><p>Tobacco Use Disorder</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb15col1" align="left" charoff="0" char="" span="1"/><col id="tb15col2" align="char" charoff="0" char="." span="1"/><col id="tb15col3" align="char" charoff="0" char="." span="1"/><col id="tb15col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Baluch WM, 1995,<xref rid="i2168-9709-14-1-33-b05" ref-type="bibr">5</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = nearly 1000</td><td rowspan="1" colspan="1">Prospective unblinded study Pharmacist-involved in behavioral modification program</td><td rowspan="1" colspan="1">Observed rates of long-term abstinence comparable with the literature rates for community-based group Observed high satisfaction of patients, pharmacists, and physicians</td></tr><tr><td align="left" rowspan="1" colspan="1">Smith MD, 1995,<xref rid="i2168-9709-14-1-33-b08" ref-type="bibr">8</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 40 220</td><td rowspan="1" colspan="1">Community pharmacist-provided comprehensive counseling to patients on smoking cessation Nicotine replacement therapy</td><td rowspan="1" colspan="1">Improved patient-reported quit rates after treatment (37% vs 62%) Improved patient-reported quit rates 10 months after treatment (33% vs 45%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Jones TE, 1998,<xref rid="i2168-9709-14-1-33-b06" ref-type="bibr">6</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 111</td><td rowspan="1" colspan="1">Prospective unblinded study Clinical pharmacist-run Stop Smoking Programme that offered nicotine patches and weekly support</td><td rowspan="1" colspan="1">Observed 29 successful patients at 3 months Observed 23 remain abstinent at 6 months Observed 19 remain abstinent at 12 months</td></tr><tr><td align="left" rowspan="1" colspan="1">Maguire TA, 2001,<xref rid="i2168-9709-14-1-33-b110" ref-type="bibr">110</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 484</td><td rowspan="1" colspan="1">Randomized, controlled Community pharmacist-provided structured counseling and follow-up to patients Nicotine replacement therapy</td><td rowspan="1" colspan="1">Improved abstinence rates (14.3% vs 2.7%, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Doescher MP, 2002,<xref rid="i2168-9709-14-1-33-b20" ref-type="bibr">20</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 32</td><td rowspan="1" colspan="1">Prospective, unblinded NRT coverage with pharmacist-delivered cessation counseling</td><td rowspan="1" colspan="1">Received counseling with NRT (81%) Self-reported high satisfaction</td></tr><tr><td align="left" rowspan="1" colspan="1">Kennedy DT, 2002,<xref rid="i2168-9709-14-1-33-b19" ref-type="bibr">19</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 48</td><td rowspan="1" colspan="1">Single-center, unblinded Community pharmacist-provided counseling</td><td rowspan="1" colspan="1">Patient reported: Obtained abstinence from smoking cigarettes at 12 months (25%) Improved long-term abstinence in women compared with men (33.3% vs 6.7%, <italic toggle="yes">P</italic> = .047)</td></tr><tr><td align="left" rowspan="1" colspan="1">Zillich AJ, 2002,<xref rid="i2168-9709-14-1-33-b07" ref-type="bibr">7</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 21</td><td rowspan="1" colspan="1">Prospective, nonrandomized, open label Pharmacist-provided tobacco cessation</td><td rowspan="1" colspan="1">Verified abstinence rates at 3 and 6 months (42% and 26%, respectively)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bauld L, 2009,<xref rid="i2168-9709-14-1-33-b111" ref-type="bibr">111</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1785</td><td rowspan="1" colspan="1">Observational Community pharmacist-provided tobacco cessation</td><td rowspan="1" colspan="1">Failed to improve quit rates compared with specialist-led, group-based services Increased number of patients treated</td></tr><tr><td align="left" rowspan="1" colspan="1">Dent LA, 2009,<xref rid="i2168-9709-14-1-33-b112" ref-type="bibr">112</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 101</td><td rowspan="1" colspan="1">Prospective, randomized, comparative, open trial Pharmacist-provided tobacco cessation</td><td rowspan="1" colspan="1">Increased smoking cessation rates in face-to-face pharmacist intervention vs a telephone-based pharmacist intervention at 6 months using cotinine levels (28% vs 11.8%, <italic toggle="yes">P</italic> = .041)</td></tr><tr><td align="left" rowspan="1" colspan="1">Philbrick AM, 2009,<xref rid="i2168-9709-14-1-33-b113" ref-type="bibr">113</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 21</td><td rowspan="1" colspan="1">Prospective, open, nonrandomized single group Pharmacist-managed smoking cessation clinic</td><td rowspan="1" colspan="1">Reduced smoking at 3 and 9 months (47.6%, 52.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bauld L, 2011,<xref rid="i2168-9709-14-1-33-b114" ref-type="bibr">114</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1785</td><td rowspan="1" colspan="1">Open Community pharmacist-provided tobacco cessation intervention</td><td rowspan="1" colspan="1">Reduced cost compared with group service (2600 vs 4800 pounds/QALY) Failed to show improved quit rates compared with group service (2.8% vs 6.3%, <italic toggle="yes">P</italic> = .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Costello MJ, 2011,<xref rid="i2168-9709-14-1-33-b115" ref-type="bibr">115</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 5182</td><td rowspan="1" colspan="1">Open, randomized Community pharmacist-conducted tobacco cessation interventions</td><td rowspan="1" colspan="1">Improved self-reported quit rates in patients completing 3 vs 1 session (27.7% vs 18%) Failed to show improved self-reported 7-day point prevalence rates</td></tr><tr><td align="left" rowspan="1" colspan="1">Khan N, 2012,<xref rid="i2168-9709-14-1-33-b21" ref-type="bibr">21</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 346</td><td rowspan="1" colspan="1">Prospective Community pharmacist-provided tobacco cessation programming</td><td rowspan="1" colspan="1">Improved patient satisfaction<xref rid="T15n1" ref-type="table-fn">a</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Mardle T, 2012,<xref rid="i2168-9709-14-1-33-b116" ref-type="bibr">116</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 400</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist-provided tobacco use disorder management</td><td rowspan="1" colspan="1">Failed to show improvement in smoking cessation for pharmacists compared to smoking cessation advisors (41% vs 75%) Observed no difference in smoking cessation rates for pharmacists compared with general practitioners (41% vs 62%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chen T, 2014,<xref rid="i2168-9709-14-1-33-b117" ref-type="bibr">117</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1006</td><td rowspan="1" colspan="1">Retrospective, open, comparison group, nonrandomized, cohort Pharmacist-managed telephone tobacco cessation clinic vs standard of care</td><td rowspan="1" colspan="1">Improved abstinence at 1 month (<italic toggle="yes">P</italic> &lt; .001) Improved abstinence at 3 months (<italic toggle="yes">P</italic> &lt; .001) Improved abstinence at 6 months (81/503 vs 48/503, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Shen X, 2014,<xref rid="i2168-9709-14-1-33-b118" ref-type="bibr">118</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1437</td><td rowspan="1" colspan="1">Prospective, open, nonrandomized Community pharmacist-led tobacco cessation program</td><td rowspan="1" colspan="1">Obtained abstinence rates at 1, 3, and 6 months (29.3%, 23.3%, and 18%, respectively) Remained abstinent (6.1%) Regressed abstinence (17.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mar&#237;n Armero A, 2015,<xref rid="i2168-9709-14-1-33-b09" ref-type="bibr">9</xref> Spain</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 23</td><td rowspan="1" colspan="1">Open, pre/post comparison Community pharmacist-prescribed nicotine replacement therapy</td><td rowspan="1" colspan="1">Achieved full cessation at 1 month (56.52%) Retained cessation at 12 months (43.48%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Augustine JM, 2016,<xref rid="i2168-9709-14-1-33-b119" ref-type="bibr">119</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 238</td><td rowspan="1" colspan="1">Retrospective database review Pharmacist-provided telephone-based quit counseling services and smoking cessation pharmacotherapy</td><td rowspan="1" colspan="1">Self-reported smoke free at 7-month follow-up (51%) Self-reported smoke free at 13-month follow-up (55%) Failed to show difference in percentages of smoke-free participants at 7 or 13 months, regardless of their first treatment (<italic toggle="yes">P</italic> = .06 and .345, respectively).</td></tr><tr><td align="left" rowspan="1" colspan="1">Fai SC, 2016,<xref rid="i2168-9709-14-1-33-b120" ref-type="bibr">120</xref> Malaysia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 176</td><td rowspan="1" colspan="1">Pharmacist-provided smoking cessation pharmacotherapy with multidisciplinary team</td><td rowspan="1" colspan="1">Achieved abstinence from smoking in intervention group (42.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gong J, 2016,<xref rid="i2168-9709-14-1-33-b121" ref-type="bibr">121</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 736</td><td rowspan="1" colspan="1">Prospective, randomized, pragmatic Pharmacist-provided tobacco use disorder management</td><td rowspan="1" colspan="1">Improved abstinence from tobacco compared with control group (42.3% vs 38.2%, <italic toggle="yes">P</italic> = .097</td></tr><tr><td align="left" rowspan="1" colspan="1">Thomas D, 2016,<xref rid="i2168-9709-14-1-33-b22" ref-type="bibr">22</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 586</td><td rowspan="1" colspan="1">Parallel-group, single-blinded, randomized controlled trial Pharmacist based tobacco cessation management</td><td rowspan="1" colspan="1">Failed to show a difference in cessation between intervention group and usual care group at 6 months (11.6% vs 12.6%) Failed to show a difference in cessation between intervention group and usual care group at 12 months (11.6% vs 11.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Watanabe F, 2016,<xref rid="i2168-9709-14-1-33-b23" ref-type="bibr">23</xref> Japan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 36</td><td rowspan="1" colspan="1">Prospective Pharmacist-provided tobacco use disorder management</td><td rowspan="1" colspan="1">Improved smoking cessation rates at institution A (40.8% to 64.5%, <italic toggle="yes">P</italic> = .024) Improved smoking cessation rates at institution B (42.9% to 100%, <italic toggle="yes">P</italic> = .017)</td></tr><tr><td align="left" rowspan="1" colspan="1">El Hajj MS, 2017,<xref rid="i2168-9709-14-1-33-b122" ref-type="bibr">122</xref> Qatar</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 314</td><td rowspan="1" colspan="1">Prospective, randomized controlled trial of brief smoking cessation counseling in 8 community pharmacies</td><td rowspan="1" colspan="1">Improved self-reported abstinence at 12 months (23.9% vs 16.9%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Forinash AB, 2018,<xref rid="i2168-9709-14-1-33-b123" ref-type="bibr">123</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 30</td><td rowspan="1" colspan="1">Randomized, open-label, prospective trial Pharmacist-provided tobacco use disorder management</td><td rowspan="1" colspan="1">Increased achievement of exhaled carbon monoxide-verified cessation in intervention vs control (57.1% vs 31.3%, <italic toggle="yes">P</italic> = .153)</td></tr><tr><td align="left" rowspan="1" colspan="1">Li VW, 2018,<xref rid="i2168-9709-14-1-33-b124" ref-type="bibr">124</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 96</td><td rowspan="1" colspan="1">Pilot pre/post comparison study Hospital pharmacist-provided smoking cessation support (counselling and NRT), inpatient follow-up during hospital stay, and 3 month postdischarge follow-up calls</td><td rowspan="1" colspan="1">Increased self-reported continuous abstinence (28.6% vs 16.4%, <italic toggle="yes">P</italic> = .035) Increased self-reported 7-day point prevalence abstinence (37.5% vs 18.2%, <italic toggle="yes">P</italic> = .009)</td></tr><tr><td align="left" rowspan="1" colspan="1">Litke J, 2018,<xref rid="i2168-9709-14-1-33-b125" ref-type="bibr">125</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 140</td><td rowspan="1" colspan="1">Retrospective Pharmacist provided medication management via telehealth and phone encounters</td><td rowspan="1" colspan="1">Achieved tobacco cessation (42%) Reduced tobacco use (39%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cheng HM, 2019,<xref rid="i2168-9709-14-1-33-b126" ref-type="bibr">126</xref> Singapore</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 74</td><td rowspan="1" colspan="1">Retrospective, single-center Pharmacist-provided counseling for tobacco use disorder</td><td rowspan="1" colspan="1">Observed smoking cessation at 2-week follow-up (15.8%) Observed patients with a reduction in the number of cigarettes smoked per day (45.6%) Reduced average number of cigarettes per day (4.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Beaupre LA, 2020,<xref rid="i2168-9709-14-1-33-b127" ref-type="bibr">127</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 103</td><td rowspan="1" colspan="1">Prospective, controlled, nonrandomized, pre/post comparison study Pharmacist offered individualized evidence-based intervention and collected visit, duration, and intervention data</td><td rowspan="1" colspan="1">Self-reported 7-day point prevalence abstinence at 6 weeks in the pharmacist group compared to control group (19% vs 4%, <italic toggle="yes">P</italic> = .04). Improved 7-day point prevalence abstinence at 6 months (33% vs. 4%, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Condinho M, 2021,<xref rid="i2168-9709-14-1-33-b128" ref-type="bibr">128</xref> Portugal</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1 35</td><td rowspan="1" colspan="1">Prospective Community pharmacists consulted with patients</td><td rowspan="1" colspan="1">Increased smoking cessation in those who participated in pharmacist consultations and telephone sessions (&#967;<sup>2</sup> = 59.994, <italic toggle="yes">P</italic> &lt; .001, &#967;<sup>2</sup> = 17.845, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gobarani RK, 2021,<xref rid="i2168-9709-14-1-33-b129" ref-type="bibr">129</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 690</td><td rowspan="1" colspan="1">Prospective, cluster randomized controlled trial Pharmacist-provided tobacco cessation</td><td rowspan="1" colspan="1">Failed to show a difference in smoking cessation rates at the 6-month follow-up Failed to show a difference in readiness to quit scores Failed to show a difference when comparing quit rates with baseline readiness to quit scores</td></tr><tr><td align="left" rowspan="1" colspan="1">Lertsinudom S, 2021,<xref rid="i2168-9709-14-1-33-b130" ref-type="bibr">130</xref> Thailand</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 532</td><td rowspan="1" colspan="1">Retrospective Community pharmacists counseled patients on smoking cessation</td><td rowspan="1" colspan="1">Increased self-reported abstinence from smoking (28.8%; 153/532) Reduced mean cigarettes smoked per day (15.3 to 1.9, <italic toggle="yes">P</italic> &lt; .001) Reduced exhaled CO levels (11.7 to 7.2 ppm, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Onda M, 2021,<xref rid="i2168-9709-14-1-33-b131" ref-type="bibr">131</xref> Japan</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 24</td><td rowspan="1" colspan="1">Retrospective, randomized, controlled Community pharmacist-led structured smoking cessation program</td><td rowspan="1" colspan="1">Improved quit rates (45.5% vs 18.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tse SS, 2021,<xref rid="i2168-9709-14-1-33-b132" ref-type="bibr">132</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 19</td><td rowspan="1" colspan="1">Single-center, prospective, nonrandomized, open, comparison Pharmacist-led tobacco cessation</td><td rowspan="1" colspan="1">Achieved smoking cessation at least once (42%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Asayut N, 2022,<xref rid="i2168-9709-14-1-33-b133" ref-type="bibr">133</xref> Thailand</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 156</td><td rowspan="1" colspan="1">Controlled Community pharmacists used PharmQuit to assist in smoking cessation</td><td rowspan="1" colspan="1">Improved smoking cessation rates and number of cigarettes smoked per day Failed to show difference between PharmQuit vs standard of care</td></tr><tr><td align="left" rowspan="1" colspan="1">Cameron CR, 2022,<xref rid="i2168-9709-14-1-33-b134" ref-type="bibr">134</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 129</td><td rowspan="1" colspan="1">Retrospective, observational, single-center, cohort study Pharmacist-led tobacco cessation in patients with cancer</td><td rowspan="1" colspan="1">Increased smoking cessation rates in pharmacy group compared with control (44.8% vs 27.5%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Guthrie AR, 2022,<xref rid="i2168-9709-14-1-33-b135" ref-type="bibr">135</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 143</td><td rowspan="1" colspan="1">Retrospective chart review, nonrandomized, comparison group Pharmacist-led chart review</td><td rowspan="1" colspan="1">Improved mean change in cigarette use (&#8722;7.9 vs &#8722;5.4, <italic toggle="yes">P</italic> = .15)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hartman-Filson M, 2022,<xref rid="i2168-9709-14-1-33-b136" ref-type="bibr">136</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 52</td><td rowspan="1" colspan="1">Prospective Pharmacist trained shelter staff to conduct smoking cessation training</td><td rowspan="1" colspan="1">Reduced smoking (40%) Reduced smoking and increased quitting attempts in those who used medication</td></tr><tr><td align="left" rowspan="1" colspan="1">Park SK, 2022,<xref rid="i2168-9709-14-1-33-b137" ref-type="bibr">137</xref> South Korea</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1 517 901</td><td rowspan="1" colspan="1">Cohort Pharmacists counseled patients with NRT vs expert counseling with NRT vs expert counseling with varenicline</td><td rowspan="1" colspan="1">Increased QALYs in pharmacist + NRT group (32 842) Increased cost savings ($26 689 958) Improved ICER in pharmacist + NRT vs Expert + varenicline (27 247 USD per QALY vs. 4074 USD per QALY)</td></tr><tr><td align="left" rowspan="1" colspan="1">Phillips LCE, 2022,<xref rid="i2168-9709-14-1-33-b138" ref-type="bibr">138</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 35</td><td rowspan="1" colspan="1">Pragmatic, mixed-method, randomized Community pharmacist-led smoking cessation program</td><td rowspan="1" colspan="1">Improved quit rates in the intensive vs abbreviated group (36% vs 22%) Increased discounted life years gained (11.6) Reduced incremental cost per additional quit in intensive vs abbreviated group ($1000 vs $1296 per life year gained)</td></tr></tbody></table><table-wrap-foot><fn><p>CO = carbon dioxide; ICER = incremental cost-effectiveness ratio; NRT = nicotine replacement therapy; QALY = quality-adjusted life-year; PP = point prevalence; US = United States.</p></fn><fn id="T15n1"><label>a</label><p>Average quit rate at the end of 6 months (25%).</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t16" orientation="portrait"><caption><p>Medical Disease With Psychiatric Comorbidity</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb16col1" align="left" charoff="0" char="" span="1"/><col id="tb16col2" align="char" charoff="0" char="." span="1"/><col id="tb16col3" align="char" charoff="0" char="." span="1"/><col id="tb16col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="left" rowspan="1" colspan="1">Author, Year, Country</th><th align="left" rowspan="1" colspan="1">Population</th><th align="left" rowspan="1" colspan="1">Design/Intervention</th><th align="left" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Malone M, 2005,<xref rid="i2168-9709-14-1-33-b139" ref-type="bibr">139</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 142</td><td rowspan="1" colspan="1">Prospective, open, nonrandomized Pharmacist performed clinical assessments, provided drug information to lifestyle challenge participants</td><td rowspan="1" colspan="1">Reduced weight in per protocol group (100.9 to 97.3 kg at 10 weeks and 95.9 kg at 20 weeks) Observed change in weight in intention to treat compared with per protocol analysis at 10 weeks (2.5% gain to 12.2% loss vs 5.9% gain to 17.1% loss) Improved vitality, general health, perceived health, binge eating scale scores, BDI scores in per protocol analysis</td></tr><tr><td align="left" rowspan="1" colspan="1">Taveira TH, 2008,<xref rid="i2168-9709-14-1-33-b140" ref-type="bibr">140</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 297</td><td rowspan="1" colspan="1">Retrospective, cohort analysis Pharmacist-provided CV risk reduction clinic</td><td rowspan="1" colspan="1">Failed to observe a difference in risk reduction for diabetes in those with or without a mental health diagnosis</td></tr><tr><td align="left" rowspan="1" colspan="1">Hansen RA, 2009,<xref rid="i2168-9709-14-1-33-b141" ref-type="bibr">141</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 314</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided medication management Heart failure, depression</td><td rowspan="1" colspan="1">Observed no difference in patients with depression vs those without depression in adherence to heart failure medications</td></tr><tr><td align="left" rowspan="1" colspan="1">Hohmann C, 2009,<xref rid="i2168-9709-14-1-33-b142" ref-type="bibr">142</xref> Germany</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 255</td><td rowspan="1" colspan="1">Prospective Community pharmacist-managed transitions of care poststroke/TIA</td><td rowspan="1" colspan="1">Failed to show change in SF-36 Failed to show change in percent of patients on anticoagulants Improved patient satisfaction scores</td></tr><tr><td align="left" rowspan="1" colspan="1">Hohmann C, 2010,<xref rid="i2168-9709-14-1-33-b143" ref-type="bibr">143</xref> Germany</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 255</td><td rowspan="1" colspan="1">Controlled, nonrandomized, prospective Pharmacists reviewed medication records, counseled patients, intervened on drug related problems</td><td rowspan="1" colspan="1">Observed lower decline in vitality scores at 12-months intervention vs control group (1/8 vs 7/8) Failed to observe change in HRQOL between groups</td></tr><tr><td align="left" rowspan="1" colspan="1">Pyne JM, 2011,<xref rid="i2168-9709-14-1-33-b144" ref-type="bibr">144</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 249</td><td rowspan="1" colspan="1">Single-blinded, randomized clinical, effectiveness trial Pharmacist-provided depression management in patients with HIV</td><td rowspan="1" colspan="1">Improved response and remission rates in the intervention group vs usual care at 6 months Improved response and remission rates not observed at 12 months</td></tr><tr><td align="left" rowspan="1" colspan="1">Taveira TH, 2011,<xref rid="i2168-9709-14-1-33-b145" ref-type="bibr">145</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 88</td><td rowspan="1" colspan="1">Randomized clinical trial Pharmacist-provided medication management for patients with diabetes and psychiatric comorbidities</td><td rowspan="1" colspan="1">Improved number of patients achieving an HBA<sub>1c</sub> &lt; 7% in the pharmacist-led arm vs standard of care (29.6% vs 11.9%, OR 3.6, 95% CI = 1.1, 12.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Carri&#243;n JA, 2013,<xref rid="i2168-9709-14-1-33-b146" ref-type="bibr">146</xref> Spain</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 447</td><td rowspan="1" colspan="1">Prospective, nonrandomized, controlled, comparison group Pharmacist interventions in patients with hepatitis C</td><td rowspan="1" colspan="1">Increased adherence and sustained viral response rates through multidisciplinary support programs</td></tr><tr><td align="left" rowspan="1" colspan="1">Ummavathy P, 2015,<xref rid="i2168-9709-14-1-33-b147" ref-type="bibr">147</xref> Malaysia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 162</td><td rowspan="1" colspan="1">Single-blinded, randomized control trial Pharmacist-provided counseling in patients with cancer and psychiatric comorbidities</td><td rowspan="1" colspan="1">Improved depression severity with each counseling session</td></tr><tr><td align="left" rowspan="1" colspan="1">Milkovich SA, 2017,<xref rid="i2168-9709-14-1-33-b148" ref-type="bibr">148</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 100</td><td rowspan="1" colspan="1">Retrospective chart review Certified diabetes educator RN-and pharmacist-based diabetes clinic</td><td rowspan="1" colspan="1">Reduced mean HBA<sub>1C</sub> more in intervention group compared with control group</td></tr><tr><td align="left" rowspan="1" colspan="1">Kanwal F, 2018,<xref rid="i2168-9709-14-1-33-b149" ref-type="bibr">149</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 242</td><td rowspan="1" colspan="1">Randomized controlled trial Pharmacist-involved in off-site depression collaborative care with depression care manager and psychiatrist</td><td rowspan="1" colspan="1">Completed a 12-month follow-up (82.8%) Increased likelihood to report depression treatment response remission and more depression free days in intervention group compared with usual care</td></tr><tr><td align="left" rowspan="1" colspan="1">Mohd-Sidik S, 2018,<xref rid="i2168-9709-14-1-33-b12" ref-type="bibr">12</xref> Malaysia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1060</td><td rowspan="1" colspan="1">Prospective, multicenter, randomized controlled trial Pharmacist counseling</td><td rowspan="1" colspan="1">Improved mean scores of self-esteem in the 1st, 2nd, and 3rd follow-ups after counselling (<italic toggle="yes">P</italic> &lt; .0001) Reduced depression and anxiety scores after the 1st, 2nd, and 3rd follow-ups after counselling (<italic toggle="yes">P</italic> &lt; .05)</td></tr><tr><td align="left" rowspan="1" colspan="1">Byrd KK, 2020,<xref rid="i2168-9709-14-1-33-b150" ref-type="bibr">150</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 453</td><td rowspan="1" colspan="1">Prospective, open, nonrandomized, pre/post comparison Community pharmacist-conducted MTM, monitored refills, and addressed therapy-related problems</td><td rowspan="1" colspan="1">Improved retention in care</td></tr><tr><td align="left" rowspan="1" colspan="1">Foster MG, 2022,<xref rid="i2168-9709-14-1-33-b151" ref-type="bibr">151</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 10</td><td rowspan="1" colspan="1">Chart review Pharmacist-led tobacco cessation</td><td rowspan="1" colspan="1">Self-reported reduction in cigarettes per day Self-reported abstinence</td></tr><tr><td align="left" rowspan="1" colspan="1">Losada-Camacho M, 2022,<xref rid="i2168-9709-14-1-33-b152" ref-type="bibr">152</xref> Bogata</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 144</td><td rowspan="1" colspan="1">Randomized study Pharmacist management in patients with depression and epilepsy</td><td rowspan="1" colspan="1">Decreased depression symptoms in the women with epilepsy assigned to the advanced model with pharmacy involvement</td></tr></tbody></table><table-wrap-foot><fn><p>BDI = Beck Depression Inventory; CV = cardiovascular; HBA<sub>1c</sub> = hemoglobin A<sub>1c</sub>; HRQOL = health-related quality of life; MTM = medication therapy management; OR = odds ratio; RN = registered nurse; SF-36 = 36-Item Short Form Survey; TIA = transient ischemic attack; US = United States.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="i2168-9709-14-1-33-t17" orientation="portrait"><caption><p>Disease State Not Specified</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col id="tb17col1" align="left" charoff="0" char="" span="1"/><col id="tb17col2" align="char" charoff="0" char="." span="1"/><col id="tb17col3" align="char" charoff="0" char="." span="1"/><col id="tb17col4" align="char" charoff="0" char="." span="1"/></colgroup><thead valign="bottom"><tr><th align="center" rowspan="1" colspan="1">Author, Year, Country</th><th align="center" rowspan="1" colspan="1">Population</th><th align="center" rowspan="1" colspan="1">Design/Intervention</th><th align="center" rowspan="1" colspan="1">Outcomes</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Evans RL, 1976,<xref rid="i2168-9709-14-1-33-b153" ref-type="bibr">153</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 22</td><td rowspan="1" colspan="1">Retrospective chart review Medication history Conditions in outpatient specialty clinic</td><td rowspan="1" colspan="1">Completed an average of 5.4 visits per patient Increased dose (10 medications) Decreased dose (16 medications) Added medication (10 medications) Discontinued medication (15 medications)</td></tr><tr><td align="left" rowspan="1" colspan="1">Dugas JE, 1978,<xref rid="i2168-9709-14-1-33-b154" ref-type="bibr">154</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 66</td><td rowspan="1" colspan="1">Retrospective 2-year review Pharmacist-led medication management and lithium education</td><td rowspan="1" colspan="1">Observed nurse and pharmacist as co-therapists to be realistic, appropriate and effective Improved compliance and outcomes through providing medication at the time and place of healthcare appointments</td></tr><tr><td align="left" rowspan="1" colspan="1">Rosen CE, 1978,<xref rid="i2168-9709-14-1-33-b38" ref-type="bibr">38</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 281</td><td rowspan="1" colspan="1">Nonrandomized comparison study Pharmacist-provided medication management for outpatient psychiatry conditions</td><td rowspan="1" colspan="1">Increased average number of patients seen/month compared with psychiatrist (180 vs 101) Increased mean number of contacts/month (222 vs 118) Increased hours of direct care/month (87.29 vs 58.17)</td></tr><tr><td align="left" rowspan="1" colspan="1">Rosen CE, 1978,<xref rid="i2168-9709-14-1-33-b39" ref-type="bibr">39</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 304</td><td rowspan="1" colspan="1">Comparison study Pharmacist-provided medication monitoring for outpatient medication health conditions</td><td rowspan="1" colspan="1">Observed higher average number of unique patients compared with psychiatrist (194 vs 110) Increased number of contacts per patient (1.29 vs 1.15) Increased number of contacts (250 vs 127) Increased hours of direct care (100.17 vs 61.92)</td></tr><tr><td align="left" rowspan="1" colspan="1">Gray DR, 1979,<xref rid="i2168-9709-14-1-33-b41" ref-type="bibr">41</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 19</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist-provided medication management for outpatient psychiatric conditions</td><td rowspan="1" colspan="1">Reduced the total number of drugs, number and severity of adverse effects, and drug use problems</td></tr><tr><td align="left" rowspan="1" colspan="1">Dobbs JH, 1981,<xref rid="i2168-9709-14-1-33-b155" ref-type="bibr">155</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Retrospective, chart review Pharmacists compared pharmacists&#8217; drug histories compared with physicians&#8217; drug histories</td><td rowspan="1" colspan="1">Recorded information not previously recorded by physicians in 24/50 charts (48%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stimmel GL, 1982,<xref rid="i2168-9709-14-1-33-b156" ref-type="bibr">156</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 100</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist-provided medication management for outpatient psychiatric conditions</td><td rowspan="1" colspan="1">Failed to observe a difference in the appropriateness of prescribing for anticholinergics Improved mean scores for neuroleptics and antidepressants compared with physicians</td></tr><tr><td align="left" rowspan="1" colspan="1">Cardoni AA, 1983,<xref rid="i2168-9709-14-1-33-b42" ref-type="bibr">42</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 15</td><td rowspan="1" colspan="1">Retrospective analysis Pharmacist-provided care for outpatient psychiatric conditions</td><td rowspan="1" colspan="1">Decreased combination of psychotropics Increased use of fluphenazine decanoate Decreased number of psychotropics per patient on discharge compared with admission</td></tr><tr><td align="left" rowspan="1" colspan="1">Saklad SR, 1984,<xref rid="i2168-9709-14-1-33-b157" ref-type="bibr">157</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 31</td><td rowspan="1" colspan="1">Retrospective, pre/post Pharmacists implemented clinical pharmacy service in acute psychiatric setting</td><td rowspan="1" colspan="1">Recorded total drugs/patient (33.9%) Recorded number of antipsychotic drugs/patient (38%) Recorded number of anticholinergics/patient (53.2%) Recorded number of doses/patient/d (42.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ahrens TN, 1988,<xref rid="i2168-9709-14-1-33-b158" ref-type="bibr">158</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 385</td><td rowspan="1" colspan="1">Prospective Pharmacist based AIMS monitoring Chronic hospitalized psychiatric patients</td><td rowspan="1" colspan="1">Identified 77 patients meeting &#8220;probably TD&#8221; (20.1%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Wolf-Klein GP, 1989,<xref rid="i2168-9709-14-1-33-b159" ref-type="bibr">159</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 140</td><td rowspan="1" colspan="1">Retrospective study Pharmacist monitored compliance with weekly counseling sessions</td><td rowspan="1" colspan="1">Addressed medication was in an unacceptable form (28%) Addressed same drug prescribed by more than one physician in their community (78%) Addressed when patients did not understand the physician instructions (50%) Addressed patients&#8217; improper medication habits despite physician advice (85%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bransgrove LL, 1994,<xref rid="i2168-9709-14-1-33-b160" ref-type="bibr">160</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist based AIMS and EPS monitoring IM antipsychotics</td><td rowspan="1" colspan="1">Observed abnormal movements in 8 patients (16%) Observed higher frequency of EPS in the haloperidol IM group compared with the fluphenazine IM group</td></tr><tr><td align="left" rowspan="1" colspan="1">Dorevitch A, 1996,<xref rid="i2168-9709-14-1-33-b18" ref-type="bibr">18</xref> Israel</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 109</td><td rowspan="1" colspan="1">Prospective Pharmacist consults Inpatient psychiatry</td><td rowspan="1" colspan="1">Accepted recommendations (88.2%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Furniss L, 2000,<xref rid="i2168-9709-14-1-33-b161" ref-type="bibr">161</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 330</td><td rowspan="1" colspan="1">Prospective trial Pharmacist-led medication review</td><td rowspan="1" colspan="1">Reduced drugs prescribed Improved drug cost savings Reduced deaths during the intervention period (4 vs 14) Failed to show reduction in deaths in the overall study period (26 vs 28)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stoner SC, 2000,<xref rid="i2168-9709-14-1-33-b162" ref-type="bibr">162</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 83</td><td rowspan="1" colspan="1">Single-center Pharmacist based MSAS, AIMS, and Dyskinesia Identification System Condensed User Scale Antipsychotics</td><td rowspan="1" colspan="1">Proposed interventions in 130 patients (54%) Accepted interventions (80%) Showed positive clinical outcomes (90%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Canales PL, 2001,<xref rid="i2168-9709-14-1-33-b11" ref-type="bibr">11</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 93</td><td rowspan="1" colspan="1">Prospective Pharmacist consults Inpatient</td><td rowspan="1" colspan="1">Improved scores on the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in the intensive psychiatric pharmacy services group Improved HAM-D scores in the intensive psychiatric pharmacy services group (65%) Failed to show change in MMSE between groups</td></tr><tr><td align="left" rowspan="1" colspan="1">van Eijk ME, 2001,<xref rid="i2168-9709-14-1-33-b163" ref-type="bibr">163</xref> The Netherlands</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 190</td><td rowspan="1" colspan="1">Randomized, controlled Pharmacists participated in individual or group visits focusing on anticholinergic use vs control</td><td rowspan="1" colspan="1">Reduced highly anticholinergic medication use in individual intervention arm (26%; 95% CI = 4%, 48%) Reduced highly anticholinergic medication use in group intervention arm (45%; CI = 8%, 67%) Increased less anticholinergic agent use in individual intervention arm (40%; 95% CI = 6%, 83%) Increased less anticholinergic agent use in group intervention arm (29%; 95% CI = 7%, 79%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Brophy GM, 2002,<xref rid="i2168-9709-14-1-33-b164" ref-type="bibr">164</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 109</td><td rowspan="1" colspan="1">Randomized, double-blind Pharmacists administered phenytoin or placebo</td><td rowspan="1" colspan="1">Reduced average duration of phenytoin treatment (13.4 vs 7.6 days) Improved number of patients receiving prophylaxis for 7 days or less (35% vs 65%) Improved cost savings ($28 000)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bultman DC, 2002,<xref rid="i2168-9709-14-1-33-b27" ref-type="bibr">27</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 59</td><td rowspan="1" colspan="1">Prospective Community pharmacist monitored antidepressant therapy Antidepressants</td><td rowspan="1" colspan="1">Reported pharmacist asked about medication concerns (70%) Reported pharmacist encouraged patients (53%) Reported pharmacist listened to concerns (54%) Reported pharmacist was helpful in solving problems (32%) Reported feeling better (57%) Reported medication did not bother them (40%) Reported missing doses, adding doses, or stopping medication (83%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Adler DA, 2004,<xref rid="i2168-9709-14-1-33-b165" ref-type="bibr">165</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 507</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist-provided depression management</td><td rowspan="1" colspan="1">Observed pharmacist intervention to be equally effective in subgroups traditionally considered difficult to treat (chronic depression and dysthymia) Improved mBDI outcomes in patients taking antidepressants (&#8722;6.3-point change vs &#8722;2.8, <italic toggle="yes">P</italic> = .01) Improved the rates of antidepressant use in primary care patients</td></tr><tr><td align="left" rowspan="1" colspan="1">Rickles NM, 2005,<xref rid="i2168-9709-14-1-33-b28" ref-type="bibr">28</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 63</td><td rowspan="1" colspan="1">Randomized, controlled, unblinded, mixed experimental design 3 monthly telephone calls with pharmacist-guided education and monitoring vs usual care (education and monitoring)</td><td rowspan="1" colspan="1">Obtained significant and positive effect on patient feedback, knowledge, medication beliefs, and progress perceptions Reduced number of missed doses at 6 months</td></tr><tr><td align="left" rowspan="1" colspan="1">Crockett J, 2006,<xref rid="i2168-9709-14-1-33-b166" ref-type="bibr">166</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 106</td><td rowspan="1" colspan="1">Parallel group, controlled Community pharmacist-managed depression</td><td rowspan="1" colspan="1">Failed to show significant change in attitude to drug treatment Maintained adherence rates compared with usual care (95% vs 96%) Improved K10 score (4 vs 4.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Caballero J, 2008,<xref rid="i2168-9709-14-1-33-b167" ref-type="bibr">167</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 125</td><td rowspan="1" colspan="1">Chart review Pharmacist consults</td><td rowspan="1" colspan="1">Achieved high rate of accepted recommendations (90%) Decreased HAM-A and HAM-D scores (52% and 56%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Patterson SM, 2010,<xref rid="i2168-9709-14-1-33-b168" ref-type="bibr">168</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 334</td><td rowspan="1" colspan="1">Randomized, controlled Pharmacists reviewed clinical and prescribing information and consulted providers versus usual care</td><td rowspan="1" colspan="1">Reduced inappropriate psychoactive prescriptions at 12 months (20% vs 50%) Observed no change in fall rate</td></tr><tr><td align="left" rowspan="1" colspan="1">Davis TD, 2011,<xref rid="i2168-9709-14-1-33-b169" ref-type="bibr">169</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 360</td><td rowspan="1" colspan="1">Randomized Pharmacists participated in collaborative care telehealth clinic</td><td rowspan="1" colspan="1">Improved response rates in minorities vs Caucasians in the intervention vs usual care group (&#967;&#178; = 8.2 <italic toggle="yes">P</italic> = .004; OR 6.2, <italic toggle="yes">P</italic> = .009)</td></tr><tr><td align="left" rowspan="1" colspan="1">Lizer MH, 2011,<xref rid="i2168-9709-14-1-33-b170" ref-type="bibr">170</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 20</td><td rowspan="1" colspan="1">Prospective, controlled, nonrandomized, single-center, pre/post Pharmacist-provided patient management</td><td rowspan="1" colspan="1">Failed to show change in adherence measures from baseline to 6 months Improved scores in the World Health Organization QOL Brief Version and physical and psychological health domains</td></tr><tr><td align="left" rowspan="1" colspan="1">Swain LD, 2012,<xref rid="i2168-9709-14-1-33-b30" ref-type="bibr">30</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 56</td><td rowspan="1" colspan="1">Prospective, case series Pharmacist medication reconciliation Outpatient, general</td><td rowspan="1" colspan="1">Performed 192 recommendations Recommended to discontinue a medication (29%) Recommended to add a medication (24%) Recommended to change a dose (23%) Recommended therapeutic substitutions (20%) Recommended therapeutic monitoring (4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bruhn H, 2013,<xref rid="i2168-9709-14-1-33-b171" ref-type="bibr">171</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 232</td><td rowspan="1" colspan="1">Prospective, randomized, controlled, comparison group Pharmacists completed medication review and prescribing vs review and making recommendations</td><td rowspan="1" colspan="1">Improved depression scores in patients with chronic pain in intervention groups (<italic toggle="yes">P</italic> = .022) Improved anxiety scores in patients with chronic pain in intervention groups (<italic toggle="yes">P</italic> = .007)</td></tr><tr><td align="left" rowspan="1" colspan="1">Kersten H, 2013,<xref rid="i2168-9709-14-1-33-b172" ref-type="bibr">172</xref> Norway</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 87</td><td rowspan="1" colspan="1">Randomized, controlled, single-blinded trial Pharmacist-initiated reduction of anticholinergic drug scale score after multidisciplinary drug reviews</td><td rowspan="1" colspan="1">Reduced median ADS score by 2 units in the intervention group (<italic toggle="yes">P</italic> &lt; .0001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Cobb CD, 2014,<xref rid="i2168-9709-14-1-33-b33" ref-type="bibr">33</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 154</td><td rowspan="1" colspan="1">Retrospective, open, nonrandomized, single-group Pharmacist-provided comprehensive medication management General outpatient medical conditions</td><td rowspan="1" colspan="1">Saved an average of $586.55/patient ($90 484; ROI 2.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Schneiderhan ME, 2014,<xref rid="i2168-9709-14-1-33-b173" ref-type="bibr">173</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 120</td><td rowspan="1" colspan="1">Prospective, multisite, controlled, comparison group, randomized trial Pharmacist-led point of care testing for metabolic syndrome in patients prescribed antipsychotics</td><td rowspan="1" colspan="1">Failed to show improvement in metabolic syndrome, abdominal obesity, dyslipidemia, hypertension, and diabetes at 12 months</td></tr><tr><td align="left" rowspan="1" colspan="1">Dhital R, 2015,<xref rid="i2168-9709-14-1-33-b174" ref-type="bibr">174</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 326</td><td rowspan="1" colspan="1">Parallel group, multicenter, randomized, blinded, controlled Community pharmacist-driven brief intervention on alcohol use</td><td rowspan="1" colspan="1">Failed to show difference in AUDIT scores (&#8722;0.57, <italic toggle="yes">P</italic> = .28) Failed to reduce participants meeting criteria for hazardous or harmful drinking (OR 0.87, <italic toggle="yes">P</italic> = .61)</td></tr><tr><td align="left" rowspan="1" colspan="1">DiPaula BA, 2015,<xref rid="i2168-9709-14-1-33-b175" ref-type="bibr">175</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 12</td><td rowspan="1" colspan="1">Retrospective Pharmacist-led buprenorphine in outpatient psychiatric clinics</td><td rowspan="1" colspan="1">Observed high attendance rate (91%) Observed low diversion rate via urine toxicology screens positive for buprenorphine (98%) Observed low diversion rate via urine toxicology screens positive for buprenorphine and negative for opioids (88%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Paquin AM, 2015,<xref rid="i2168-9709-14-1-33-b44" ref-type="bibr">44</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 501</td><td rowspan="1" colspan="1">Retrospective, secondary data analysis Pharmacists conducted phone calls to older adults after discharge</td><td rowspan="1" colspan="1">Reduced hospital readmission rates in intervention group vs comparison group 1 vs comparison group 2 (25% vs 37.1% vs 34%, respectively)</td></tr><tr><td align="left" rowspan="1" colspan="1">Phimarn W, 2015,<xref rid="i2168-9709-14-1-33-b176" ref-type="bibr">176</xref> Thailand</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 68</td><td rowspan="1" colspan="1">Cross-sectional Community-pharmacist provided depression counseling to students</td><td rowspan="1" colspan="1">Improved CES-D scores for both group and individual counseling (<italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Doyle D, 2016,<xref rid="i2168-9709-14-1-33-b177" ref-type="bibr">177</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 502</td><td rowspan="1" colspan="1">Multicenter Pharmacist consults and interventions Primary care disease states</td><td rowspan="1" colspan="1">Reduced total medications across all sites combined (5.5%) Reduced Beers list medications across all sites combined (14.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Kanwal F, 2016,<xref rid="i2168-9709-14-1-33-b178" ref-type="bibr">178</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 263</td><td rowspan="1" colspan="1">Prospective, randomized, controlled effectiveness trial Pharmacist-provided depression management in patients with HIV</td><td rowspan="1" colspan="1">Increased self-report of treatment response in intervention group vs usual care (19% vs 13%) Increased self-report of remission (12% vs 6%) Showed no difference in total number of depression-free days in intervention vs usual care (50.9 vs 50.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">Parikh M, 2016,<xref rid="i2168-9709-14-1-33-b179" ref-type="bibr">179</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 114</td><td rowspan="1" colspan="1">Retrospective review Pharmacist-provided medication management for outpatient psychiatric conditions in primary care</td><td rowspan="1" colspan="1">Increased number of patients who reached therapeutic goal (60%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Louzon P, 2017,<xref rid="i2168-9709-14-1-33-b47" ref-type="bibr">47</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 1005</td><td rowspan="1" colspan="1">Phase 2 study Pharmacist directed sedation Inpatient, academic center</td><td rowspan="1" colspan="1">Reduced hours of patient exposure to continuous sedation Reduced continuous infusions of sedatives (46%) Reduced ICU and total hospital length of stay</td></tr><tr><td align="left" rowspan="1" colspan="1">Moga DC, 2017,<xref rid="i2168-9709-14-1-33-b180" ref-type="bibr">180</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Parallel-arm, randomized control trial Pharmacist-provided medication therapy management</td><td rowspan="1" colspan="1">Improved scores in medication appropriateness index in intervention vs control (change of 3.6 [1.1] vs change of 1.0 [0.9], <italic toggle="yes">P</italic> = .04)</td></tr><tr><td align="left" rowspan="1" colspan="1">Pardo D, 2017,<xref rid="i2168-9709-14-1-33-b181" ref-type="bibr">181</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 168</td><td rowspan="1" colspan="1">Single-center, pre/post intervention, retrospective chart review Pharmacist prior authorization consults for co-prescribing opioids and benzodiazepines Inpatient, VA</td><td rowspan="1" colspan="1">Achieved approval of 136 out of 168 consults (80.1%) Reduced co-prescribing (34.6%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Badr AF, 2018,<xref rid="i2168-9709-14-1-33-b182" ref-type="bibr">182</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 197</td><td rowspan="1" colspan="1">Biphasic, pre/post Pharmacist medication recommendations</td><td rowspan="1" colspan="1">Reduced prescribing of sedative/hypnotic orders in 97 patients (25%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bingham J, 2018,<xref rid="i2168-9709-14-1-33-b183" ref-type="bibr">183</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 20</td><td rowspan="1" colspan="1">Pilot study Pharmacist-delivered risk assessment Conditions managed in outpatient specialty clinic</td><td rowspan="1" colspan="1">Increased Duke physical scores at follow-up Reduced anxiety, depression, and anxiety-depression scores at follow-up</td></tr><tr><td align="left" rowspan="1" colspan="1">Gibu M, 2018,<xref rid="i2168-9709-14-1-33-b184" ref-type="bibr">184</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 81</td><td rowspan="1" colspan="1">Retrospective, open, nonrandomized, pre/post cohort Pharmacist-provided outpatient psychiatric medication management</td><td rowspan="1" colspan="1">Performed 152 interventions Reduced average encounters in psychiatric emergency services (300/month to 237/month, <italic toggle="yes">P</italic> = .041)</td></tr><tr><td align="left" rowspan="1" colspan="1">McMillan SS, 2018,<xref rid="i2168-9709-14-1-33-b34" ref-type="bibr">34</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 295</td><td rowspan="1" colspan="1">Prospective, pre/post comparison Community pharmacist-led medication support program</td><td rowspan="1" colspan="1">Improved perceptions of illness (<italic toggle="yes">P</italic> &lt; .002) Improved mental health domain of QOL (<italic toggle="yes">P</italic> &lt; .001) Improved concerns about medication (<italic toggle="yes">P</italic> = .001) Improved global satisfaction with medication (<italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mooney EV, 2018,<xref rid="i2168-9709-14-1-33-b185" ref-type="bibr">185</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 104</td><td rowspan="1" colspan="1">Prospective Community pharmacist-administered long-acting injectable medications Antipsychotics</td><td rowspan="1" colspan="1">Patient reported: Satisfied with level of privacy (98%) Liked convenience of scheduling an appointment (86%) Trusted the pharmacist to administer the medication (96%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chavez B, 2019,<xref rid="i2168-9709-14-1-33-b186" ref-type="bibr">186</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 248</td><td rowspan="1" colspan="1">Retrospective Pharmacist consultation Depression BZD, antidepressants, mood stabilizers</td><td rowspan="1" colspan="1">Improved treatment rates for individuals with depression Decreased benzodiazepine use Increased use of SSRIs and mood stabilizers</td></tr><tr><td align="left" rowspan="1" colspan="1">Heins K, 2019,<xref rid="i2168-9709-14-1-33-b187" ref-type="bibr">187</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 110</td><td rowspan="1" colspan="1">Community pharmacist-provided CMM for clinic patients</td><td rowspan="1" colspan="1">Increased enrollment (23% to 69%) Increased number of patients prescribed clozapine (78 to 100) Increased duration of therapy (267.4 to 598.7 days)</td></tr><tr><td align="left" rowspan="1" colspan="1">Maryan S, 2019,<xref rid="i2168-9709-14-1-33-b188" ref-type="bibr">188</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 22</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist-provided clozapine therapy management with psychiatrist in patients with schizophrenia</td><td rowspan="1" colspan="1">Decreased number of antipsychotics in pre-pharmacist to post-pharmacist analysis (&#8722;0.27 + 0.65) Decreased number of psychotropics (&#8722;0.18 + 0.41) Decreased HBA<sub>1C</sub> (&#8722;0.04% + 0.25%) Decreased clozapine dose (&#8722;7.96 + 19.58 mg) Decreased total cholesterol (&#8722;15.73 + 42.31 mg/dL)</td></tr><tr><td align="left" rowspan="1" colspan="1">Shilpa HSS, 2019,<xref rid="i2168-9709-14-1-33-b189" ref-type="bibr">189</xref> India</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 109</td><td rowspan="1" colspan="1">Prospective interventional study Clinical pharmacist-initiated interventions on deprescribing due to inappropriate BZD and Z-drug use</td><td rowspan="1" colspan="1">Deprescribed or discontinued BZDs (30.69%) Reduced cost after deprescribing BZDs, (Z = 5.465, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stuhec M, 2019,<xref rid="i2168-9709-14-1-33-b190" ref-type="bibr">190</xref> Slovenia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 24</td><td rowspan="1" colspan="1">Prospective, open, pre/post comparison, nonrandomized, single-site study Pharmacist-led interventions on QOL in nursing home patients</td><td rowspan="1" colspan="1">Reduced mean number of medications per patient (12.2 vs 10.3 (<italic toggle="yes">P</italic> &lt; .05) Reduced the number of potentially inappropriate medications and drug&#8211;drug interactions Improved QOL improved on the EQ-5D VAS (<italic toggle="yes">P</italic> &lt; .05)</td></tr><tr><td align="left" rowspan="1" colspan="1">Raynsford J, 2020,<xref rid="i2168-9709-14-1-33-b191" ref-type="bibr">191</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 66</td><td rowspan="1" colspan="1">Chart review Medication intervention for general practice surgeries</td><td rowspan="1" colspan="1">Performed interventions (104) Clarified discharge information (12/104) Reviewed high-dose and multiple antipsychotic deprescribing (18/104) Corrected errors (10/104) Investigated adherence issues (16/104) Followed up with missing health checks (22/104) Answered queries from surgery staff (23/104)</td></tr><tr><td align="left" rowspan="1" colspan="1">Watkins VA, 2020,<xref rid="i2168-9709-14-1-33-b192" ref-type="bibr">192</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 42</td><td rowspan="1" colspan="1">Retrospective Community pharmacist driven health coaching program</td><td rowspan="1" colspan="1">Reduced number of prescriptions per patient (7.2 to 6.2; <italic toggle="yes">P</italic> = .02) Improved blood pressure (systolic 130.8 to 125.7 mmHg; <italic toggle="yes">P</italic> = .04 and diastolic 76.9 to 73.7 mmHg; <italic toggle="yes">P</italic> = .04)</td></tr><tr><td align="left" rowspan="1" colspan="1">Ahmed S, 2021,<xref rid="i2168-9709-14-1-33-b193" ref-type="bibr">193</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 46</td><td rowspan="1" colspan="1">Retrospective cohort analysis Pharmacist-provided pharmacogenomics profiling Patients with a mental health&#8211;related disability</td><td rowspan="1" colspan="1">Improved medication effectiveness scores before and after prescription changes (8.39 [SD = 1.22] to 2.30 [SD = 1.01]; <italic toggle="yes">P</italic> &#8804; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Butala N, 2021,<xref rid="i2168-9709-14-1-33-b194" ref-type="bibr">194</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 390</td><td rowspan="1" colspan="1">Prospective quality improvement study Psychiatric pharmacist-driven TD screening service</td><td rowspan="1" colspan="1">Increased number of AIMS screenings attempted for high-risk individuals (85.1%) with 46 patients (61.3%) completed</td></tr><tr><td align="left" rowspan="1" colspan="1">Hefazi E, 2021,<xref rid="i2168-9709-14-1-33-b195" ref-type="bibr">195</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 151</td><td rowspan="1" colspan="1">Retrospective review Pharmacist-driven discharge medication reconciliation</td><td rowspan="1" colspan="1">Observed greater mean number of discrepancies in patients with at least 1 psychotropic medication at discharge (<italic toggle="yes">P</italic> &lt; .001) Observed greater number of pharmacist interventions in patients who had at least 1 psychotropic medication upon discharge (<italic toggle="yes">P</italic> = .005) Failed to show change in 30-day readmission rates</td></tr><tr><td align="left" rowspan="1" colspan="1">Lowrie R, 2021,<xref rid="i2168-9709-14-1-33-b196" ref-type="bibr">196</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 24</td><td rowspan="1" colspan="1">Retrospective Pharmacist-led homeless outreach engagement nonmedical independent prescribing perscriptions</td><td rowspan="1" colspan="1">Failed to show a difference in ED visits (92% in both groups) Failed to show reduction in hospitalizations in intervention vs control (92% vs 75%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Margulis A, 2021,<xref rid="i2168-9709-14-1-33-b197" ref-type="bibr">197</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 111</td><td rowspan="1" colspan="1">Retrospective, open, pre/post comparison, single-center, nonrandomized study Pharmacist involvement (none, partial, and consistent) in reviewing antiretroviral medications in psychiatric hospital</td><td rowspan="1" colspan="1">Increased number of appropriate ARV regimens initiated in partial pharmacist involvement compared to no pharmacist (62% vs 32%; <italic toggle="yes">P</italic> = .01) Increased number of appropriate ARV regimens in consistent pharmacist involvement compared to partial pharmacist involvement (84% vs 62%; <italic toggle="yes">P</italic> = .036) Improved appropriate prophylaxis initiated in consistent pharmacist involvement vs partial vs no involvement (57% vs 50% vs 11%, respectively)</td></tr><tr><td align="left" rowspan="1" colspan="1">Papastergiou J, 2021,<xref rid="i2168-9709-14-1-33-b24" ref-type="bibr">24</xref> Canada</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 213</td><td rowspan="1" colspan="1">Prospective, single-blind, randomized, controlled Community pharmacist-provided depression treatment</td><td rowspan="1" colspan="1">Improved depression, generalized anxiety and disability measures Improved treatment satisfaction</td></tr><tr><td align="left" rowspan="1" colspan="1">Sahr M, 2021,<xref rid="i2168-9709-14-1-33-b198" ref-type="bibr">198</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 24</td><td rowspan="1" colspan="1">Pilot study Pharmacist-provided tobacco cessation</td><td rowspan="1" colspan="1">Self-reported vape-free and nicotine-free at 12 weeks in the NRT + behavioral support arm vs vape-taper + behavioral support arm vs self-guided arm (42.9% vs 75% vs 77.8%) Self-reported vape-free and nicotine-free at 6 months in the NRT + behavioral support arm vs vape-taper + behavioral support arm + self-guided arm (42.9% vs 75% vs 44.4%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Stuhec M, 2021,<xref rid="i2168-9709-14-1-33-b199" ref-type="bibr">199</xref> Slovenia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 224</td><td rowspan="1" colspan="1">Retrospective, observational, pre/post comparison Pharmacist-provided recommendations as a part of an interdisciplinary medical team</td><td rowspan="1" colspan="1">Performed 315 recommendations for 224 patients Accepted recommendations (93.7%) Decreased drug-related problems (93.8%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Accomando M, 2022,<xref rid="i2168-9709-14-1-33-b200" ref-type="bibr">200</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 139</td><td rowspan="1" colspan="1">Retrospective review Pharmacist vs non-pharmacist identified discrepancies completing medication reconciliation</td><td rowspan="1" colspan="1">Identified discrepancies (298) with no longer taking and omission being most common (33% and 32%, respectively)</td></tr><tr><td align="left" rowspan="1" colspan="1">Bawazeer G, 2022,<xref rid="i2168-9709-14-1-33-b201" ref-type="bibr">201</xref> Saudi Arabia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 80</td><td rowspan="1" colspan="1">Nonrandomized, controlled study Pharmacist-led deprescribing inappropriate medications for elderly patients</td><td rowspan="1" colspan="1">Observed patient acceptance with deprescribing was the lowest with tricyclic antidepressants (50%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Chulasai P, 2022,<xref rid="i2168-9709-14-1-33-b202" ref-type="bibr">202</xref> Thailand</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 273</td><td rowspan="1" colspan="1">Open, parallel-group, randomized, clinical Community pharmacist-provided smoking cessation counseling and Quit with US intervention</td><td rowspan="1" colspan="1">Improved smoking abstinence (58.4% vs 30.9%, <italic toggle="yes">P</italic> &lt; .001)</td></tr><tr><td align="left" rowspan="1" colspan="1">Farag M, 2022,<xref rid="i2168-9709-14-1-33-b203" ref-type="bibr">203</xref> Australia</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 134</td><td rowspan="1" colspan="1">Retrospective, cohort Pharmacist vs no pharmacist at Mental Health Hospital in the Home programs</td><td rowspan="1" colspan="1">Increased medication reconciliation completion (87% vs 29%) Increased accurate adverse drug reaction list (97% vs 58%) Increased accurate discharge medication list (74% vs 45%) Increased accurate medication profile (99% vs 68%) Increased medication chart review (99% vs 0%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Light J, 2022,<xref rid="i2168-9709-14-1-33-b204" ref-type="bibr">204</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 412</td><td rowspan="1" colspan="1">Retrospective, cross-sectional study Pharmacist-led medication reconciliation</td><td rowspan="1" colspan="1">Decreased likelihood of patient visiting outpatient comprehensive psychiatric emergency program within 30-days (<italic toggle="yes">P</italic> = .012) Decreased odds of psychiatric relapse within 30 days by 1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">McDuffie AC, 2022,<xref rid="i2168-9709-14-1-33-b205" ref-type="bibr">205</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 50</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist-provided tobacco cessation counseling</td><td rowspan="1" colspan="1">Increased 30-day point prevalence abstinence in pharmacist group compared with PCP group (22.2% vs 9.4%, <italic toggle="yes">P</italic> = .23) Increased patient satisfaction regarding discussion of medications used to quit smoking (100% vs 65.6%, <italic toggle="yes">P</italic> = .004)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mertens V, 2022,<xref rid="i2168-9709-14-1-33-b206" ref-type="bibr">206</xref> Belgium</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 37</td><td rowspan="1" colspan="1">Prospective, unblinded Clinical pharmacist completed comprehensive geriatric assessment, including abbreviated MMSE, GDS-4 for depression, and systemic check for STOPP/START criteria</td><td rowspan="1" colspan="1">Formulated average of 7.7 recommendations to optimize medication use per patient</td></tr><tr><td align="left" rowspan="1" colspan="1">Oliveira J, 2022,<xref rid="i2168-9709-14-1-33-b207" ref-type="bibr">207</xref> Portugal</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 148</td><td rowspan="1" colspan="1">2-stage observation study Pharmacist-led medication reconciliation</td><td rowspan="1" colspan="1">Identified 560 clinically sound intentional discrepancies with 95 mild, 100 moderate, and 29 severe medication errors</td></tr><tr><td align="left" rowspan="1" colspan="1">Pals H, 2022,<xref rid="i2168-9709-14-1-33-b208" ref-type="bibr">208</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 60</td><td rowspan="1" colspan="1">Retrospective chart review Pharmacist-led buprenorphine management for opioid use disorder</td><td rowspan="1" colspan="1">Provided care to 28/60 patients Achieved same-day induction for most patients requesting urgent access</td></tr><tr><td align="left" rowspan="1" colspan="1">Sacarny A, 2022,<xref rid="i2168-9709-14-1-33-b209" ref-type="bibr">209</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 2237</td><td rowspan="1" colspan="1">Randomized control trial Pharmacist initiated email alert to practitioners with patients recently prescribed opioids and BZDs</td><td rowspan="1" colspan="1">Failed to detect a difference in patients&#8217; receipt of opioids (adjusted difference 1.1 days, <italic toggle="yes">P</italic> = .81) Failed to detect a difference in patients&#8217; receipt of BZDs (adjusted difference &#8722;0.6 days, <italic toggle="yes">P</italic> = .30) Failed to detect a difference in patients&#8217; receipt of opioids and BZDs together (adjusted difference &#8722;0.1 days, <italic toggle="yes">P</italic> = .41)</td></tr><tr><td align="left" rowspan="1" colspan="1">Steel A, 2022,<xref rid="i2168-9709-14-1-33-b210" ref-type="bibr">210</xref> United Kingdom</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 34</td><td rowspan="1" colspan="1">Multidisciplinary residential home quality improvement project Multidisciplinary team, including pharmacist to provide comprehensive geriatric assessment and mental health review</td><td rowspan="1" colspan="1">Reduced admissions for those reviewed and a reduction in overall admission costs (75%) Reduced polypharmacy by an average of 2 medications per resident across the 3 sites Increased cardiopulmonary resuscitation decisions (63%) Increased advance care planning discussions (76%)</td></tr><tr><td align="left" rowspan="1" colspan="1">Vaillancourt R, 2022,<xref rid="i2168-9709-14-1-33-b211" ref-type="bibr">211</xref> US</td><td rowspan="1" colspan="1"><italic toggle="yes">N</italic> = 38</td><td rowspan="1" colspan="1">Retrospective review Medication review of patients interested in using, or already using, medical cannabis when prescribed for insomnia or comorbid conditions</td><td rowspan="1" colspan="1">Reduced or discontinued prescription medications for sleep (39%) Self-reported improvement in sleep or related condition (71%) Self-reported adverse effects from medical cannabis use (21%)</td></tr></tbody></table><table-wrap-foot><fn><p>ADS = Anxiety and Depression Scale; AIMS = Abnormal Involuntary Movement Scale; ARV = antiretroviral; AUDIT = Alcohol Use Disorders Identification Test; BZD = benzodiazepine; CES-D = Center for Epidemiologic Studies Depression Scale; CMM = comprehensive medication management; ED = emergency department; EPS = extrapyramidal symptoms; EQ-5D VAS = EQ visual analog scale; GDS-4 = Geriatric Depression Scale; HAM-D = Hamilton Depression Rating Scale; HbA<sub>1c</sub> = hemoglobin A<sub>1c</sub>; ICU = intensive care unit; IM = intramuscular; mBDI = modified Beck Depression Inventory; MH = mental health; MMSE = Mini-Mental State Examination; MSAS = Modified Simpson-Angus Scale; NRT = nicotine replacement therapy; OR = odds ratio; PCP = primary care physician; QOL = quality of life; ROI = return on investment; SSRIs = selective serotonin reuptake inhibitors; STOPP/START = Screening Tool of Older Persons&#8217; Prescriptions/Screening Tool to Alert to Right Treatment; TD = tardive dyskinesia; US = United States; VA = Veterans Affairs.</p></fn></table-wrap-foot></table-wrap></app></app-group></back></article></pmc-articleset>